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Around a third of people with diabetes will develop a foot ulcer requiring specialist podiatry 
treatment during their lifetime. The formation of a foot ulcer for people with diabetes is a 
consequence of chronic hyperglycaemia, which causes poor wound healing and damage to 
nerves and blood vessels. This study has two aims. The first was to describe wound healing 
trajectories from baseline (Day 0), to wound closure, for wounds that had healed within six 
months. Our hypothesis was that a clinical marker exists, such as a certain time point along the 
wound healing trajectory, which is associated with subsequent rapid healing. The second aim 
was to understand patient perceptions associated with wound images and how discussion about 
images might optimise self-care, as few studies have explored this aspect of clinical care. 
Images undertaken as part of routine clinical care, enables patients to visualise their foot ulcers, 
maybe for the first time. Both patient and podiatrist can jointly view the current foot ulcer image 
on a computer screen and compare this with an earlier electronic image, to gauge wound healing 
progression. These images thus have the potential to provide a communication medium for 
facilitating patient self-management discussions. 
Methods 
This study consisted of two parts. Part 1 included an exploratory retrospective analysis of 
wound healing as measured by surface area metrics, from 103 individual patients who had 
attended the high-risk foot ulcer clinic over the previous three years. 
Part 2 focused on descriptive qualitative research of semi-structured interviews of patients 
attending the high-risk foot ulcer clinic, studying their perceptions of wound imaging, including 
clinical utility, during routine clinic appointments. Interviews were audio-recorded and 
transcribed, thereby allowing thematic analysis of participant responses and identification of 
themes. 
Results and findings 
Part 1 results determined wound healing trajectories for the 103 individual patient wounds, 
showed no identifiable time point, after which there would be no deterioration in wound 
healing. A greater than 50% reduction in wound surface area at four weeks has previously been 
described as a marker of wound healing success, however only 61.2% of healed wounds in this 
study met this parameter.  
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Analysis of 31 patient interviews for Part 2 described participants’ positive reactions to being 
able to visualise and discuss their wound images. This visualisation and discussion led to 
valuable insights and enhanced understanding of clinical aspects of wound healing. Patient 
engagement increased with the self-care advice around wound healing, provided by the 
podiatrists and other specialist clinicians. Patients also considered that these discussions 
positively impacted on their health literacy.  
Conclusion 
The study showed that sharing and discussing wound images helps advance patient education 
and understanding. In doing so, the patient can feel more included in their care and more likely 
to participate in self-care. The study also shows that real-world wound healing trajectories do 
not provide the podiatrist or patient with certainty around length of time needed to complete 
wound healing, thus it can be difficult to answer the patient’s question “when will my wound 
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Chronic wound  
Wounds that fail to proceed through the normal phases of wound healing in an orderly and 
timely manner (Frykberg & Banks, 2015, p. 561) 
Concordance  
Emphasises a therapeutic relationship between clinician and patient, where each other’s 
perspective is taken into account, and supports informed treatment choices (Chakrabarti, 2014, 
p. 31). 
Diabetic peripheral neuropathy 
The presence and/or signs of peripheral nerve dysfunction in people with diabetes after the 
exclusion of other causes (Hicks & Selvin, 2019, p. 2). 
Digital planimetry 
The method of wound surface area measurement through tracing over the wound onto an acetate 
material and then transferring the tracing onto computer aided software for digital measurement 
using a planimetric tablet (Foltynski et al., 2015, p. 2). 
Endogenous 
Produced internally in the body, for example, insulin is produced in the pancreas by the beta 
cells. 
Exogenous 
Produced outside of the person’s own body, for example, insulin can be made synthetically and 
is injected subcutaneously either through an injection or a continuous basal delivery device 
known as an insulin pump. 
Peripheral arterial disease (PAD) 
A chronic disease due to the build-up of plaque (atherosclerosis) in the large arteries limiting 
blood flow to arteries and blood vessels (Brown, 2019). In this research PAD relates to a macro-





Peripheral vascular disease (PVD) 
Peripheral vascular disease occurs when the peripheral blood vessels become occluded due to 
the increased viscosity of the blood caused by hyperglycaemia. In this research, PVD relates to 
micro-vascular complications of diabetes where the small vessels and capillaries are affected 
(Cade, 2008). 
Planimetry 
The measurement of perimeters and surface area through tracing the wound boundary to 
evaluate size (Farlex Partner Medical Dictionary, 2012). 
Sequential explanatory design 
A mixed methods research design that relates to the collection and analysing of two consecutive 
data sets, the quantitative followed by the qualitative. These results and findings are then 
integrated and reported in the discussion (Ivankova, Creswell, & Stick, 2006).   
Stereophotogrammetry 
Uses 3D coordinates of points on an object to estimate measurements between two or more 
images taken from different positions (Capitán, Simon, & Capitán-Cañadas, 2019). 
Wound healing definition 
Defined by the United States Food and Drug administration as: “100% re-epithelialisation of 
wound surface with no discernible exudate and without drainage or dressing, confirmed at two 











In Aotearoa New Zealand, the Ministry of Health, in 2018 estimated that 253 000 people had 
diabetes. This number equates to 5.4% of the total population (Ministry of Health, 2019b; 
Statistics New Zealand, 2019). Most people with diabetes (PwD) have type 2 diabetes, which 
typically comes on in midlife or later. The second most common diabetes diagnosis is type 1 
diabetes (previously called insulin dependent diabetes or juvenile onset diabetes). Type 1 
diabetes often presents in childhood or early adulthood, hence its old name of juvenile onset 
diabetes.  
People with diabetes are at increased risk of developing foot ulcers. The estimated lifetime risk 
of developing an ulcer may be as high as 34% (Armstrong, Boulton, & Bus, 2017). Also, 
diabetes is associated with poor wound healing, which is related to hyperglycaemia. Most 
people with diabetic foot ulcers (DFU) have evidence of underlying nerve damage (peripheral 
neuropathy) affecting the feet and, or damage to the arterial sufficiency of the foot (peripheral 
vascular disease). The progression of this underlying damage can be gradual, insidious, and at 
least initially, is usually asymptomatic. People with type 1 diabetes have a long lifetime 
exposure to high glucose levels, with longstanding survivors of type 1 diabetes having a very 
high incidence of diabetic peripheral neuropathy (DPN) (Hicks & Selvin, 2019). People with 
type 2 diabetes (T2DM) have a 50% risk of developing DPN (Boulton, 2020; Iqbal et al., 2018; 
Schaper et al., 2019). 
Due to the increased risk of PwD developing a DFU, determining an optimal treatment plan for 
DFU is very important. Slow rates of wound healing may indicate a suboptimal treatment plan. 
One of the Wound Healing Society (WHS) guidelines states that “patients who fail to show a 
reduction in ulcer size by 50% or more after four weeks of therapy should be re-evaluated and 
other treatments should be considered” (Lavery et al., 2016, p. 120). Measuring wound healing, 
ideally, in an objective way through assessment of a wound healing trajectory, is therefore an 
integral part of the management of a DFU. The wound healing trajectory is assessed using serial 
measures of wound surface area (cm2) over time. 
Through the use of retrospective analyses of wound surface area measurements, this exploratory 
real-world retrospective research will assess if wound healing trajectories appear predictable. 
If healing rates are indeed as predictable as the research literature would suggest, this would 
help inform clinicians caring for people with a DFU, to frame patient expectations, around the 
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likelihood of healing within a given time period. This in turn would enhance patient centred 
care, especially if patients felt a sense of involvement in their own DFU healing. To undertake 
this research, information was derived from patients attending a high-risk diabetic foot ulcer 
clinic within secondary level district health board care. This quantitative research will be 
reported and analysed separately to the qualitative research and will be referred to as Part 1. 
Part 2 incorporates the second aim which fulfils the qualitative aspect of this research. Using 
semi-structured interviews, patients from the high-risk foot ulcer clinic will give their 
perspective of wound imaging technology used within routine podiatry visits to promote 
education, communication, and person-centred care. Also, information was needed about 
patient perceptions of healing of their DFU. By combining Part 1 and Part 2 of this research, it 
will show how patient centred clinical care can be enhanced through patient-clinician 
communication. 
Background and Need 
This chapter will provide a broad overview of the pathophysiology of both type 1 diabetes 
mellitus and type 2 diabetes mellitus, including macrovascular and microvascular system 
implications. This will lead to the progression of diabetes being associated with diabetic foot 
ulcers. Though this research is solely about PwD and DFU, it is important to maintain the 
person’s individual identity and not label them as their diagnosis, through avoiding use of the 
noun “diabetic”. Diabetes is one part of their whole person, akin to hair colour, or handedness.  
The purpose of this study is to develop greater clinical insights into how diabetic foot ulcer 
electronic measurements might be used to enhance our clinical understanding of wound healing. 
This will be done using the following two approaches. Firstly, it will utilise quantitative data 
collection and analyses of DFU healed at six months to describe wound healing trajectories in 
a sub population of patients with intermediate healing times, in between those of fast healers 
and chronic delayed healers. The second approach will employ a qualitative methodology to 
address if the sharing of electronic wound images with patients promotes understanding and 
self-management. This research will assess the utility of wound imaging technology utilised 
within these real-world clinic visits to promote education, communication, and person-centred 
care from the patient’s perspective. The structure of this thesis will also be discussed within this 




Part 1: Exploratory retrospective analysis of wound measurements 
Wound Healing 
Wound healing is often assessed and assumed to be effective if signs of healing, such as wound 
area reduction, is seen at twenty-eight days (Santamaria, Ogce, & Gorelik, 2012). This interim 
measurement of success is often used within pharmaceutical wound healing trials looking 
specifically at wound healing products, with one study finding a “different reality” in the 
reporting of wound healing in pharmaceutical trial wound healing rates, due to an exclusion 
bias towards patients with chronic medical conditions and multiple comorbidities (Fife, Eckert, 
& Carter, 2018, p. 79). Wounds in these trials are often superficial (that is, not deep) and small, 
with the patient’s overall health not affected by other chronic illnesses. This same research also 
informs us about the importance of measuring wound healing in the financially competitive 
health care delivery setting in the United States of America (USA) whose wound healing 
success reports are available in a public forum. The appearance of being a highly effective 
clinical organisation in a financial bonus-led system, can result in embellished reports of 
success (Fife et al., 2018). Fife et al. (2018) postulates that a practice reporting a 92% wound 
healing success would be more believable if their success was in fact nearer to 40% (Fife et al., 
2018). The model of care in New Zealand differs to that of the USA along with other countries 
whose health care consumers belong to many and varied health insurance (or similar) plans that 
dictate the level of care received commensurate to the amount they have subscribed. As most 
of the New Zealand health system is government funded, it is unlikely health professionals 
might inflate their outcomes, as there is no direct incentive for them to do so. This could lead 
to the assumption that the data collected within the New Zealand health sector is more 
transparent and therefore more reliable. In New Zealand, there is no direct need to achieve a 
high percentage of DFU data capture, as this is not required for billing purposes.  
Assessing wound healing 
Utilising electronic wound imaging software and related hardware allows for the collection of 
data (metrics) relating to wound surface area and wound healing trajectories within routine 
clinical care. This is turn provides a greater understanding of healing times within specialist 
high-risk wound clinics such as the Diabetes high-risk foot ulcer clinic where this research has 
occurred. The term wound healing trajectory relates to the progression of wound healing from 
baseline to healed, as the wound moves through the stages of healing. The trajectory can be 
depicted on a graph if measurements of surface area are collected at each wound treatment 
clinic appointment, and this allows for reporting of percentage change over time. The collection 
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of data enables in-house clinical audit and assessment of wound care best practice. Schultz et 
al. (2003) acknowledge the large difference in healing between acute and chronic wounds 
(Schultz et al., 2003). As acute wound healing progresses, the four phases of cellular action are 
to stem bleeding; generate inflammation to aid coagulation and protect from bacteria; manage 
cellular proliferation to promote tissue regeneration; and support remodelling of the cellular 
matrix progress uniformly with one phase supporting the next (Morton & Phillips, 2016). The 
healing model of a chronic wound shows that healing is impeded at the inflammatory phase, 
restricting the progression to re-epithelialisation and tissue remodelling, which increases the 
risk of the wound becoming infected (Darwin, Vaughn, & Lev-Tov, 2019; Powers, Higham, 
Broussard, & Phillips, 2016).  
The acronym T.I.M.E. sets a parameter with which to judge effective healing and was 
developed during a wound care expert conference in 2002, beginning with assessment of wound 
bed preparation for healing through visual inspection. This is documented through asking four 
questions within the acronym T.I.M.E: T – is the wound Tissue viable and able to respond to 
the cellular response required for wound healing? I – are there any signs of Infection, such as 
slough, heat, redness in surrounding tissue, and being malodorous? M – how Moist or dry is the 
wound looking? A wound that is too dry will not epithelialise effectively, and a wound that is 
too moist is at risk of infection and will delay wound margin progression. E – wound Edge, are 
there signs of the wound margins progressing inwards through the process of Epithelialisation 
(European Wound Management Association (EWMA), 2004, p. 2; Gray, 2015; Schultz, 
Mozingo, Romanelli, & Claxton, 2005; Schultz et al., 2003)? The majority of literature 
reviewed relating to chronic wound healing acknowledges that venous and foot ulcers in people 
with diabetes are most likely to become chronic due to becoming impeded, at the inflammatory 
stage, increasing the risk of infection occurring to further delay healing. 
In reviewing literature relating to signs of successful wound healing, the majority of studies 
have parameters that rule out chronic diabetic foot ulcers in their study specific inclusion and 
exclusion criteria. Knighton, Ciresi, Fiegel, Austin and Butler (1986) describe assessment of 
wound healing products for chronic non healing wounds by measuring time to 50% or 100% 
epithelialisation (Knighton, Ciresi, Fiegel, Austin, & Butler, 1986). This paper is cited often in 
later papers as the landmark for the describing of successful wound healing and has been used 
in evidence for the T.I.M.E. model of assessment (Schultz et al., 2003). 
Complete wound healing of chronic wounds can take one to two years, though this incorporates 
remodelling of the cellular matrix beneath the closed wound, and also accounts for the wound 
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not breaking down again following weight bearing, demonstrating functional as well as 
anatomical stability (Hicks et al., 2018). As cellular matrix remodelling is not visually evident, 
wound closure is most commonly described as the time at which the open wound margins 
migrate together, through the process of epithelialisation, and no longer visually resemble an 
open wound (Frykberg & Banks, 2015). The Canadian Society for Vascular Surgery 
retrospective study on wound healing acknowledges that diabetic wounds not assessed by a 
health care professional within the first month of presentation have a higher likelihood of poor 
healing and increased chance of associated complications; the Society also classifies wounds 
that have not healed within six weeks as chronic (Hicks et al., 2018). Once treatment 
commences, wound care treatment codes of practice determine that advanced therapies should 
be employed if the wound is not showing signs of healing within four weeks (Frykberg & 
Banks, 2015). Wound healing rates may be impacted by delayed time from inception of ulcer 
to beginning of treatment, due either to the patient not recognising an ulcer is present, or the 
need for sharp debridement to remove bacterial biofilms, exudate and tissue that is no longer 
viable (Atkin et al., 2019; Frykberg & Banks, 2015; Hilde et al., 2017).  
As stated in this background, foot wounds in people with diabetes, do not heal in the usual 
process. They may not move quickly beyond the inflammatory stage and may require specialist 
podiatry treatment, along with education and Multi-disciplinary team (MDT) input and support. 
Despite this, it has been reported through other published research that DFU can heal, with the 
majority attaining wound closure by six months (European Wound Management Association 
(EWMA), 2004; Gould & Li, 2019; Jeffcoate, Chipchase, Ince, & Game, 2006). Wounds that 
take longer than six months to heal are defined as “hard to heal” (Driver et al., 2019; Zhou, 
Schenk, & Brogan, 2016).  
Managing patient care, including wound management in the community or the patient’s own 
home, allows people to feel as if they are making progress, due to requiring less specialist input. 
It relieves the person of the stress of driving to an appointment at a clinic with limited or no 
parking availability and navigating roads outside their community at busy traffic times. The 
ability to identify patients whose DFU will heal outside of specialist podiatry input, even though 
they might not meet the 40 – 50% epithelialisation at twenty-eight days of treatment “gold-
standard”, will allow for a more successful treatment and patient triaging. Sharing this new 
knowledge with the community care teams will assist them in treating and supporting patients 
in their wound healing journeys, which at times feel more like an ultramarathon when wound 
healing becomes prolonged.  
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Both in New Zealand and internationally, the percentage of the population who develop 
diabetes is increasing. This leads to increased numbers of patients developing a DFU, thus there 
is increased pressure on specialist departments treating PwD related complications, including 
DFU to ensure they are assessing and treating DFU, as efficiently and effectively as possible. 
Providing real-world evidence relating to the healing of DFU may provide the MDT, along with 
the patient, a more accurate overview of time to healing and healing time projections to allow 
for more accurate treatment planning and time management. 
Part 2: Patient perception of wound imaging and utility 
Collaborative care between patient and clinician enhances wound healing opportunities 
A holistic approach is required for the PwD who is attending the specialist high-risk foot ulcer 
clinic, as the best chance of successful healing is through understanding that there is a 
physiological, psychological, and financial impact of managing a DFU, for the person with a 
DFU. As any person ages beyond 60 years, their wound healing ability decreases, through 
sluggish wound re-epithelialisation and impaired production of connective tissue (Jones, 2009). 
Nutritional status is an important assessment. People who are nutritionally deficient create a 
barrier to an optimal wound healing environment, even outside of third world countries, as 
malnourishment is not limited to the elderly or those with low incomes (Thomas, Yaakov, 
Mark., Mayhugh, & Moore, 2018). Protein deficient dietary intake impacts on wound healing 
by decreasing wound remodelling through impaired platelet function and fibroblast deficiency, 
which acts to prolong the inflammatory phase of the healing process; similarly, smoking also 
inhibits healing at the inflammatory phase (Thomas et al., 2018). The World Health 
Organisation (WHO) defines malnutrition as both under or over nutrition affecting 462 million 
and 1.9 billion people respectively in 2014 (World Health Organization, 2018). Malnutrition 
and vitamin deficiency is often thought to occur only in people with a body mass index below 
20 kg/m2, but the WHO terms the combination of excess body mass along with vitamin and 
mineral deficiency as a “double burden” of malnutrition (World Health Organization, 2018), 
with one underlying cause being reduced health literacy and understanding of the need for 
healthier food preparation and eating (Finn, Mohd Farudz, & Mad Dan, 2015). 
Information sharing aids health literacy 
Health Literacy has been defined as: “The degree to which individuals can obtain, process, 
understand, and communicate about health-related information needed to make informed health 
decisions” (Berkman, Davis, & McCormack, 2010, p. 16). The New Zealand Ministry of Health 
(NZMOH) acknowledges health literacy as a barrier to prevention and management of disease 
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within New Zealand and at times this is due to conflicting messages patients receive from 
multiple health care professionals. The development of an integrated team of health care 
professionals that can provide education at different points of the care continuum can assist 
with increasing patients’ health literacy, empowerment for self-management and life style 
modification (Zuercher, Diatta, Burnand, & Peytremann-Bridevaux, 2017). Specialist 
dieticians can assist with nutritional advice and support to improve awareness and 
understanding of foods that can aid healing. Specialist podiatrists can treat the wound along 
with referring to orthotic, infectious diseases, or vascular specialty services as required. Nurse 
specialists can provide education and advice relating to the specific disease that may impact on 
healing. Specialist physicians will medically assess the patient and alter treatment modes as 
required, along with liaising with other specialist health care professionals (HCP). Limited 
health literacy has been reported as impeding a person’s ability to communicate effectively and 
confidently with their primary health professional, and highlights the feeling of inadequacy to 
voice the need for further explanation or understanding (Ishikawa & Yano, 2011).   
Patient health literacy is an important factor required to assist in the treatment of a chronic 
wound, as it facilitates patient engagement. People with limited health literacy may have 
difficulty with reading instructions, understanding verbal communication or to visualise 
mentally education being given (Zuercher et al., 2017). Health literacy is promoted through a 
variety of educational learning tools, whether they are visual, tactile, or auditory based. It is 
first important to develop a positive relationship with the patient, where they feel able to 
communicate and be communicated with, enabling them to feel in the centre of their care 
(Ministry of Health, 2012). It has been shown that the higher the level of health literacy a person 
has, increases the likelihood of them participating and engaging with their care, whether that be 
taking medications as prescribed to assist with healing or utilising off-loading equipment to 
assist with optimal ulcer healing (College of Nurses Aotearoa NZ Inc & New Zealand Nurses 
Organisation, 2012). Engaging the patient in their care throughout treatment of a chronic wound 
or condition can create an opening for the assessment of health literacy, to provide a foundation 
for education and information sharing (Zuercher et al., 2017). 
Patient participation in their care 
Kumah-Crystal and Mulvaney (2013) reviewed patient participation and understanding of 
blood glucose technology and associated images of graphed blood glucose values through a 
review of published intervention studies (Kumah-Crystal & Mulvaney, 2013). Their findings 
were that using interactive communication within routine clinical appointments, patient specific 
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information, and graphical images shared between patient and clinician allowed for education 
and optimised self-awareness. The feedback incorporated the utility of these interactions in 
enhancing health literacy and increasing self-care motivation. 
Acknowledging the patient is central to their care, can be overlooked when new technology is 
introduced, even though it can be used to assist in the provision of education during 
appointments. People require different styles of education and information sharing, that will 
enhance their understanding of their care and involve them in decision-making. The sharing of 
the wound images with patients can aid their feeling of inclusion in the care being provided to 
them, and further benefit patients as they make decisions with regard to wound care adherence, 
such as off-loading, or understand the need for further intervention, some of which will be 
invasive, such as amputation. Imaging technology that allows for the tracing and recording of 
wound area measurements can assist in assessing wound healing and provide important 
information as to the different rate of healing for a DFU and guide specialist health 
professionals as to projected outcomes. 
While multiple randomised controlled studies look at various pharmaceutical wound healing 
products, it is acknowledged that each person needs individualised treatment of their foot ulcer, 
tailored to treat their specific type of pathophysiological ulcer (Papazoglou et al., 2010). In the 
same way, glycaemic control requires tailoring to the individual person and their lifestyle, 
taking into account factors such as shift work, religious fasting periods and physical barriers to 
exercise, such as congestive cardiac failure or an amputation, where ambulation may be 
impeded (Tregunno & Costa, 2017).  
The building of respect and communication during routine podiatry appointments can allow for 
outside services to be recommended which may be able to assist the PwD. To an extent, the 
person attending the high-risk foot ulcer clinic is a captive audience while their wound is being 
assessed and dressed. Opportunities develop for the discussion of difficulties a person may be 
having, such as maintaining good glycaemic control, while they are being requested to utilise 
off-loading to assist with healing. The podiatrist can complete a “Green Prescription” that acts 
as a referral for the person to access exercise help and support groups. The Green Prescription 
(GRx) is an exercise programme developed to assist people to focus on exercise that they are 
able to tolerate. It has been shown that people with low health literacy respond better to advice 
given by a respected health professional (Ishikawa & Yano, 2011). In the same way, the GRx 
is a prescription, written by a HCP, to enable the person to be assessed and an exercise plan 
developed that can be done at home, while the person is sitting down, off-loading their wound 
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to promote healing. The GRx helps the patient access a support group, set patient specific goals, 
and provides encouragement and support to help motivation (Ministry of Health, 2017). Insulin 
resistance is decreased when people with diabetes take part in regular exercise, resulting in a 
positive effect on blood glucose control (Way, Hackett, Baker, & Johnson, 2016). Exercise 
suggestions can be provided for people required to stay off their foot in the case of off-loading 
to aid DFU healing, a situation that can often lead to increased insulin resistance. Utilising GRx 
and sharing of wound healing informatics with patients increases health literacy and self-
efficacy, having a beneficial effect on patient “buy-in” with their treatment plan as they feel 
they have contributed to the process of designing their individualised treatment plan. 
Shared decision making within collaborative care 
Person-centred care along with shared decision-making has been described as promoting 
concordance to treatment plans. Concordance is defined as an agreement between patient and 
clinician, following discussion and information sharing of the treatment process that will be 
undertaken (Chakrabarti, 2014). The success of improved treatment concordance is gained 
through involving the person in their care planning, enhancing their health literacy with regard 
to their specific condition, and enabling them to take ownership of their treatment through the 
process of autonomy (Sandman, Granger, Ekman, & Munthe, 2012). Diabetic foot ulcers in a 
person with diabetic peripheral neuropathy may not heal without the need for surgical 
intervention or amputation. Incorporating education relating to glycaemic control, taking 
antimicrobial treatment as prescribed or adhering to off-loading of the affected foot to reduce 
pressure on the ulcer site are important aspects of treatment. These conversations can be 
enhanced throughout the podiatry appointment and when the patient and podiatrist are 
reviewing the DFU wound images from previous appointments. Collaborative viewing of 
wound images can aid the person’s understanding for the need to take antibiotics, improve 
glycaemic control, or follow the podiatrist’s advice about keeping their foot elevated. Utilising 
person-centred care along with shared decision-making allows the person to feel they are being 
included in their treatment plan. As wound imaging technology is used more frequently, this 
can be used to help the person see their wound and track healing progression. It can also be 
used to help explain the treatment plan the wound care specialist is developing in collaboration 
with the patient and encourage person-centred care. In doing so, the health care professional 
working with this model endeavours to practise with enhanced integrity, with patient well-being 
at the forefront. (Munthe, Sandman, & Cutas, 2012). Person-centred care is described by 
Epstein et al. (2010) as increasing quality of life through improving illness endpoints (Epstein, 




Diabetes mellitus is a long-term condition related to the inability of the pancreas to produce 
insulin or utilise insulin produced to ensure glucose homeostasis within the body (Egan & 
Dinneen, 2014). Statistics show the incidence of diabetes both worldwide and in New Zealand 
as continuing to increase. The WHO reports that 4.7% of the world’s population in 1980 had a 
diagnosis of diabetes (World Health Organization, 2016). The incidence of diagnosed diabetes 
in 2014 had risen to 8.7% (World Health Organization, 2016). In terms of population numbers, 
this is almost an increase of four times that of the 1980 statistics. Diabetes is often described as 
a burden in the health sector because of the financial implications of extended care. Diabetes is 
also an ongoing burden to those with diabetes along with their family/whānau and support 
people. 
New Zealand’s prevalence of diabetes is also increasing. In 2018 the population of New 
Zealand was estimated at 4,699,755 with 253,480 having diabetes, that is 5.4% of the 
population (Ministry of Health, 2019b; Statistics New Zealand, 2019). Most government 
statistics combine both type 1 and type 2 diabetes together under the heading of diabetes, 
although as discussed in the next paragraph, though they might both require treatment for 
aberrant glycaemic control, they have quite different aetiologies. The New Zealand diabetes lay 
organisation, Diabetes New Zealand estimates up to 10% of people diagnosed with diabetes 
have type 1 diabetes (Diabetes New Zealand, 2014). Māori and Pasifika peoples have a 
significantly greater occurrence of T2DM, along with those with Indo-Asian ethnicity (Health 
Quality & Safety Commission of New Zealand, 2020). People of European ethnicity have a 
lower proportion of type 2 diabetes, however they have a greater likelihood of developing type 
1 diabetes compared people of non-European ethnicity (Derraik et al., 2012).  
Classifications 
There are multiple classifications of diabetes, however, all share a common definition of being 
associated with elevated levels of blood glucose or hyperglycaemia. The two main 
classifications of diabetes are type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus 
(T2DM). Hyperglycaemia in people with T1DM results from irreversible damage to the 
pancreatic beta cells, typically due to an autoimmune inflammatory response, which is indicated 
by the formation of specific diabetes related autoantibodies, such as glutamate decarboxylase 
autoantibodies (Couzin-Frankel, 2017). Type 2 diabetes mellitus develops through a 
combination of environmental and genetic factors, such as age, dietary intake, obesity and lack 
of regular physical activity (Ling & Pasquali, 2016). These factors affect the production of 
11 
 
insulin through pancreatic beta cell dysfunction, due to loss of beta cell mass, along with loss 
of beta cell function as well as insulin resistance (Meier & Bonadonna, 2013). Insulin resistance 
relates to cellular tissue inability to respond to released insulin, caused by an imbalance in 
glucose metabolism (American Diabetes Association, 2013; Ormazabal et al., 2018). Diabetes 
mellitus is recognised as an illness related to an inability to produce or utilise insulin to maintain 
blood glucose levels within the normal biochemical range. Without endogenous or exogenous 
insulin, blood glucose levels become elevated, which is known as hyperglycaemia. 
Hyperglycaemia 
Hyperglycaemia relates to circulating blood glucose above the body’s normoglycaemic 
threshold, which is defined as less than or equal to 7 mmol/L, when in a fasting state (World 
Health Organization, 2016). Hyperglycaemia often presents without symptoms, or with 
symptoms that are initially easily ignored, such as increased thirst, tiredness, or weight loss. 
The occurrence of hyperglycaemia is attributed to an inability to regulate glucose, either 
ingested or released from liver or muscle cells through the process of catabolism (Samuel & 
Shulman, 2016). Insulin, produced by beta cells in the islets of the pancreas, is the hormone 
that enables the uptake of glucose by the liver, muscle, and fat cells in an effort to maintain 
normoglycaemia through anabolism. A contributing factor to hyperglycaemia is the insufficient 
production of insulin, or resistance to the action of insulin that is produced (Bouché, Serdy, 
Kahn, & Goldfine, 2004). Meier and Bonadonna (2013) postulate that beta cell dysfunction 
may be caused by beta cell death related to exhaustion of beta cells due to hyperglycaemia 
(Meier & Bonadonna, 2013). The beta cells could also have been malformed in utero and may 
relate to children who were malnourished in utero, due to the mother’s diet lacking in nutrients, 
or gestational diabetes with associated hyperglycaemia (Portha, Chavey, & Movassat, 2011). 
Beta cell loss of function and loss of mass both occur independently of each other in type one 
diabetes (Meier & Bonadonna, 2013). Persistent hyperglycaemia leads to oxidative stress and 
the creation of advanced glycation end products (AGE) which have been implicated in the 
formation of micro-vascular and macro-vascular complications (Evans, Goldfine, Maddux, & 
Grodsky, 2002). 
Macro-vascular effects of hyperglycaemia 
Hyperglycaemia is a contributing factor to macro-vascular complications along with 
dyslipidaemia, hypertension, inflammatory response, insulin resistance or increased plasma 
viscosity (Bornfeldt & Tabas, 2011). Activated inflammatory pathways affect the 
cardiovascular system through the altering of smooth muscle within blood vessels, allowing for 
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the formation of thrombotic tissue, leading to myocardial infarction or cerebrovascular 
accidents (Alexandru et al., 2016; Grandl & Wolfrum, 2018). Peripheral artery disease (PAD) 
and peripheral vascular disease (PVD) are often used synonymously. For the purpose of this 
thesis, peripheral artery disease (PAD) will be defined as a condition related to macro-vascular 
complications, with diabetic peripheral vascular disease relating to the lower limb and small 
vasculature system affected by hyperglycaemia. The macro-vascular effects of diabetes relate 
to the large blood vessels, including the iliac, popliteal and femoral arteries implicated in lower 
limb complications of hyperglycaemia (Thiruvoipati et al., 2015). Pain or cramping in the legs 
on walking, known as intermittent claudication, is a symptom of PAD caused by occlusion of 
the lower extremity vessels due to atherothrombosis formation, resulting from the decreased 
action of nitric oxide due to hyperglycaemia (Thiruvoipati et al., 2015). Hyperinsulinaemia, a 
by-product of hyperglycaemia and insulin resistance, is associated with prothrombosis through 
the degradation of vascular smooth muscle cells due to nitric oxide and oxidative stress (Lemkes 
et al., 2010) altering the arterial structure and function (American Diabetes Association, 2003). 
If combined with hyperlipidaemia, hypertension, and a history of smoking, the impact on the 
vascular system is greater than in someone without diabetes (American Diabetes Association, 
2003). Re-vascularisation, whether through angioplasty or stenting in the lower extremities, has 
proven success haemodynamically, as evidenced by improved vascular perfusion in the feet 
along with improved ankle-brachial-pressure-index (ABPI) recordings (Fakhry et al., 2018). A 
significant decrease in lower limb amputations has also been shown post revascularisation in 
those with PAD (Wiseman et al., 2017). 
As discussed above, the vessels involved in the macro-vascular effects of diabetes are larger, 
obscuring the effects of hyperglycaemia longer as the build-up of hyperglycaemic by-products 
is less obvious over a longer period of time, similar to the effects of elevated levels of 
cholesterol and formation of lipoproteins and atherosclerotic changes (Wengrofsky, Lee, & 
Makaryus, 2019). The PwD may observe pain on walking that decreases the distance they are 
able to walk before pain begins, this may be evidence of intermittent claudication, a symptom 
of macrovascular disease that can lead to an increased risk of DFU (Boulton, 2020; Nativel et 
al., 2018). The impact of the larger vessels becoming blocked inhibit vascularisation to smaller 
vessels. This may be addressed with re-vascularisation to the affected limb, through the 
insertion of a stent to the blocked vessel, or through a popliteal by-pass graph intervention.  
As evidenced in diabetic macro-vascular disease, elevated levels of glucose have changed the 
consistency of the blood, causing blood vessels to become narrower due to the atherosclerotic 
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changes, this is also the case for diabetic micro-vascular disease where the smaller blood vessels 
become occluded due to the effects of hyperglycaemia. 
Micro-vascular effects of hyperglycaemia 
Micro-vascular effects of hyperglycaemia are determined by the duration and frequency of each 
episode of elevated blood glucose levels above the recommended norm (Petrie, Guzik, & 
Touyz, 2018). Whilst the later-stage macro-vascular effects of diabetes can be seen as life 
threatening, and may produce symptoms which bring the patient to the attention of their HCP, 
the insidious development of micro-vascular complications can be easily ignored and not 
recognised until the damage can no longer be reversed. Large arteries can be re-vascularised in 
the case of an angioplasty, or damage can be by-passed with the harvesting and utilization of 
veins from other parts of the body, therefore allowing oxygen and nutrients to flow to vital 
organs affected by the blocked arteries. With the smaller vessels affected being microscopically 
fine and exceedingly numerous, there are no medical pharmaceuticals or instruments that can 
enable these very small vessels to be unblocked. Resultant angiogenesis can occur as an attempt 
to naturally bypass the blocked vessels and create a new vascular pathway within the organs, 
especially the retina in the progression of diabetic retinopathy (Cheng & Ma, 2015). 
Advanced glycation end products (AGE) are described as an endogenous by-product of 
hyperglycaemia, composed of altered proteins and lipids (Nowotny, Jung, Höhn, Weber, & 
Grune, 2015). These AGE stimulate the increased release of vascular endothelial growth factor 
(VEGF) resulting in vascular permeability along with angiogenesis. During this period of 
oxidative stress the effect of nitric oxide is reduced through the activation of C-reactive protein 
due to excessive production of reactive oxygen, affecting the smooth muscle cells lining the 
vascular walls, decreasing tone and leading to adherence of sclerotic deposits (Brownlee, 2005). 
Angiogenesis, the growth of immature micro-capillaries, occurs as a response to 
hyperglycaemia and leptin resistance, resulting in a lack of satiety and increased circulating 
serum leptin (Gupta & Zhang, 2005), which in turn feeds the hyperglycaemia. Diabetic 
retinopathy is attributed to neovascularisation, which leads to vision deterioration and loss for 
the PwD. This can lead to foot injuries due to reduced visual acuity where obstacles that can 
injure the feet may not be seen before the incident occurs (Al-Rubeaan et al., 2015). Also related 
to vision impairment, the PwD may not see a break in the skin integrity from a previous injury 
that needs to be observed and managed to prevent worsening of the affected area (Baba, Davis, 
& Davis, 2014).  
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Diabetic nephropathy is identified through a hastened decline in renal function, as evidenced 
by a greater than 4.5 ml/min/1.73m2 of the estimated glomerular filtration rate (eGFR) reduction 
per year, in association with an albumin-creatinine ratio (ACR) of more than 30mg/g (Thomas 
& Karalliedde, 2015). Mesangial cells within the glomerular expand in response to elevated 
blood glucose, causing a reduction in the glomerular filtration rate (Tervaert et al., 2010). Renal 
impairment shown through an eGFR below 60 ml/min/1.73m2 is an indicator for decreased 
wound healing due to elevated levels of urea, which are known to inhibit tissue growth required 
for cellular repair (Maroz & Simman, 2013). A decreased renal function can be an indicator 
that micro-vasculature in the feet have been similarly affected.  
Increased viscosity of the blood occurs occluding the microscopic vessels at the periphery of 
the vessel tree (Thiruvoipati et al., 2015), that have branched out from the vasculature system 
as seen in the eyes, kidneys and feet, as well as the brain. Vascular dementia is reported as 
having a threefold increased risk in those with diabetes (Naidu et al., 2016). The capillary 
membranes become thicker, occluding the flow of blood (Petrie et al., 2018). The impaired 
vascularity, described above, impacts on the function of blood vessels inhibiting the transport 
of blood products and resulting in inadequate perfusion of the foot, which impairs healing. This 
impaired healing can lead to acute foot wounds becoming chronic, non-healing diabetic foot 
ulcers (DFU). 
Hyperglycaemia and diabetic foot ulcers 
Hyperglycaemia underpins the development of macro and micro vascular complications in 
PwD, whether due to lack of beta cell function or insulin resistance. When the action of insulin 
is inhibited, serum glucose is unable to be transported out of the circulatory system for storage 
and use in adipose and skeletal muscle cells, setting off a cascade of physiologic effects through 
activation of inflammatory pathways. As discussed earlier, hyperglycaemia leads to decreased 
vascular perfusion, degradation of vascular smooth muscle and oxidative stress, which are 
precipitants to the progression of a DFU (Ormazabal et al., 2018).  
Diabetic foot ulcers 
Foot ulcers in PwD are often identified as chronic, slow to heal wounds, which can impact 
greatly on a person’s quality of life (QoL), heightening the importance for early detection of a 
DFU and early intervention to treat and prevent ulcer formation (Wukich & Raspovic, 2018). 
Early detection of a DFU can occur through patient education in the process of daily foot 
inspection, whether independently or in conjunction with a significant other, or with a 
community podiatrist. There is an increased risk of amputation related to a DFU, with a reported 
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80% of non-traumatic lower extremity amputations following a DFU (Centers for Disease 
Control and Prevention, 2016). In New Zealand, the rate of lower limb amputation in diabetes 
is around 0.1 – 0.5 per 100 patients with diabetes (Health Quality & Safety Commission of New 
Zealand, 2017). Along with routine foot examination, an advanced knowledge of projected 
healing times relating to a DFU can enable the clinician to better inform the PwD of likely 
outcomes and assist with care planning related to the DFU. This research aims to identify 
healing times for DFU treated during routine clinical care to better inform health care 
professionals working within these areas. 
Regular foot examination 
Health care professionals who care for PwD should recognise the importance of foot 
assessment. There appears to be little research on the value HCP place on foot inspections and 
whether foot inspections are carried out. De Berardis, et al., (2004) showed that physicians 
appeared to show implicit bias towards patients with low incomes or levels of education, with 
them being less likely to engage the person in education relating to self-care and foot inspection. 
Less than half the patients surveyed reported having their feet examined by an HCP in the past 
year. Furthermore, the presence of overt risk factors for DFU such as peripheral vascular 
disease, diabetic neuropathy or macro-vascular complications did not increase the likelihood of 
feet being examined (De Berardis et al., 2004). Specialist diabetes services provided better foot 
examination and education as opposed to primary care. While the reasons for not performing a 
foot examination are not listed by De Barardis, et al., (2004) time pressure during the 
appointment, or the expectation that the patient would be aware of a foot ulcer and would raise 
it as a concern may be factors in this oversight. Examining the feet during routine clinical care 
and providing foot care education encourages patients to examine their feet regularly (De 
Berardis et al., 2004). 
Causal factors 
The causal pathway for a DFU can begin with something as seemingly benign as ill-fitting 
footwear. The friction created by the footwear rubbing repeatedly on the same spot causes 
irritation, leading to a break in the skin integrity (Boulton et al., 2008). Diabetic peripheral 
neuropathy can lead to altered proprioception by affecting the PwD balance perception and can 
increase the risk of falls or tripping, due to decreased toe-obstacle clearance during walking 
(Boulton, 2006b; Ettinger, Boucher, & Simonovich, 2018). Feet can be injured, and the skin 
broken during these occurrences. Without regular foot inspections these injuries can go 
undetected and may precede the formation of a DFU (Boulton, 2006a). Foot deformities, such 
16 
 
as a bunion, calluses or bony prominences can create pressure areas that lead to skin break 
down. Males are also at higher risk of DFU, with a greater number of men requiring amputation 
surgery, especially in those with T2DM, though why they are at higher risk has not yet been 
determined (Boulton, 2006b). Diabetic wounds are reported to differ physiologically (Figure 1) 
in the way they heal, due to the degradation of growth factors by inflammatory cytokines that 
are required for wound healing leading to the diabetic wound becoming chronic (Lobmann et 
al., 2002). 
Infection 
Infection is a large component in the non-healing of any wound. The addition of infection to a 
diabetic wound, alongside peripheral vascular disease and/or diabetic peripheral neuropathy, 
creates an environment in which healing can be prolonged, or unable to occur, through the 
disruption to the normal healing process (Boulton, 2019). This process involves four stages: (i) 
platelet accumulation at the wound site; (ii) influx of inflammatory cells; (iii) wound bed 
preparation and tissue granulation with epithelialisation; and (iv) cell remodelling for tissue 
strength during wound closure (Han, 2016). In the diabetic wound, the healing process becomes 
inhibited during the inflammatory process and is unable to move to the next stage (Davis, 
Kimball, Boniakowski, & Gallagher, 2018).  
In the presence of diabetic peripheral neuropathy in conjunction with infection, the expected 
systemic markers of infection such as increased white blood cells and febrile response are 
absent, related to a decrease in inflammatory response to pathogens (Hobizal & Wukich, 2012). 
Infected tissue, fed by high blood glucose levels, decreases immune response by damaging 
neutrophil function, as well as T-lymphocyte response (Carey et al., 2018), which in turn 
increases susceptibility to infection.  
Infection impacts glycaemic control by causing stress-induced hyperglycaemia (SIH), which is 
described as being unrelated to diabetic hyperglycaemia, as it occurs as a natural physiological 
response in people without diabetes to acute illness or catabolic illness, such as infection 
(Carmona-Bayonas, Font, & Ayala de la Peña, 2013). This stress response releases stored 
glucose and causes increased insulin resistance, through the action of glucocorticoids, growth 
hormone, and cytokines, precipitating the release of epinephrine, similar to the flight-fight 
response (McCowen, Malhotra, & Bistrian, 2001). This response is of significance to PwD as 
it creates a cycle of hyperglycaemia causing infection, causing hyperglycaemia (Marik & 
Bellomo, 2013), affecting immune response to bacterial attack (Clement et al., 2004). The 
infection along with hyperglycaemia impacts the healing capacity at wound sites, especially in 
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DFU when peripheral vascular disease and diabetic peripheral neuropathy are also present. 
Studies have also shown that increased age is associated with insulin insufficiency, and bed rest 
is associated with insulin resistance, with both factors having been shown to reduce insulin 
sensitivity in skeletal muscles (McCowen et al., 2001). This impacts on the person with a 
neuropathic ulcer who is required to utilise off-loading, a form of bed rest.  
Renal disease 
Wound healing in a DFU can be negatively impacted by the presence of renal disease. This may 
be due to the effects of hyperglycaemia on the kidney, or can occur unrelated to the process of 
diabetes (Lewis, Raj, & Guzman, 2012). Studies show that a quarter of those with chronic 
kidney disease and impaired kidney function defined as an eGFR below 60 ml/min/1.73m2 also 
have PVD, as evidenced by ankle brachial index pressure (ABPI) less than 0.9, demonstrating 
the increased risk of PVD with and without the diagnosis of diabetes (Lewis et al., 2012; 
Schaper et al., 2019). An ABPI between 1.0 – 1.4 is stated as sufficient evidence to exclude the 
presence of PVD (Boulton et al., 2008). Chronic kidney disease results in elevated uricaemia 
and uricaemic toxins that cause immune dysfunction through the inhibition of mesenchymal 
stem cells during the process of wound healing, due to the increased accumulation of reactive 
oxygen species causing hypoxia at the wound site; this causes decreased tissue perfusion and 
has a detrimental effect on wound healing (Khanh et al., 2017). 
Quality of Life 
The associated slowness to heal of a DFU can have a significant impact on the PwD Quality of 
Life (QoL). Studies have shown the decreased QoL scores as being further impacted the longer 
the DFU took to heal, along with not healing or reoccurring (Macioch et al., 2017). Other QoL 
factors impacted by DFU were an increased risk of depression, a lack of satisfaction with life, 
along with difficulty adjusting to psychosocial challenges, such as off-loading or wearing of a 
moon boot, which can impact on the person’s ability to continue in employment (Jaksa & 
Mahoney, 2010). Alavi et al., (2014), reports people with a non-healing foot ulcer have a 
decreased QoL score of 10 – 40%, which is comparable to the QoL score of someone with 
chronic lung disease or breast cancer (Alavi et al., 2014).   
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Figure 1: Causal pathway of diabetic foot ulceration 




Diabetic peripheral neuropathy  
Diabetic peripheral neuropathy (DPN) affects up to 50% of PwD and would appear to be the 
greatest causative agent in the formation of DFU, as the nerves are rendered inoperable due to 
the effects of hyperglycaemia (Cancelliere P, 2016). People with DPN are 1.7 times more likely 
to develop foot ulcers than those without this neurological impairment (Centers for Disease 
Control and Prevention, 2016). Sensory neuropathy is one of three main classes of DPN. 
Sensory neuropathy is more commonly associated with nerve damage causing loss of feeling 
to surrounding affected areas in the periphery, often referred to as occurring with a “stocking-
glove” pattern beginning in the toes and moving up the foot (Sytze Van Dam, Cotter, 
Bravenboer, & Cameron, 2013). People with sensory DPN can also experience hypersensitivity 
and pain as opposed to paraesthesia. Up to 20% of people with DPN have pain associated with 
sensory neuropathy (Singh, Kishore, & Kaur, 2014). The pain is often described as similar to 
electric shocks or knife-like stabbing pain which is worse at night, impacting on the person’s 
quality of life due to sleep disturbance (Singh et al., 2014). Peripheral neuron cell death and the 
inhibition of neuron neogenesis occurs in diabetes through metabolic and micro-vessel 
adaptations, as evidenced through activation of the polyol pathway. The polyol pathway in DPN 
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is activated through a combination of three circumstances: i) hyperglycaemia; ii) conversion of 
glucose by the enzyme aldose reductase enzyme to sorbitol, which is then converted to fructose 
by the enzyme sorbitol dehydrogenase, resulting in the synthesis of AGE; and iii) imbalance of 
factors resulting in decreased cellular ability to respond to oxidative stress leading to damage 
of peripheral neuronal cells (Lorenzi, 2007). Neuronal ischaemia through micro-vascular 
dysfunction occurs through endothelial injury due to nitric oxide altering the ability of the vessel 
wall to relax. Once sensory DPN has occurred, an ill-fitting shoe causing friction may not be 
noticed, allowing for the formation of an ulcer. Similarly, those with sensory DPN are at 
increased risk of burns through the lack of nerve response to heat pain (Morales-Vidal, Morgan, 
McCoyd, & Hornik, 2012).           
Motor DPN affects muscle fibres resulting in muscle weakness through oxidative stress, and 
this causes axonal injury, leading to poor balance and an increased risk of falls (Morales-Vidal 
et al., 2012). Impaired proprioception due to motor DPN results in the person’s inability to 
recognise their position and movement of their body, including balance. The “finger to nose” 
proprioceptive test is a non-time-consuming observation to assess impaired proprioception 
through asking the patient to close their eyes and touch their nose with their finger. Depending 
on the level of impaired proprioception, the finger will miss by only millimetres or up to 
centimetres (Bo Khin, 2017). While the patient falling may not cause a break in the skin for an 
ulcer to form, a traumatic injury could lead to bed rest where pressure ulcers on the heels of the 
feet could occur. 
Autonomic diabetic neuropathy (ADN) affects sympathetic, parasympathetic, and enteric 
nerves associated with chronic diabetes and poor glycaemic control. The autonomic effects of 
diabetic neuropathy affect the cardiovascular system, altering heart rate and blood pressure 
control, leading to the inability to physically tolerate exercise (Morales-Vidal et al., 2012). 
Sweat gland function is disrupted by ADN, resulting in dry pedal skin and fissure formation, 
which can lead to an increased risk of infection (Morales-Vidal et al., 2012).  
A compromised vascular supply to the neurons precedes neurodegenerative changes, adding to 
the toxic hyperglycaemic reaction through the polyol pathway and oxidative stress, whereby 
the Schwann cells protecting nerve axons and nerve signals are compromised (Tesfaye et al., 
2010). Smoking, hypercholesterolaemia, high blood pressure and obesity advance the 
progression of ischaemia further through adding to the decrease in blood flow to the sensory 
nerves (Singh et al., 2014) (Figure 1).  
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Assessment of DPN through sensory tools is most commonly undertaken using a 10g 
monofilament. The monofilament assesses pressure sensation by pressing the monofilament 
against pressure points until it bends at a number of separate points on the foot, with The New 
Zealand Society for the Study of Diabetes recommending six sites per foot in their guidelines. 
The guidelines are agreed upon to ensure consistency and accuracy of the assessment between 
podiatrists and clinicians. Subjective reporting of the sensation indicates a pass or fail (Leung, 
2007). Tactile sensation is assessed using cotton wool or gauze. A 128Hz tuning fork can be 
used to test for vibration sensation in non-specialised podiatry settings (New Zealand Society 
for the Study of Diabetes, 2013). A neurothesiometer creates a vibration. This device is first 
tested on the patient’s thumb to give an indication of the sensation the patient should be 
reporting. The neurothesiometer vibration is then increased in volts until the patient 
acknowledges the sensation. The voltage can be recorded and used as a comparison at further 
podiatry reviews (Iqbal et al., 2018). Assessment of ankle reflexes can also indicate the presence 
of neuropathy. On presentation to a specialist diabetes podiatry service, these assessments will 
be undertaken to determine an expected course of treatment. The monofilament and 
neurothesiometer, are routinely used in the high-risk foot ulcer clinic, as part of the assessment, 
prior to diagnosis of DPN. Monofilament and neurothesiometer were both keywords given to 
the third party when searching for evidence of DPN in the study populations for both parts of 
this research.  
Diabetic peripheral vascular disease 
Peripheral vascular disease (PVD) in diabetes is involved in up to 50% of DFU, often found in 
combination with DPN and or infection, where healing is delayed through a prolonged 
inflammatory phase (Davis et al., 2018). Whilst PVD may not cause the initial break in skin 
integrity, it increases the risk of a DFU developing through the impact PVD has on the 
circulation of oxygen and nutrient rich blood to the peripheral extremities, such as the feet. This 
peripheral ischaemia adds to the increased risk of infection due to a decrease in leucocytes at 
the site when the skin’s integrity is broken (Lipsky & Berendt, 2006). The leucocyte function 
is also affected by hyperglycaemia (Lobmann, Schultz, & Lehnert, 2005). Hyperglycaemia 
affects the small blood vessels in the feet through increased coagulation, causing occlusion in 
the vessels (Khalil, 2017). People with PVD present with cold feet due to decreased circulation, 
along with absent or decreased pulse detection in the pedal vessels. Ankle brachial pressure 
indexes (ABPI) are often used as an assessment tool for PVD, though in advanced disease where 
leg arteries have become calcified, this may be inaccurate. Many studies discussing PVD note 
that intermittent claudication, the subjective report of lower leg/calf pain on walking, is an early 
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indicator of PVD. In the population of PwD, intermittent claudication is present in only 50% of 
those with diabetic PVD, due to vascular stenosis, when DPN is also present (Chung et al., 
2010). Krishnan and Rayman (2006) report a study showing decreased axon reflex flare, shown 
as decreased vascular perfusion, resulting in an increased risk of infection due to decreased 
vascularity, especially in the diabetic foot (Krishnan & Rayman, 2006). Evidence of PVD or 
DPN will be collected for the patients whose wounds have healed within six months to 
determine if the impact of the presence or absence of PVD and DPN affects wound healing 
outcomes. 
Neuro-ischaemia 
As described by Mangesh Tiwaskar (2017) neuro-ischaemia is “the double trouble” (Tiwaskar, 
2017). Similar to the use of “the triple whammy” by HCP which relates to potential for harm if 
three medications (ACEi, diuretic and NSAID) are combined, so the use of “double trouble” 
refers to the potential for harm, in this case the combination of PVD and DPN (Roberts, 2014). 
The impact on PwD having PVD and DPN concurrently increases their risk of tissue injury 
related to decreased pain sensation, along with an increased risk of poor healing and or infection 
due to PVD where vascular perfusion is limited through calcification of the pedal capillaries 
leading to the formation of a chronic, non-healing, DFU, that will require assessment and 
treatment through a high-risk foot ulcer clinic. 
Impaired renal function and wound healing 
Decreased renal function is recognised as impacting on wound healing. It is acknowledged by 
most researchers, that it is difficult to tease out the magnitude of the effect of renal function on 
wound healing, as it occurs in conjunction with other neuropathic and vascular conditions that 
are attributed to the disease progression of diabetes (Maroz & Simman, 2013). What is agreed 
upon is that, like the peripheral vasculature of the foot, the small blood vessels in the kidneys 
are also impaired, resulting in venous insufficiency. It is acknowledged that estimated 
glomerular filtration (eGFR) naturally decreases by 1 millilitre per minute per year for every 
individual over the age of 40 years, and this decrease is then compounded by the vascular effect 
of hyperglycaemia (Maroz & Simman, 2013). As renal function decreases, uraemic toxins 
accumulate. These toxins are an accumulation of compounds that outside of impaired kidney 
function would normally be removed from the blood and excreted in the urine. The build-up of 
uraemic toxins interfere with each stage of healing through disrupting wound homeostasis, 
through increased production of reactive oxygen species as well as advanced glycation end 
products, affecting the mesenchymal stem cells wound healing abilities through prolonging 
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inflammation and inhibiting fibroblast action, leading to a decrease in tissue granulation (Khanh 
et al., 2017). Wound tissue oxygenation and perfusion is decreased when anaemia is present 
(Scholnick Kyle, 2016). Anaemia can result from chronic kidney disease due to reduced 
production of erythropoietin, a hormone released from the renal cortex that is necessary for the 
production of red blood cells (Jelkmann, 2011). One explanation for the erythropoietin 
production inhibition is glomerular fibrosis related to hyperglycaemia, and hypertension 
causing injury to the glomerular (Loewe, Stefanidis, Mertens, & Chatzikyrkou, 2016). Along 
with the very small capillaries becoming damaged due to hyperglycaemia, which as shown here 
affect renal function as well as vascular perfusion in the feet. Another factor related to poor 
renal function as described above is the reduced production of erythropoietin, leading to 
anaemia, affecting wound healing through the decrease in oxygenation to the wound bed due 
to low levels of oxygen rich blood (Hayes, Alzuhir, Curran, & Loftus, 2017). 
As discussed earlier this thesis undertakes research on two inter-related problems which will be 
assessed through the use of a quantitative (Part 1) and qualitative (Part 2) methodology. 
Part 1 – Quantitative  
Statement of the Problem: Diabetic foot ulcers are not associated with clearly defined wound 
healing trajectories to allow for prediction of successful healing.The development of foot ulcers 
is an increased risk in PwD due to the biochemical effect of chronic hyperglycaemia, with an 
85% likelihood of the foot ulcer preceding an amputation in PwD (Boulton, 2019). The national 
incidence of foot ulcers in PwD is not recorded by the New Zealand Ministry of Health 
(NZMOH), though the prevalence of diabetes is 5.2% of the population. Of this cohort, 0.2 – 
0.3 per 100 will have a lower limb amputation (Health Quality & Safety Commission of New 
Zealand, 2017).  
Detection of DFU that have an increased chance of healing and remaining healed, can assist 
with triage of patients. For example, the care of DFU that have a high likelihood of healing can 
be transferred to community-based specialist wound clinics that operate between primary and 
secondary health care. On review of current literature, there is a substantial amount written 
about time to healing predictions within a clinical trial setting and as discussed previously, in 
this setting some form of patient selection bias in inevitable. It has been difficult to locate 
research that utilises real-world clinic data for DFU wound healing that has not excluded 
difficult to heal wounds prior to analysis. 
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Part 2 – Qualitative 
Statement of the Problem: The clinical utility of incorporating patient perceptions of digital 
wound imaging technology into co-design of the PwD self-management plan, has not been 
explored.   
Inclusion of patients into their care planning has been long acknowledged and taught within 
nursing. Including the patient in their care planning most often occurs within the tertiary health 
care sector to ensure documentation is fulfilled that will pass an audit review, to show how risks 
have been mitigated for patient safety. Within a long-term chronic condition, the formalised 
documentation is not often created due to each person being seen by multiple health clinicians 
and specialist groups along their treatment journey. As one patient stated in their semi-
structured interview, it is not often that the specialist reviewing them leaves them feeling as if 
they are concerned about their whole person, rather, they have just addressed the body system 
under review. Wound healing papers recommend the implementation of person-centred care 
for improved healing outcomes, recognising that it does not just benefit the person, but the 
clinician and health system also (Lindsay et al., 2017; Mullings & Merlin-Manton, 2018). Few 
studies have been found which address the patient perception of viewing images, including 
radiology images, to benefit health care outcomes, however there were no articles found that 
assessed patient perception and utility of wound imaging within a real-world specialist podiatry 
setting. 
Purpose of the study 
In the New Zealand health system an initial referral to a specialist diabetes podiatrist is created 
typically by a primary care health provider, either from a general medical practice or 
community podiatrist when a DFU is first detected or deemed to require specialist input due to 
lacking signs of epithelialisation. As the referral comes from primary care, a delay of days to 
weeks from community referral to first specialist assessment can result. Also, lack of patient 
awareness of the existence of a foot ulcer due to the ulcer location on the foot, visual 
impairment, or lack of sensation related to peripheral neuropathy, leading to no awareness that 
the skin is being worn and broken down, may delay the initial presentation to a health care 
professional (Grech & Dissanayake, 2011; Kenealy, Grech, Milne, Bevan, & Kenealy, 2009). 
Patients with DFU are also referred from within tertiary care during hospitalisation for other 
health needs. While not unique to New Zealand, the delay from time of first identification of 
the ulcer to the time of first assessment of the ulcer by specialist services is different to the 
standard of care for people with diabetic foot ulcers in many other countries, where the health 
pathway requires immediate referral to a specialist diabetes podiatry service (National Institute 
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for Health and Care Excellence, 2015; Wounds International Expert Working Group, 2013). 
Due to the delayed referral to a specialist diabetes podiatry service, wound healing trajectories 
within New Zealand specialist podiatry clinics can often appear to worsen before they improve, 
often relating to the need for physical debridement of non-healing tissue. The initial 
debridement or delay in specialist podiatry treatment can affect the perceived wound healing 
progress, though not the outcome at six months.  
Aim 
The aim of this study is to investigate if DFU healed by six months to find if they uniformly 
show a greater than 50% surface area reduction at four weeks from baseline assessment (day 
0). These findings will heighten health practitioners’ awareness of wound healing trajectories 
for wounds within a real-world high-risk podiatry clinic and assist with information sharing and 
education of fellow staff and patients.  
This research will benefit care planning within the multi-disciplinary team within the podiatry 
service and greater understanding of a sub-group of patients who may, at a later stage of healing, 
be successfully managed within community primary care. 
The secondary research aim is to assess the patient's perception and perspective of the 2-D 
wound imaging technology being utilised during usual care at the specialised diabetes podiatry 
clinic. As early as the 1960s Donabedian was writing about the need for assessing patients' 
experience of care in an attempt to improve treatment (Donabedian, 1997). Picker created in-
depth patient experience questions as described by Brady and Shaller (2013) which have been 
adopted by New Zealand District Health Boards (NZ DHB) to survey discharged patients as to 
their hospital experience (Brady & Shaller, 2013; New Zealand Health Quality & Safety 
Commission, 2013). The researcher used the NZ DHB survey domains to inform the semi-
structured interview question selection, as well as incorporating Picker’s principles of the 
importance of involving the patient in their care and listening to their opinions and viewpoints. 
The researcher thus hopes to gain awareness of the impact that sharing of wound images and 
healing graphs has on the patient’s perception of their wound healing journey. In other health 
areas there has been a resultant positive engagement in care and greater interest in decisions 
around possible interventions when people are included in their care pathway (Curry, 
Nembhard, & Bradley, 2009). 
This is a mixed methods study using an explanatory sequential design, as the quantitative (Part 
1) and qualitative (Part 2) data have been collected consecutively. The two data sets will be 
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analysed separately and the results for each part reported separately. This design allows for the 
integration of the results and findings in the discussion chapter where person-centred care, 
wound healing and the utility of wound imaging technology within routine clinical care will 
merge in a complementary capacity (Creswell & Plano Clark, 2017).  
Expected outcomes 
It is hypothesised that analysis of the wound healing metrics, may show a new timeline 
expectation of when realistically a DFU within the New Zealand health care system should 
show signs of healing and will likely progress to being completely healed by six months. 
Alternatively, if this new marker point is not reached, it could indicate the need to explore 
interventions outside of the podiatry clinic that could assist with healing, such as popliteal by-
pass grafts to enhance blood flow and circulation to the periphery, or amputation of the digit. 
The qualitative findings (Part 2) will enhance awareness as to patient perceptions of the wound 
images and associated graphs that the patient can see, to assist in understanding their wound 
healing and need for interventions. This approach could be incorporated into teaching packages 
for staff members to assist in their understanding, as well as promoting the use of imaging 
devices in a patient centric way. 
Thesis structure 
The structure of this thesis consists of a mixed methods design that incorporates quantitative 
and qualitative research through an explanatory sequential design (Andrew & Halcomb, 2009; 
Ivankova et al., 2006). Through this mixed methods design the quantitative and qualitative 
sections of the design from literature review through to reporting of the results will be kept 
separate and will be grouped as Part 1 and Part 2, with the complementary combining of wound 
healing results and the participant perspective of wound imaging occurring in the discussion 
chapter. 
Chapter 1 is tasked with Introducing the research question and statement of need. It will provide 
a broad overview of diabetes mellitus, micro and macro vascular consequences of 
hyperglycaemia and how these impact on the foot for the PwD and a DFU. 
Chapter 2 will further drill down in greater detail to describe current wound healing research 
and definitions of wound treatments and healing trajectory expectations. Person-centred care 




Chapter 3 discusses the methodologies and methods used to examine the wound imaging 
metrics for the quantitative exploratory retrospective data review (Part 1). The Part 2 
methodology involves convenience sampling through semi-structured interviews with patients 
attending the high-risk foot ulcer clinic, with a thematic analysis of the findings to determine 
the utility of wound imaging in relation to patient education and treatment concordance. 
Chapter 4 will present the results of Part 1 analysis of wound healing trajectories, along with 
continuous and categorical variables analysed in relation to wound healing days. Part 2 will 
present the findings identified through thematic analysis and the supporting participant quotes 
that support the selection of these themes.  
Chapter 5 will discuss the results and findings of the Part 1 and Part 2 research and show how 
they complement the other and will enhance further education and research related to wound 
imaging and person-centred care. This chapter will conclude with a summary of the research 
and a projected proposal of future research that should be undertaken to further enhance these 
learnings. 
Conclusion 
This chapter has provided a wide overview as to the effects of hyperglycaemia on the 
progression of diabetes-related complications. It has outlined the effects of hyperglycaemia 
through large vessel (macrovascular) disease along with the implications to small vessels 
(microvascular) and the resultant damage to nerve endings. 
The aim of the thesis along with thesis structure has been outlined. Chapter 2 will provide an 
in-depth review of literature relating to diabetic foot ulcer wounds, the determination of a 
chronic wound, healing expectations and modes of measuring wound margins. It will explore 
person-centred care related to patient-clinician health care decision-making, along with 






Diabetic foot ulcers, as shown in chapter one, have multiple degrees of causality relating to the 
progression to ulcerative state, and healing success. As a DFU is not an acute wound, but a 
wound that heals slowly, multiple factors can be found as to why the wound has not healed, 
compared to wound healing in a person without diabetes. Chapter two will provide an 
integrative literature review relating to DFU wound healing, best methods for assessing wound 
healing trajectories within routine clinical care, along with real-world evidence of wound 
healing predictors outside a randomised clinical trial (RCT). The principles of person-centred 
care and the use of collaborative decision-making between patients and clinicians will be 
explored to gain an understanding of current practices to enhance the patient journey with 
regard to successful wound healing within an environment of a chronic long term illness, 
incorporating the use of imaging as part of routine clinical care.  
Objectives and methods 
This integrative literature review will investigate a realistic time point showing healing 
progression for DFU healed at six months, along with the involvement of the PwD in the use 
of technology within the healthcare setting, their perceptions of this technology and their 
advancement towards greater patient centred care. It will investigate limitations within the 
literature and show the need for this research, revealing how the results will benefit both patients 
and clinicians. 
Literature review aims: Investigate wound healing time points that suggest positive healing 
outcomes at six months. 
2. Assess different measurement methods in current use and their utility. 
3. Discuss current literature available relating to the enhancement of communication, 
understanding and health literacy when personal health related images are shared with a 
health consumer, as evidenced by greater adherence to the person-centred care plan. 
Introduction 
Diabetes is a chronic, progressive disease that results in a lifetime risk of developing diabetic 
foot disease in 19 – 34% of PwD (Schaper et al., 2019; World Health Organization, 2016). This 
research aims to examine wounds healed at six months, over a three-year period, from within a 
“real-world”, high-risk, diabetic foot ulcer clinic. Though there was inclusion, exclusion criteria 
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applied to the exploratory retrospective analysis, the wounds were not selected to fit a pre-
determined model to prove a successful wound healing product, such as pre-determining 
baseline surface area (cm2) or excluding wounds that may show signs of infection. As stated by 
Torraco (2005) an integrative literature review should aim to reveal a new perspective, the new 
perspective of this research is to show real-world evidence of healing for DFU outside of 
controlled wound healing studies (Torraco, 2005). 
Multiple RCT have been published relating to effective wound treatment products for DFU 
(Blume, Walters, Payne, Ayala, & Lantis, 2008; Driver, Hanft, Fylling, & Beriou, 2006; Lu et 
al., 2011; Veves, Sheehan, Pham, & Study, 2002). These publications advise healing time 
points to be used to determine the probability of successful wound healing within a given time 
period. Of note is the use of selective inclusion and exclusion criteria preventing difficult to 
heal wound inclusion in these RCT (Fife, Eckert, & Carter, 2018). Within each RCT there will 
be set parameters that will achieve selection of a subject group, that allow an answer to be 
procured of the research question or hypothesis most effectively, such as PwD with a current 
foot ulcer. Even though utilising randomisation balances the patient group being used to reduce 
bias, as described by Hariton and Locascio (2018) it can also be used to select a very particular 
subject group to manipulate a desired result, such as DFU with a surface area measurement less 
than 2cm2 at study start or with no infection seen at screening (Hariton & Locascio, 2018). 
Study subjects are then divided indiscriminately into either a routine treatment group or to a 
group that will receive the new wound healing product as part of their treatment routine. 
Sylvester (2017) notes RCT with a smaller cohort of subjects returns a lower level of evidence 
for findings, especially when compared with a much larger sampling RCT (Sylvester et al., 
2017). In response to the published findings of wound healing within RCT scenarios, this 
research serves to address wound healing within a real-world high-risk foot ulcer clinic for 
people with diabetes. To reduce bias, the first wound that met the study parameters for each 
individual patient was selected, as opposed to choosing the wound with the largest surface area 
or fastest wound healing trajectory. In published data relating to the assessment of DFU wound 
healing, the prediction of outcomes are often drawn from metrics gathered through RCT using 
confined parameters (Schultz et al., 2005; Sheehan, Jones, Caselli, Giurini, & Veves, 2003; 
Warriner, Snyder, & Cardinal, 2011). 
The review of the literature will seek to clarify the definition of a healed wound, along with an 
outcome endpoint for the wound healing (Bolton et al., 2004; Lavery, Barnes, Keith, Seaman, 
& Armstrong, 2008). This review will evaluate different methods of measuring and determining 
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wound healing, which will relate to Part 1 of this research (Papazoglou et al., 2010; Wang et 
al., 2015).  
At the centre of these assessments is the PwD with a mean age of 65 years born twenty-five 
years prior to the arrival of the first recognised digital camera in 1975 (Trenholm, 2007), who 
have aged alongside the rapid development of technology. Part 2 SSI (semi-structured 
interview/s) will seek to determine how well participants have adjusted to this new use of 
technology and the implementation of wound imaging into their routine clinic visits and 
discussions with clinicians. There is limited published literature on the person’s perspective of 
viewing medical images. The majority of research published relating to the use of wound 
imaging are comparison articles promoting one imaging device over another, often used to 
validate percentage area reduction metrics to show a wound has healed over a predicted time 
frame (Bowling, Paterson, & Ndip, 2013). There is minimal published evidence relating to 
patient perceptions of diabetic foot ulcers and the impact it has on quality of life in the earlier 
part of this decade. Numerous publications have emerged in the past five years which all 
acknowledge a decrease in quality of life (QOL) scores in people with a chronic DFU, and also 
describe increased evidence of morbidity and mortality for people with a DFU (Chamanga, 
2018; Godoy-Coronao, Illesca-Pretty, Cabezas-González, & Hernández-Díaz, 2018; Vileikyte, 
Crews, & Reeves, 2017). The researcher could not find published evidence relating to the 
patient perceptions of the use of wound imaging during routine clinical workflow within a real-
world high-risk podiatry foot ulcer clinic at this time, though research conducted by the 
University of Melbourne, Australia studied the Haptic hexis views of people with chronic 
wounds attending a tertiary hospital for wound care which involved imaging and sharing of 
images with patients (Austin & Santamaria, 2004). Haptic hexis relates to a person’s feeling 
related to a physical aspect of their being, such as a wound. Their perception of how the wound 
looks, smells, feels, and any associated pain alters this experience.  
Search strategy 
The primary literature search was undertaken through CINAHL, Medline (Ovid), The Joanna 
Briggs Institute (Ovid), British Medical Journal (BMJ), Google Scholar, PubMed, UpToDate 
and Web of Science. Keywords used in search included: Diabetes, diabetic foot ulcers, 
Wound(s), Wound healing, Wound healing trajectories, Wound Image(es)(ing), electronic 
wound measure(ment), Patient centred(centered) care, person-centred(centered) care, decision-
making, shared decision-making, collaborative decision-making, education tools, learning 
style(s), treatment adherence, treatment concordance. Most literature was reviewed from 2010 
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to 2019, though earlier publications were used for accuracy of information when cited in later 
research such as a seminal paper that may have directed practice today. Only literature with 
available online full text written in English or with an accurate English translation were used, 
including reference lists from relevant articles.  
Part 1 – Exploratory retrospective analysis of wound surface area reduction  
Inclusion: For this part of the literature review the search terms were combined using - 
Wound(s), Wound healing, Time to healing, Wound healing trajectories, Wound 
Image(es)(ing), Electronic wound measure(ment), Wound healing outcomes, Diabetic foot 
ulcers, Chronic wounds.  
Exclusion: Papers using animals with acute initiated wounds were excluded, as were papers 
with surgical incision wounds which were not related to diabetes or diabetic foot ulcers.  
Summary: Many papers discussing chronic wound healing integrate DFU, venous leg ulcers 
and pressure ulcers together. Those that acknowledged the differences in healing times and 
related factors were included. Many of the articles reviewed involved RCT, which can be seen 
to provide more reliable data due to stringent controls. Clinical trials could also provide greater 
restriction to the data being collected due to exclusion criteria that can eliminate PwD whose 
wound may be infected or too large in size, yet these are real incidences and should be included 
in an authentic real-world study. These articles provide useful information when informing 
clinicians on the benefits of wound healing products, but do not show their true utility within a 
real-world non clinical-trial setting. In an attempt to ensure studies do not end before a products 
benefit is authenticated, the FDA (2006) require large industry wound treatment and device 
conglomerates to adhere to their wound healing primary endpoint as part of their permission to 
conduct these trials within the United State of America (Driver et al., 2019; U.S. Food and Drug 
Administration, 2006). The FDA (2006) guideline states that once a wound is deemed to be 
healed, it must be kept under observation and reassessed for up to three months post re-
epithelialisation before complete healing is acknowledged (U.S. Food and Drug 
Administration, 2006). The high-risk foot ulcer clinicians also follow this guideline and see 
patients after wound closure has been achieved to ensure the wound has remained healed.  
Part 2 – Patient perspective of wound imaging within a high-risk foot ulcer clinic 
Inclusion: For this part of the literature review the search terms were combined using - Patient 
centred(centered) care, Person-centred(centered) care, Decision-making, Shared decision-
making, Collaborative decision-making, Education tools, Learning style(s), Treatment 
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adherence, Treatment concordance, Diabetes, Diabetic foot ulcers, Chronic wounds. The search 
was limited to articles written in English with the predominant time frame from 2010. Reference 
lists from relevant articles were also reviewed to ensure the correct context is being given. 
Exclusion: Discussion papers, literature reviews and editorials were excluded from this review. 
Wound healing definition 
 
 
Multiple publications are available that discuss wound healing techniques, trajectories, and 
products, but there is a lack of consensus and understanding of what defines a healed wound. 
On review of research papers identified, that discuss wound healing, whether relating to stages 
of wound healing, as an endpoint or outcome measure within a RCT or as part of a wound 
healing product, 75% of articles in this review did not define their understanding of a healed 
wound (Figure 2).  
While the 142 wound healing publications identified in a key word search as described earlier, 
113 were discarded for lack of a clear definition of what they determined a healed wound 
outcome to be. The discarded papers were reconsidered later, when wound healing 
Figure 2: Wound healing definition selection 
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measurement and trajectories were being investigated, as the definition of a healed wound was 
often described as part of a larger article relating to wound healing times or trajectories.  
The Wound Healing Society (WHS) adopted the Lazarus (1994) wound healing definition, 
which has become a foundation definition that is still recognised today (Lazarus et al., 1994). 
Wound healing as defined by Lazarus (1994) has three healing classifications, that of being 
ideally healed, acceptably healed, or minimally healed (Lazarus et al., 1994). Like Margolis 
(1996) many researchers have adopted and further promoted this definition of an acceptably 
healed wound and it is now used as a seminal foundation within many wound healing 
publications (Margolis, Berlin, & Strom, 1996). In discussing acute healing compared with 
chronic, or difficult to heal wounds, Franz et al. (2000) utilises the definition of ideal or 
acceptable healing as a wound healing outcome relating to wound healing trajectories (Franz, 
Kuhn, Wright, Wachtel, & Robson, 2000).  
The WHS is credited for the complete wound healing criteria being defined as “100% re-
epithelialization of the wound surface with the absence of drainage” in a RCT comparing a new 
dressing product to usual care (Sheehan et al., 2003). The WHS updated their wound treatment 
guidelines for chronic wounds in 2006, however they did not further define a healed wound 
(Robson & Barbul, 2006; Steed et al., 2006). In 2006 the United States Food and Drug 
Administration (FDA) created standards to be used in the development of wound treatment 
products that defined complete wound closure as “skin re-epithelialization without drainage or 
dressing requirements confirmed at two consecutive study visits two weeks apart” (U.S. Food 
and Drug Administration, 2006, p. 12).  
The FDA also recommend within RCTs that study subjects be followed up and the previous 
wound site reassessed at least three months after initial report of healing to ensure complete 
wound closure is maintained. This more defined description of a healed wound was adopted by 
Kurd (2009) as an outcome measure for their prognostic RCT (Kurd, Hoffstad, Bilker, & 
Margolis, 2009). St-Supery (2011) also recommends the use of Lazarus (1994) WHS levels of 
wound healing; that is, minimally, acceptably, and ideally healed; in their literature review of 
wound dressing product methodologies. Frustration is expressed by St-Supery (2011) that there 
is no agreed benchmark being used regarding wound healing assessment, which they also find 
surprising in a wound healing product RCT, where a healed wound is the outcome objective. 
St-Supery (2011) also recommends the use of the FDA standard of reassessing wound closure 
stability, through continuing assessment of the healed wound for up to three months post 
33 
 
achieving objective healing to ensure wound healing stability has been maintained (St-Supery 
et al., 2011).  
Wound healing assessment as a key outcome is acknowledged by Angspatt, Puttilerpong, 
Sirithanakorn and Aramwit (2018) as they critically assess traditional and non-traditional 
evaluation of wound healing (Angspatt, Puttilerpong, Sirithanakorn, & Aramwit, 2018). 
Though the main emphasis of this research relates to assessing the state of the wound, subjective 
and objective signs of healing, such as decreased wound pain, patient reported decrease in odour 
from wound, exudate, wound area measurement and vascular endothelial growth factors will 
have been assessed and addressed by the treating podiatrists. Angspatt et al., (2018) also 
supports the value of grading the level of wound healing being achieved as per Lazarus (1994), 
incorporated with the FDA (2006) definition of complete wound closure without ooze or 
drainage, along with Stromberg’s (1994) recommendation of follow-up three months after a 
wound has initially objectively healed (Angspatt et al., 2018; Stromberg, Chapekar, Goldman, 
Chambers, & Cavagnaro, 1994).  
In the International Working Group on the Diabetic Foot (IWGDF) (2019) latest guidelines for 
care, prevention and treatment of diabetic foot disease, the criteria, and definitions of DFU 
appear to have adopted the FDA (2006) definition. The IWGDF define a “healed foot ulcer” as 
showing complete epithelialisation of intact cutaneous tissue being void of any drainage or 
exudate from the previous ulcerated site (van Netten et al., 2019, p. 3). Though this is the most 
recent definition for a healed ulcer available at this time, it fails to acknowledge the point they 
previously made in these guidelines, that relates to the increased risk of ulcer recurrence at a 
previously healed site, due to the decreased strength of healed cutaneous tissue post wound 
repair and remodelling by 8 – 59% (Schaper et al., 2019). This exploratory analysis has shown 
the importance of reassessing wounds post initial observance of being healed, to ensure the 
wound has remained healed. Recurrence of foot ulcers occur within 40% of healed ulcers within 
the first year post healing according to the IWGDF Guidelines (2019) (Schaper et al., 2019). 
This recurrence rate is gleaned from a robust study of data collected over a four year period 
examining DFU outcomes, with minimal exclusion criteria, rendering it a real-world study 
compared to a RCT (Schaper et al., 2019).  
Jeffcoate et al., (2006) provides a clear definition of the healed ulcer outcome measure as being 
“complete epithelialization without discharge” (Jeffcoate et al., 2006, p. 1785). The ulcers in 
Jeffcoates (2006) research were followed up for a 12-month period from time of first 
presentation, allowing for ulcer recurrence data to be collected for the 449 patients involved. 
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Of the healed ulcers, 59.2% remained healed at the 12 month follow-up assessment (Jeffcoate 
et al., 2006). 
Wound healing within a controlled environment, such as a RCT, with tight inclusion and 
exclusion parameters should provide a clear endpoint as agreed to by the IWGDF as showing 
complete re-epithelialisation without discharge or ooze. Further to this, the optimum agreement 
of a healed wound should be reassessed within a three-month period to ensure the wound has 
not reoccurred, due to the underlying healed tissue lacking the remodelling required to 
strengthen it to a point where it can resist further insult. 
Chronic wounds 
Differentiating between an acute or chronic wound 
As discussed in Chapter 1, wound healing should progress through four stages of healing, 
Haemostasis, Inflammation, Proliferation and Maturation to achieve wound closure (Sharp & 
Clark, 2011; Singh, Young, & McNaught, 2017). Acute and chronic wounds are categorised as 
to their likelihood of healing as primary and secondary intention to heal (Singh et al., 2017). 
Primary intention to heal relates to a wound that has been created with a clean surgical incision, 
with even, straight wound edges that are able to be brought together cleanly with sutures, staples 
or tissue adhesives (Singh et al., 2017). Chetter et al., (2019) reiterate that not all surgical 
wounds heal by primary intention. Wounds containing foreign bodies that are required to 
remain open to allow for cleaning and removal of the foreign particles, infected wounds, 
wounds containing necrotic tissue or that have been left with a deep cavity post-surgery such 
as pilonidal sinus surgical intervention, heal by secondary intention, and are specifically 
referred to as surgical wounds healing by secondary intention (Chetter et al., 2019; Gray, 2015; 
McCaughan, Sheard, Cullum, Dumville, & Chetter, 2018; Vermeulen et al., 2004).  
Chronic wounds such as DFU heal by secondary intention as the size and shape of the wound 
does not allow for the edges to be approximated by sutures or staples. The inflammatory process 
is prolonged due to the impact of diabetes impairing vascular perfusion to the wound bed, 
slowing the creation of granulation tissue to fill the void, promoting an increased risk of 
infection due to the extended time it takes for re-epithelialisation to occur (Sharp & Clark, 2011; 
Singh et al., 2017). 
As earlier mentioned, 142 papers were extracted under the search terms of wound healing, 
diabetes, and diabetic foot wounds. Of these publications forty one discuss chronic wounds and 
provided the basis to define a chronic wound as: healing that is delayed by twelve or more 
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weeks from the initial break in skin integrity, where during the inflammatory stage healing 
becomes inhibited, leading to defective remodelling of the extra cellular matrix, failure to 
epithelialize and prolonged inflammation (Bolton et al., 2004; Moffatt, Murray, Keeley, & 
Aubeeluck, 2017; Schultz et al., 2003; Singh et al., 2017). 
Factors implicated in the interruption of wound healing phases  
A healed wound is one that has progressed through the four stages of healing: Homeostasis, 
which employs vasoconstriction to prevent fluid loss; Inflammation signified by redness, 
swelling, pain and heat at the wound site; Proliferation reconstruction of tissue matrix through 
granulation and reepithelialisation, allowing for revascularisation to the affected area; Re-
modelling, this phase occurs once the wound integrity has been restored providing 
strengthening to the area over a period of one to two years (Franz et al., 2000; Guo & Dipietro, 
2010; Jayachandran, Rodriguez, Solis, Lei, & Godavarty, 2016; Lindley, Stojadinovic, Pastar, 
& Tomic-Canic, 2016; Okonkwo & DiPietro, 2017; Schultz et al., 2011).  
 
As shown by Häggström (2014) (Figure 3) the usual phases of wound healing progress 
smoothly through each phase. This figure is used as a comparison to the progression of healing 
for chronic wounds. It allows the reader to visualise the time points that can be interrupted to 
delay wound healing and cause them to become a chronic healing wound.  
Wound healing most commonly becomes impaired during the inflammatory stage of healing 
(Singh et al., 2017). Whilst inflammation is a usual feature of the healing process, whereby 
fibroblast and endothelial cells are activated to aid wound repair, this inflammation is controlled 
and within the sphere of normal healing, does not inhibit the progression to the next stage of 
healing (Guo & Dipietro, 2010; Koh & DiPietro, 2011; Menke, Ward, Witten, Bonchev, & 
Diegelmann, 2007). During impaired wound healing, the self-limiting feature of inflammation 
is not functional, leading to uncontrolled inflammation and further damage to the wound bed 
(Menke et al., 2007). 
Figure 3: Phases of Wound healing (used with permission) (Häggström, 2014) 
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Impaired wound healing in PwD can occur in any of the four stages of healing as a direct or 
indirect result of hyperglycaemia (Baltzis, Eleftheriadou, & Veves, 2014). Hyperglycaemia 
directly affects wound healing by changing the chemical environment within the wound, 
making it more prone to infection, especially within the inflammatory phase. The indirect effect 
of hyperglycaemia relates to the development of peripheral vascular disease as it decreases the 
availability of oxygen rich blood perfusing the wound site. The existence of peripheral 
neuropathy inhibits healing due to neuropeptides affecting vasopermeability through the 
reduction in sensory fibres and pain markers slowing healing at the wound site (Ackermann & 
Hart, 2013; Baltzis et al., 2014). 
There is consistent agreement in the literature that chronic wounds occur when the earlier 
defined stages of healing are interrupted or delayed, most commonly in the inflammation stage 
(Chen, Hao, Fu, & Han, 2016; Singh et al., 2017; Zelen, Stover, Nielson, & Cunningham, 2011). 
There is also agreement that PwD are more prone to developing a chronic or non-healing wound 
due to the increased risk of infection, peripheral vascular disease and diabetic peripheral 
neuropathy related to hyperglycaemia (Sheehan et al., 2003; Singh et al., 2017; Zelen et al., 
2011). Due to the pre-disposition for healing to stall in the inflammatory stage, DFU healing 
will be impaired, and classed as a chronic non healing wound (Davis et al., 2018; Singh et al., 
2017). 
Pre-disposing risk factors that can lead to an acute wound becoming chronic, such as age, 
glycaemic control, renal function status, signs of infection, such as elevated body temperature, 
along with the visual appearance of the wound for signs of inflammation, bio-film, slough and 
epithelialisation (Boulton, 2006a; Davis et al., 2018; Treece, Macfarlane, Pound, Game, & 
Jeffcoate, 2004). Along with these assessment measures comparing the surface area of the 
wound from dressing change to dressing change, allows for further insight into wound healing 
progression (Darwin et al., 2019; Margolis, Allen-Taylor, Hoffstad, & Berlin, 2004; Zelen et 
al., 2011).   
Evaluation of patient specific variables in conjunction with assessment of the actual wound 
occur simultaneously within a high-risk foot ulcer clinic. 
Defining a time point to re-classify a wound as chronic 
Franz et al. (2000) separates acute from chronic wounds by clarifying that an acute wound is 
one that occurs through a surgical procedure and is first treated as a closed wound due to the 
closing of the wound through the use of surgical staples or sutures (Franz et al., 2000).  
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A number of wound healing articles refer to chronic wounds as wounds that have failed to heal 
within a predicted timeframe, without specifying the time point one should be aiming for within 
the realms of healing (Frykberg & Banks, 2015; Jung et al., 2016; Marfella et al., 2012; Sheehan 
et al., 2003). Due to multiple co-morbidities and confounding factors that affect wound healing, 
it is often stated that “there is no specific timeframe or healing rate under which a wound is 
considered chronic” (Darwin et al., 2019, p. 295).   
The strongest agreement of the time point when a non-healing wound should be classified as 
chronic is twelve weeks or three months (Chamanga, 2018; Iqbal, Jan, Wajid, & Tariq, 2017; 
Singh et al., 2017). While most studies state a time point at which a wound will be re-classified 
as chronic, there is not complete agreement between wound specialists. There remain widely 
divergent opinions based on differing rationales for these end points. Hinchcliffe et al. (2016) 
argue that a wound can be assessed for chronicity as early as four weeks into the healing 
process, therefore allowing for early revascularisation in the case of an ischaemic DFU to 
ensure a greater likelihood of long term healing (Hinchliffe et al., 2016). Conversely, Jung et 
al. (2016) state that to achieve rapid identification of slow healing wounds a period of fifteen 
weeks would be used in the assessment and analysis phase before determining a wound be 
classified as chronic. As this model was used as a prognostic determinant of outcome, the 
increased time point is likely to increase the accuracy of the results as the wounds have had a 
longer assessment period (Jung et al., 2016). 
Wound healing assessment 
The aim of Part 1 is to assess wound healing in DFU, to determine if, within a natural clinic 
setting, there are obvious wound healing trajectories, or percentage wound surface area 
reductions for DFU healed by six months, that can be used to inform clinicians and their 
patients. The following review of research relating to determining signs of successful wound 
healing will be viewed to determine what the current parameters and understandings are. 
Wound bed assessment involving ongoing evaluation of wound healing assists the clinician to 
determine treatment efficacy, with the knowledge that the longer the DFU progresses the more 
difficult it can be to heal (Darwin et al., 2019). This guideline forms part of the WHS updated 
recommendations relating to DFU treatment (Lavery et al., 2016). These WHS guidelines 
recommend DFU treatment method should be reviewed, if over a period of four weeks from 
baseline, the DFU has not reduced in size by 50%. The WHS justify this time period as an 
acknowledged predictor of healing probability and treatment efficacy. The evidence used in 
these guidelines come from six articles, four of which are analysis of wound healing product 
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RCT with narrow inclusion and exclusion criteria not conducted in a real-world setting 
(Cardinal, Eisenbud, Phillips, & Harding, 2008; Lavery, Barnes, Keith, Seaman, & Armstrong, 
2008; Snyder, Cardinal, Dauphinée, & Stavosky, 2010; Warriner et al., 2011).  
Wound area reduction 
Coerper, Beckert, Kuper, Jekov and Konigsrainer (2009) assessed DFU area reduction within 
a natural clinic environment over a seven-year period to determine the probability of healing 
for wounds healed by a 50% reduction from baseline to four weeks (Coerper, Beckert, Küper, 
Jekov, & Königsrainer, 2009). While this is a more realistic real-world study compared to a 
RCT, their wound area was small averaging 1.18cm2. The Eurodiale study found an ulcer size 
greater than 5cm2 was a predictor of non-healing (Prompers et al., 2008). Within the Coerper 
et al., (2009) study it is important to note that wound measurement tracing was performed 
before each sharp debridement or wound specialist intervention rendering the tracings smaller 
at the beginning of the appointment than at the end, this gives a less accurate indication of actual 
wound healing as the measured area may involve tissue that then is required to be removed 
(Coerper et al., 2009). Using wounds that showed a reduction in area of over 50% at four weeks 
from baseline Coerper et al., (2009) calculated a probability determinant for wound healing at 
twelve and sixteen weeks that finds a 52.3% probability of healing after twelve weeks, but at 
sixteen weeks only a 46.7% probability of healing. No explanation of why the decrease in 
healing probability is given, however it could relate to infection, glycaemic control, peripheral 
vascular disease, diabetic neuropathy, or other factors that impact on successful healing. The 
other referenced article for this guideline relates to a diabetic foot risk classification system in 
which 1666 PwD underwent foot assessments and were followed on average for twenty-seven 
months. It is not apparent that subjects had current DFU during the data collection period and 
the objective was not to measure or make determinants of wound healing. Data collection 
appears to consist of collecting historical narratives as to whether the PwD involved have 
previously had a DFU or amputation (Lavery, Peters, et al., 2008). These articles show little 
evidence for use within a real-world setting outside of a RCT.  
Khoo and Jansen (2016) subscribe to the ideal that a wound showing a reduction in area of 30% 
or more following two to four weeks treatment is a predictor of effective treatment, though on 
review of this publication it is evident that this relates mainly to pressure and venous leg ulcers 




Wound measurements incorporating percentage change from baseline as a comparison, has 
become an increasingly common method of assessing relative wound healing, especially in 
clinical trials involving wound healing products. Jessup (2006) states calculating percentage 
change shows small wounds as healing faster than large wounds and they promote the use of 
linear advancement of wound edge calculation for the best overall accuracy between small and 
large wounds (Jessup, 2006; St-Supery et al., 2011).  
Vidal et al., (2016) describes a linear regression algorithm for predicting wound healing as a 
method that requires a large amount of data to be able to produce a statistically significant result 
(Vidal et al., 2016). The measurement of continuous linear regression is useful to use 
retrospectively when large data points at different stages of wound healing has been collected 
on multiple wounds, though it does not give a real time indication on the progression of wound 
healing (Robson, Hill, Woodske, & Steed, 2000). Assessing healing through linear regression 
was a popular method, pre-digital age as it could easily be calculated from a length and width 
measurement. Using retrospective referencing, the earliest published paper found describing 
predictive wound healing through the measurement of length, width or depth is the 1983 article 
by Marks, Hughes, Harding, Campbell and Ribeiro, using linear regression to establish a time 
frame to establish a marker from which to predict probability to heal (Marks, Hughes, Harding, 
Campbell, & Ribeiro, 1983).  
As outlined, this researcher’s secondary objective, is to gain information and understanding to 
assist in the sharing of up-to-date evidence with patients, to enhance understanding of delayed 
wound healing and the direction of change that may be required to assist in the progression of 
healing, this is similar to Marks et al., research objective (Marks et al., 1983). This 1983 
research is a real-world study of surgically excised pilonidal sinus wounds as well as 
laparotomy wounds and their rates of healing, not inhibited by the need to assess the potential 
benefits of a specified wound healing product. Wounds with a smaller breadth or depth than 
five millimetres were excluded, possibly due the assumption they will heal in a shorter time 
frame than larger wounds. Wounds with tracking sinuses or wound edge undermining were 
acknowledged by Marks et al., as being difficult to accurately measure for size to predict 
healing.  
Though linear regression graphs provide a more accurate visual depiction of healing rates over 
time, they are not easily transferred into everyday discussion or for those with limited 
understanding of statistics. Instead, later articles on wound healing predictors have used 
percentage change as their descriptors, in a way that is easier for the majority to visualise and 
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understand, though the results they are representing are an average (mean) of all results at that 
time point.  
Different wound types are shown by Marks et al., to produce different healing rates, which is 
also affected by the presence of infection. An early healing rate algorithm calculated the 
difference between two sequential wound surface area measurements and divided this result by 
the time in days that occurred between these two measurements (Carrel & Hartmann, 1916), 
through subsequent converting of the result into a percentage it is possible to see a percentage 
change between each measurement. This seminal publication, while having little power and 
interchanging between human and animal subjects for the assessment of wound healing, does 
show wound healing trajectory curves similar to those of modern day. The wounds are often 
from otherwise healthy, young patients, without the interference of multiple comorbidities to 
confound progressive wound healing.  
Percentage change 
The 1987 publication by Bulstrode, Goode & Scott outlines wound healing assessment through 
the use of a camera linked to a computer as a form of primitive digital imaging to measure 
healing rates through wound surface area reduction (Bulstrode, Goode, & Scott, 1987). This 
publication discusses the need to assess healing outcomes to allow for wound healing prediction 
to be done through the use of percentage change as opposed to absolute change, especially when 
measuring delayed healing, as in the case of diabetic foot ulcers. It was recognised by Bulstrode 
et al., that precision and accuracy were required when obtaining these measurements and being 
able to do so in a non-invasive environment was optimum to measurement reliability (Bulstrode 
et al., 1987).  
Bulstrode (1987) acknowledges the importance of interrater and intrarater reliability that can 
be achieved in a way that is not economically cumbersome or time-consuming. This research 
by Bulstrode (1987) provided some great results in the form of index data for wound imaging 
and prediction of healing using percentage change, although not under real-world conditions. 
Patients included into the study had no underlying medical conditions such as diabetes. The 
patients were admitted and prescribed bed rest for six weeks or until their ulcers healed, 
whichever came first. In reality, in New Zealand, patients are discharged home and requested 
to adhere to bed rest or off-loading, although outside of an inpatient environment, this is 
difficult to be completely adhered to, due to self-care requirements.  
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Of note, is that in some instances study subjects within the Bulstrode (1987) research had their 
baseline wound measurement reset after debridement occurred, therefore altering their wound 
healing percentage change over time. The implication of this is that the baseline measurement 
was reset, therefore altering the data to be analysed, as it moved the days from baseline to 
healing closer together, giving results of faster wound healing, whereas in reality the initial 
wound baseline may have added three or more weeks to the analysis. As Darwin (2019) writes, 
a more popular measure for predicting wound healing outcome is percentage change in wound 
surface area from baseline to successive wound healing (Darwin et al., 2019). 
The assertion that “time to complete healing” can be predicted for 50% of wounds at week three 
is unsatisfactory for people with the other 50% of wounds (Bulstrode et al., 1987, p. 210). With 
an accuracy parameter equivalent to flipping a coin, patients with multiple wounds, requiring 
multiple appointments over many years could become less trusting of their clinician’s ability to 
predict healing, but also to treat them. Thirty years after the foundational research by Bulstrode 
et al. (1987), the need remains to determine if accurate predictions of wound healing can be 
made for a greater majority of people with DFU, or if due to the complexity of disease and 
multiple confounding factors affecting healing, it remains only true for 50% of DFU. Full 
thickness leg ulcers described by Rijswijk in 1993 resulted in a 54% prediction of healing from 
the mean healing time of 54 days (van Rijswijk, 1993(b)). This study also found a greater than 
30% reduction in ulcer size following two weeks of treatment as a predictor for successful 
wound healing. Although this study was evaluating a wound treatment product — DuoDERM 
™, all patients who volunteered to participate were included, allowing for a large variety of 
causative factors that may impact on successful healing, similar to those encountered in the 
treatment of DFU. 
Gethin and Cowman’s (2006) research compared a manual and a digital wound healing 
assessment system. During this research they ascertained that wounds generally showed signs 
of healing by four weeks. They also observed there was little difference in wound healing, when 
measured as percentage change between assessments, as to the initial size of the wounds they 
were observing. Surface area as an assessment was agreed to be the more useful measurement 
for determining wound reduction and healing as opposed to measuring length, width, and depth, 
due to inconsistent wound shape and easy to recognise wound margin. 
As shown here, wound healing assessment techniques have evolved with technology to allow 
for greater accuracy to allow for wound healing predictions to be made, though there is sparse 
information outside of RCT, describing healing trajectories in specialised secondary care 
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diabetic foot ulcer clinics. The frequent use of predicting wound healing outcomes from twenty-
eight days appears to arise from a misinterpretation of the DFU guidelines that recommend 
reassessment of wound healing techniques and the need for possible intervention if a wound is 
not showing significant healing at four weeks. It does not state that a wound that hasn’t reduced 
by 50% surface area from baseline to four weeks will not heal (Schaper et al., 2019). 
Wound healing as an endpoint 
A problem in defining wound healing is the number of research studies that do not define wound 
closure or wound healing endpoints to a degree where comparisons can be made between 
studies and wound healing products (Gottrup, Apelqvist, & Price, 2010; Gould & Li, 2019).  
Enoch and Price (2004) raise the valid point that an endpoint of complete epithelialisation is 
not realistic for people with a chronic non-healing ulcer, rather an endpoint related to wound 
area reduction, or an outcome not involving an amputation would be more realistic (Enoch & 
Price, 2004). Driver (2017) suggests that to define wound healing as achieving complete 
epithelialization is an outdated mode of thinking, especially in the field of diabetes and DFU, 
wound healing endpoints should be re-defined, with the option to utilise multiple endpoints to 
match the person and their wound (Driver et al., 2017). These comments appear to be directed 
at the constraints placed on RCT being conducted within the United States by the US FDA 
(2006)., as they have set clear ground rules around the classification of a healed wound which 
defines healing as the re-epithelialization of skin, not requiring drainage or dressings over two 
visits that occur two weeks apart (Driver et al., 2017).  
Wound measurement for accuracy and reproducibility 
The documentation of results that are meaningful for a colleague to interpret, should wound 
care of the patient be transferred, is necessary to assist with assessment of wound healing 
progression.  
When measuring wounds, intraclinician precision is necessary for producing highly accurate 
results within the research context (Wysocki, 1996). In the real-world, within clinical workflow, 
standard operating procedures (SOP) are agreed on by clinicians relating to how a wound should 
be accurately measured. Various methods available for the measurement of wounds can dictate 
low levels of accuracy available for wound measurement. Whilst wound assessment includes 
both qualitative and quantitative measures, wound measurement, in this instance, relates to the 
data that informs Part 1 of this research.  
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Prior to the availability of electronic wound imaging (e-imaging) wounds were measured using 
a variety of methods. Length and width could be measured using a disposable tape measure, by 
using the analogue clock method, whereby the twelve pointed towards the head and the six to 
the feet, to allow for documentation and describing on the time point of the clock, relating to 
the position on the wound that the measurement was taken from. For example: length was 
measured from 2pm to 8pm, the longest margin of the wound, with 12pm being nearest to the 
head. Alternatively, the measurement could be taken from the longest and widest point of the 
wound, though as the wound heals these points may occur in different places. Consistency is 
difficult to maintain if different wound care specialists take the measurements at various time 
points (on the clock), if there is not an agreed method of measuring (van Rijswijk, 2013).  
Wound area could also be evaluated by placing a clear acetate material onto the wound and 
tracing the wound shape (Flanagan, 2003; Oyibo et al., 2001; Renner & Simon, 2010; Sheehan 
et al., 2003) (Jørgensen, Sørensen, Jemec, & Yderstræde, 2016; Khoo & Jansen, 2016). The 
acetate wound tracing could then be transposed onto a software programme such as ImageJ ™ 
or Visitrak™ to measure the surface area and allow for a record to be kept of the wound 
parameters (Adams & Carter, 2011; Angspatt et al., 2018; Stacey, Phillips, Farrokhyar, & 
Swaine, 2017). The use of a commercial grid acetate showed the area of the wound and the size 
as determined by how many whole grid squares were shown inside the wound area. Due to 
wounds not being of uniform shape, each grid square that was partially included in the wound 
tracing was counted dependent on the percentage of inclusion within the tracing (Gethin & 
Cowman, 2006). For example: if half of the grid was included, then half the square was counted, 
if over half the square was included, then it was counted as a whole square, if less than half the 
square was included in the wound tracing, it was not counted at all. While this concept may be 
considered suitable by researchers conducting small randomised controlled studies on wound 
treatment products, it does not lend itself to be used within routine clinical care.  
The tracing of a wound onto acetate takes little time compared with time required to count fully 
and half covered grid squares. Between clinician interpretation of what determines a partially 
covered square enough to be counted can also vary. Wound dressing grids have previously been 
used to record the size and shape of a wound to allow for retrospective visual analysis of wound 
healing progress. Dressing tape, such as Smith-Nephew Opsite Flexigrid™ is an adhesive 
dressing, with a clear acetate backing, that can be placed over a wound. The backing cover has 
a printed grid image, allowing for the wound margin to be traced before removal and storage in 
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a person’s medical notes. Accuracy and reproducibility within these methods does not afford 
the precision that more recent methods of electronic wound imaging and wound tracing employ.  
The use of digital software to aid in calculating wound area of acetate wound tracings provides 
for greater ease of communicating wound size and healing. This method though is also time-
consuming, as requires the wound to be retraced onto the software digital surface to enable 
analysis and calculation, there is increased room for error due to retracing accuracy risk. Yet 
this method does allow for metric data to be transferred and stored in a database such as 
Microsoft excel™ for further analysis.  
Internationally, health care systems are increasingly being digitised, that is, they are becoming 
“paper-lite”. This has wide-ranging implications in wound care documentation. One of the 
implications is the reduced ability to employ acetate documentation. The introduction of digital 
photography, beginning with the Polaroid™ camera and progressing to cell phone digital 
images allows for images to be taken for comparison, however these methods do not allow for 
accurate wound surface area tracing, and rely on visual assessment of the photo to gauge wound 
size increase or reduction, even if tape measures or rulers are placed alongside the wound to 
give an indication of size. Variable room lighting, phone pixel quality, angle and distance from 
the wound can also alter the perception of the wound image and impair accurate assessment. 
The gold standard would be a portable calibrated device, which can upload wound images 
directly into the patient electronic health record (e-health record), where it can be accessed by 
multiple clinicians involved in that person’s care, and is able to show wound healing 
progression over time. 
Measuring length, width and depth were the most common methods employed in the 20th 
century for assessing wounds and provided consistent metrics for determining wound healing 
trajectories. Since the inception of 2-D and 3-D wound imaging and the availability of this 
method within routine clinical work flow, whereby wound margins can be traced with a high 
level of accuracy between clinicians, digital surface area has become the routine measure used 
to assess wound healing trajectories. High levels of accuracy, through methods of precision, are 
more likely to occur if the same clinician images the same wound and traces the wound margin 
(Seat & Seat, 2017). Within wound care specialty teams, the development of SOP, along with 
training and regular reviews, can aid in achieving high levels of accuracy (Wounds Australia, 
2016). The SOP should address the angle at which the image is taken with the top of the camera, 
acting as “north” as on a compass, pointing in the direction of the head. A decision on the inner 
or outer aspect of the wound margin also needs to be agreed upon for consistency when tracing 
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wound area. To provide accuracy and consistency in wound percentage size reduction, a method 
of measurement must be used that is able to be validated and adopted easily by other clinicians 
(Khoo & Jansen, 2016; St-Supery et al., 2011). Whether wound measurement is used within a 
natural clinical environment or RCT, it is important to assess interrater and intrarater 
consistency for reliability and validity of measurements (Seat & Seat, 2017). Intrarater 
reliability occurs through observing an individual clinician consistently tracing the wound 
margin on various wounds. Interrater reliability occurs when multiple clinicians are assessed 
for accuracy in tracing the wound margin on the same wound (Nixon, Rivett, & Robinson, 
2012). Shah, Wollak and Shah (2015) reflect on the importance of consistency between 
clinicians, which can be achieved with clear guidelines, set down as SOP, between clinicians 
to ensure and enhance precision (Shah, Wollak, & Shah, 2015). 
Circumferential wounds can make measuring and healing progress difficult to assess or 
accurately measure. Circumferential is usually associated with wounds caused by burns as they 
cover a large part of the body, rather than a specific site. Wounds on the feet are often described 
as circumferential as they spread around toes, or from the underside of the foot to the top of the 
foot, or around the heel. These wounds are difficult to measure, especially with photography, 
unless a programme can incorporate a technique whereby accurate circumferential 
measurements are able to be made. This supports the use of surface area measurements to assess 
wound healing progress and lends itself to the use of percentage reduction as opposed to using 
linear measurements. As shown below, Figure 3 shows an uneven wound that has more than 
one option for measuring length (a and b), yet with using imaging software, the wound margin 





Within a MDT, with consistent staffing and regular training, accuracy and precision can be 
achieved, however this is less likely to occur in a tertiary acute hospital setting where staff 
interchange frequently and the importance of adhering to a set SOP may not be recognised or 
informed.  
Evolution of wound measurement 
The International Working Group on the Diabetic Foot guidance for wound healing 
recommends the use of percentage reduction as a method for assessing wound healing (Game 
et al., 2015). In a review by Jørgensen et al., (2016) of assessment methods of wound healing 
using surface area and volume measurement techniques since 1994 were described (Jørgensen 
et al., 2016). Measurements ranged from the basic and inexpensive use of single use paper tape 
measures or rulers to measure length and width. In their systematic review Jørgensen et al., 
found this most basic and least expensive method to also have the lowest accuracy, due to 
wounds not conforming to regular sizes or having uniform edges. Differing mathematical 
formulas are discussed to use with length, width, and depth measurement to achieve a more 
accurate assessment of wound size. This appears a time-consuming and increasingly technical 
approach that may lend itself to small studies relating to wound healing within a controlled 
environment, but not within routine clinical care, although these measurements are promoted 
as being easy to obtain and more accurate than routine measuring.  
Figure 4: Linear wound measurement 





The study using this elliptical algorithm surveyed 81 diabetic wounds to compare this 
measuring technique to other available methods. It was not used at each wound assessing 
appointment in which wound healing trajectories could be determined. Though both manual 
and digital planimetry measure wound size through the use of grid square counting, by tracing 
the wound onto acetate, the digital version has not been shown to lose accuracy due to the need 
to retrace around the original wound tracing to transfer this to a digital forum. The benefit of 
digital planimetry allows for data storage, wound allocation, and easier retrospective analysis 
of change in wound size. Though not as cost effective as the manual version, digital planimetry 
lends itself to longer term usefulness. Due to the need to place a ruler or acetate directly on or 
near the wounds for these methods of measuring there is an increased risk of site contamination 
and introduction of infection. The move to non-contact measuring devices, with which to 
capture wound images, may deter those with budget considerations, but long term may have an 
economic benefit, due to the removal of a possible source of wound infection and wound 
healing inhibitor.  
Digital planimetry, along with stereophotogrammetry both require studio photography 
conditions, with the wound imaging device positioned at the same distance from the wound for 
each photo to aid accuracy (Wendland & Taylor, 2017). Stereophotogrammetry uses specialised 
software to create a 3-dimensional image from two 2-dimensional images taken of the wound 
that includes length, width and depth (Thawer, Houghton, Woodbury, Keast, & Campbell, 
2002). It has been reported that due to the variation in camera quality, wound margins can be 
hard to locate and then measure. The easy part would appear to be taking the photo. To then 
draw and measure the wound parameters, requires the use of a secondary software programme 
which can be problematic to those with limited computer software literacy. While the majority 
of publications argue that in the case of circumferential wounds, the use of acetate for manual 
planimetry to measure wound area is the most feasible and accurate compared with digital 
photography or stereophotogrammetry, technology has advanced where digital circumferential 
images can be taken in two or more sections and electronically joined together for measurement 
(Wendland & Taylor, 2017). 
Summary 
This review of literature shows that wounds often show signs of chronicity within the first four 
weeks of treatment, therefore requiring review of treatment methods with the view to 
implementing different treatments or interventions, such as, off-loading, investigation and 
treatment of infection, vascular procedures, larvae applications or surgical interventions to 
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assist healing. Wound imaging that utilises digital planimetry allows for inter and intrarater 
precision to occur and allows for the storage of metric data for comparison and later review. 
Surface area percentage change assists with the interpretation of wound healing metrics and 
allows for retrospective determinations to be made of wound healing progress. 
Within a real-world setting wound healing times can be impacted by real life factors such as 
diabetic peripheral neuropathy or peripheral vascular disease, as well as age, gender, ethnicity, 
renal function and glycaemic control, which impact on wound healing trajectories and highlight 
that one wound healing prediction model will not fit all wound healing scenarios. The use of 
electronic wound imaging within routine clinical care allows for wound healing trajectory data 
to be captured for the clinician to use, to inform other HCPs along with the person in their care. 
There is a paucity of data available for the utility of electronic wound imaging within a “real-
world” high-risk foot ulcer clinic, where data can be captured, without the need to adhere to 
inclusion and exclusion parameters of a clinical study. This research will aim to bridge this gap 
in understanding and evidence for the use of electronic imaging along with assessing if people 
with successfully healed DFU show a wound healing trajectory that can be used as a predictor 
to aid clinicians as they treat the wounds and communicate progress with patients.  
Part 2 of this integrative literature review will examine relevant articles relating to patient 
perceptions of the use of imaging within medicine to inform and educate as part of person-




Part 2 — Enhanced person-centred care through clinician-patient wound 
image review  This section of the literature review relates to the patient perception of the 
wound images, captured during routine visits to the high-risk foot ulcer clinic. It focuses on 
information sharing between the clinician and patient and how this may promote person-
centred care. It was anticipated that through including the person in their care planning and 
treatment goals, self-management of diabetes and wound care would be heightened. This 
review will investigate current research on person-centred care, illness self-management, 
along with the impact sharing of images with patients has on understanding their medical 
condition. 
Person-centred care  
Care of PwD requires a multiple disciplinary team approach between primary, secondary and 
tertiary care as the need arises (Australian Diabetes Educators Association (ADEA), 2019). 
Communication between each team member is essential to ensure the best possible outcome 
for the PwD. Of more importance is the understanding that the PwD needs to be in the centre 
of this care. Following guidelines first set out by the Picker Institute, person-centred care 
involves: sharing of knowledge in an educational format, involving people significant to the 
PwD, respecting their wishes, beliefs and cultural mores, providing easy to obtain information, 
inclusion of the persons needs and preferences, seamless integration of care between multiple 
HCPs, along with an acknowledgement of the person’s fears and anxieties within the context 
of the treatment being provided (Australian Diabetes Educators Association (ADEA), 2015; 
Shaller & Consulting, 2007). The New Zealand Ministry of Health has adopted the principle of 
person-centred services along with “Priority areas for action” in their 2015-2020 Living well 
with diabetes document (Ministry of Health, 2015). The emphasis being on enabling long-term 
condition self-management though the health care provider, supporting family/whānau 
involvement, as well as promoting communication between the PwD primary, secondary, and 
tertiary health care providers. The New Zealand Nurses Organisation encourages members to 
adopt a model of care that puts the person at the centre of their care in a way that enables them 
to respond to their needs. This model involves respect of the person’s values along with their 
ability to make decisions about the care they would like to receive, through listening and 
focussing on their needs, as opposed to putting the tasks that need to be done in the centre of 




Multiple publications describe person-centred care and patient centred care interchangeably. 
As people with diabetes spend the majority of their lives living within the normal flow of society 
as opposed to being a patient in a tertiary hospital it is more relevant to discuss their ongoing 
diabetes care as person-centred, as their healthcare is provided mainly through the primary and 
secondary healthcare sector. Person-centred care differs from patient centred care by 
acknowledging the person continues to be part of society and contribute to society as well as 
living with a long-term condition. Patient centred care can conjure up the picture of someone 
who is physically unwell, maybe in an acute phase of an illness, requiring tertiary hospital care 
(Barnett, 2018). 
Person-centred care (PCC) acknowledges the person’s needs and preferences through the 
building of a professional relationship with the foundation of respect and understanding (Eaton, 
Roberts, & Turner, 2015). This enhances communication between the PwD and HCP to achieve 
care in which the PwD feels included and can take part in. Although Robinson et al., (2008) 
writes about patient not person-centred care their article makes some synergistic points that link 
well with person-centred care through describing patient preferences relating to dealings with 
HCPs, with respect, health knowledge competence, civility and availability as necessary 
components to encourage the health consumer to partake in their care (Robinson, Callister, 
Berry, & Dearing, 2008).   
Collaborative decision-making 
It has been reported that PCC is an integral part of collaborative decision-making as it 
encourages and enhances communication between the PwD and those involved in their care 
(Robinson et al., 2008). Collaborative decision-making incorporates shared decision-making 
together with informed decision-making. Shared decision-making occurs between a person and 
their health care professional (HCP), where different options are given for the same outcome to 
occur, with both HCP and PwD taking responsibility for the decision. For example, someone 
with diabetes may be given the option of administering their insulin through an insulin pump 
as opposed to multiple daily injections. Here two different administration systems are offered, 
however the same outcome is desired – that is: the person will administer insulin as prescribed. 
Informed decision-making refers to the person being given as much education and support 
about different health care options in a way that is tailored to their level of understanding, so 
they feel fully informed before making their decision. The correct information should be 
provided effectively in a clear and non-threatening way, with plenty of time allowed for 
discussion and consideration (Robinson et al., 2008). Informed decision making may occur in 
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a patient with an ischaemic foot ulcer that has become static in its rate of healing, impacting on 
the patient’s lifestyle and mood. The HCP respects that the patient’s decision may not be the 
decision the HCP feels would be in the person’s best interests, however, provides as much 
information and advice prior to the PwD making their final treatment decision. An example 
could be a person with a DFU, which is not healing and requires radiological investigation, 
regarding the possible need for a femoral bypass graft, being offered revascularisation as an 
opportunity to optimise healing. If, following full and frank discussion, the PwD declined the 
option of revascularisaiton, the outcome of complete healing over a shorter time period would 
be different and may instead lead to an amputation. This can be difficult to the HCPs who follow 
evidence-based practice along with their own treatment experience and knowledge. Not 
offering these options is an example of a traditional paternalistic approach (Delaney, 2018). 
Trust and self-management 
The building of rapport, along with respect, is necessary to a successful therapeutic working 
relationship between HCP and PwD (Allinson & Chaar, 2016). The psychological impact of 
building a respectful working relationship between patients and health care professionals has 
been demonstrated to positively affect treatment adherence, due to people having a greater 
understanding of their care and the reasons for it (Williams, Walker, Smalls, Hill, & Egede, 
2016). Being included in decision-making enhances treatment adherence through the person 
having a greater sense of owning the treatment decisions (Krot & Sousa, 2017). Vedhara et al., 
(2016) identify psychological wellbeing as significantly impacting on a PwD and associated 
DFU healing outcomes, due to the effect on glycaemic control and treatment concordance 
which can influence diabetes related complications (Vedhara et al., 2016). Research has shown 
that up to one third of people presenting with a DFU have a diagnosis of depression (Nube et 
al., 2016). Difficulty finding pleasure in daily activities can result in decreased energy to care 
for oneself, or wound self-management, which can be components of low mood, along with 
difficulty communicating concerns or following detailed explanations as to care required and 
decisions needing to be made. Low mood and its associated features have a positive association 
with poorer healing outcomes for DFU, which in return adds to the person's propensity for 
depression (Nube et al., 2016). Early assessment and re-assessment of a person’s psychological 
well-being is an important step in the treatment phase of DFU, which will be more apparent to 
the HCP who builds a therapeutic relationship that encourages trust and rapport, to identify 
impediments to care that can be addressed externally (Doyle, Lennox, & Bell, 2013). 
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Communication and education 
As the HCPs and PwD work together in collaboration, it can enhance communication, which 
in turn allows for a non-threatening forum where questions can be asked, and education given. 
Education can take many forms and should be tailored to the situation and the person the 
education is being given to. With one on one information sharing, specific education can be 
given that may not be possible in a group setting. It has been found that if the PwD has been 
included in the decision-making process and feel they have ultimately made the decision to 
choose their course of treatment; they are more likely to adhere to this chosen pathway of self-
management (Robinson et al., 2008). It has also been noted that treatment adherence can be 
over two times greater if the HCP can communicate effectively (Thompson & McCabe, 2012). 
Adherence is the preferred term in contrast to compliance, as lack of compliance denotes a 
negative, conscious decision not to comply. Adherence is thought to be achieved at greater 
levels when shared decision-making within PCC is employed. Nine differing degrees of shared 
decision-making are described by Sandman et al., however they acknowledge that these nine 
variants do not allow for enough in-depth discussion or education to the point where the person 
is fully informed prior to making their decision (Sandman et al., 2012). This is where 
collaborative decision-making allows for the inclusion of the MDT members, together with the 
PwD and their support people, being able to come together, discuss, listen, learn and make a 
decision where the PwD is kept at the centre (Katon et al., 2010). Within the field of diabetes, 
collaborative care can involve diabetes specialist nurses, dieticians, podiatrists, psychologists, 
diabetologists, cardiologists, orthotists, along with clinicians from infectious diseases, 
orthopaedics and vascular specialties to work together with the PwD to provide holistic care. 
Education tools 
People with a chronic long-term illness, such as diabetes, require education and support over 
many years for their condition. The use of visual education tools, such as images (pictures) can 
be used to help discuss treatment options, risks and benefits of types of treatment, along with 
communicating progress within different facets of the long-term condition (Robinson et al., 
2008). In secondary care, specialised diabetes clinics support electronic blood glucose meter 
and insulin pump downloads that provide a picture of the person’s glucose control and insulin 
use. Interstitial glucose monitoring has added to this further, through providing a running record 
of basal glucose levels in a twenty-four hour graph. This information allows the clinician to 
speak to the PwD using the graph as a prop in the discussion (Figure 5). The PwD is also 
encouraged to recognise patterns within the graphs so they can download the information at 
home, allowing them to have a heightened understanding and involvement in their care. When 
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it comes to presenting data within the podiatry setting, in the form of images and graphs, people 
who attend specialist diabetes care services may be familiar with this method of communicating 
health needs as they may have already developed a familiarity with this form of information 
sharing with their blood glucose monitoring systems.  
 
 
The image (Figure 6) below shows downloaded data from a blood glucose meter that records 
finger prick blood glucose levels each time an individual pricks their finger with a lancing 
device, draws blood and applies it to the strip in the meter. The light blue dots are each 
individual test shown in a “modal” day format over a one-month period. As you can see the 
person consistently tests before each meal, two hours after breakfast and lunch and before bed. 
The black line is an average at each time point with the time of day being displayed on the “X” 
axis and the blood glucose levels represented on the “Y” axis. This data can be downloaded at 
a diabetes clinic visit and discussed with the person, when making decisions about possible 




Figure 5: CGMS graphical report 






Visual aids within diabetes have been specifically developed around patient education needs, 
such as conversation maps®, where a picture is chosen to begin conversation and discussion 
within a group of people who share the same diagnosis. For example: there may be a picture of 
someone exercising. People may discuss how difficult it is to include regular exercise into their 
daily routine, with others contributing ways in which they have done this that the others may 
find useful to adopt. Blood glucose control during aerobic or anaerobic exercise may be 
discussed with learned experiences being shared of at which time point to expect the greatest 
impact on blood glucose control. While conversation maps within diabetes have been shown to 
have varied effectiveness, they do add to the group of educational methods available to diabetes 
educators, and can suit people with a visual style of learning (Hung et al., 2017). The use of 
visual aids to convey risk versus benefit to those making decisions in a highly stressful and 
emotionally fraught situations is explained by Tokunboh et al., (2018) during the acute phase 
post stroke (Tokunboh et al., 2018). Within this context pictograms such as icon arrays or 
Palings palettes (see figure 7) have assisted in patient decision-making for invasive procedures 
such as the risk of miscarriage following amniocentesis compared with person’s demographic 
risk of having a child with a diagnosis of down syndrome (Paling, 2003). Visual aids, such as 
the use of icons have been promoted as a means of communicating medical risks to people 
classified as having low health literacy, by supporting risk versus benefit discussions, to assist 
with shared decision-making (Galesic, Garcia-Retamero, & Gigerenzer, 2009). 
 




When educating other HCPs about the importance of encouraging foot self-examination by 
PwD, visuals, such as figure 7, can be used to support the need to examine the whole foot, but 
especially the heel and big toe, due to the increased prevalence of ulcers in these sites (Heenan, 
2019). As Garcia-Retamero and Cokely (2013) suggest, visual aids are more effective when 
they present the information clearly and in a relevant format. This could be in the form of 
pictograms, graphs, or for a diabetes podiatrist - comparison wound images (Garcia-Retamero 
& Cokely, 2013). Incorporating visual pictures into education aids patient understanding within 
the clinic setting. As diabetes progresses, the increased likelihood of visual and cognitive 
impairment should be taken into consideration during education (Garcia-Retamero & Cokely, 
2013). With 30% of people with DFU having an increased risk of clinical depression, the ability 
to process highly technical information may be decreased. Using visual aids can enhance HCP 
and PwD collaboration, through dulling the intensity of the information being shared, therefore 
rendering the interaction less threatening, allowing the person to be more attentive to the 
information being shared (Paling, 2003).  
The realisation that health consumers also benefit from pictograms and graphs to aid decision-
making and treatment concordance has had little evidence published to support this. While 
Figure 7: Diabetic foot ulcer site probability  
(Heenan, 2019) ©iconarray.com 
56 
 
clinicians have observed this is the case, few studies have been shared to show, from the 
patient’s perspective, this to be a beneficial way they can engage in treatment. Another form of 
visual communication and information sharing is emerging using telemedicine.  
Studies are emerging that show the effectiveness of telemedicine within the health care system, 
along with the use of electronic health applications (e-health apps) that support long-term illness 
self-management. Diabetes e-health apps support the PwD to record their blood glucose levels, 
food intake, exercise and insulin dosages to allow for a pattern to be recorded for later reference 
(Jimenez, Lum, & Car, 2019). Some e-health apps provide a free-text field so the person can 
annotate specific notes relating to the time point. These notes could explain a blood glucose 
result, discuss food being consumed or relate to specific exercise being undertaken (Mosconi, 
Radrezza, Lettieri, & Santoro, 2019). In the community, e-health apps allow for community 
HCP to photograph and record wounds for comparison with previous images taken. Patients 
can also use the e-health apps to document their wounds and send these images to their health 
professional for review (Gray, Armfield, & Smith, 2010). Ensuring precision with these devices 
to gauge the size of the wound is difficult without a uniform size tag being used, such as a 10c 
coin, or a disposable tape measure. These images are often not able to be uploaded into the 
patient's e-health record or stored alongside multiple uploads for retrospective analysis, 
however they allow for sharing of the latest wound image information for discussion and review 
within a multi-disciplinary team setting. One barrier noted by Chavez et al., in using this system 
is the potential for mislabelling of the wound, when multiple clinicians are uploading the data, 
allowing for a lack of consistency (Chavez et al., 2019). Most e-health apps are not configured 
to allow for the direct upload of patient data directly into the patient’s e-health record. Later 
uploading of data incurs double handling for recording of results, leading to an increased risk 
of assigning the image to the wrong patient. Chavez et al., (2019) reports these issues were less 
prevalent when the e-health app was managed by a wound care specialist HCP and the image 
was uploaded at the time of it being captured. 
The use of visual cues is often aligned with the education of people with low health literacy, as 
opposed to acknowledging that different people have different styles of learning (Peregrin, 
2010). The decline in cognitive processing is acknowledged in PwD as the illness progresses 
and if prolonged periods of poor glucose control have occurred, this, in effect, could change a 
person with high health literacy into somebody who cognitively responds better to images and 
pictures, to comprehend and understand the education being given (Barros et al., 2014). Most 
publications found, relating to the use of images in patient education, were retrospective 
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Figure 8: The process of collaborative decision-making 
reviews of information retention following education, not in the use of images for decision-
making. 
Conclusion 
Through this review of the current literature relating to wound imaging of DFU and the patient’s 
view of this process, it was found that there is a paucity of data assessing the patient perspective 
of their care within the field of diabetes. There were limited articles relating to patient centred 
care and education methods that could enhance shared decision-making. This literature review 
for Part 2 has shown there is not an education model designed specifically around the sharing 
of medical images, whether they are radiological or photographic, for use by clinicians to 
promote understanding and awareness for the patients as they make decisions towards the 
advancement of their care. 
This research aims to show whether images used within the secondary care, diabetes high-risk 
foot ulcer clinic, enhance patient awareness of their wound healing and allows for enhanced 
understanding when interventions are required. The semi-structured interviews will assess the 
patient perception of the use of the wound images along with associated graphs to inform the 
PwD of the healing trajectory of their DFU. Having a greater understanding of the impact of 






Research methodology, design, and methods 
Introduction 
This chapter discusses the methodology and methods of sample selection, data collection and 
analysis used to gain a better understanding of diabetic foot ulcer healing trajectories within a 
high-risk podiatry clinic, outside a clinical trial setting along with exploring the person with 
diabetes perspective of treatment, which incorporates the use of a wound imaging device.  
Methodology  
 “the system of principles and procedures used in scientific endeavors” (Venes & Taber, 
2013)  
This research incorporates both quantitative (Part 1) and qualitative (Part 2) methods into the 
design. A review of multiple research methodologies has ascertained that an explanatory 
sequential mixed methods design will complement the research aims and objectives and allow 
for an expansive analysis of findings from both aspects of this research, that is Part 1 and Part 
2 (Andrew & Halcomb, 2009; Johnstone, 2004). An explanatory sequential mixed methods 
design allows for the collection and analysis of quantitative and qualitative data at differing 
time points and then integrated in the discussion chapter where the results and findings will 
mesh together in a complimentary fashion (Andrew & Halcomb, 2009). The use of mixed 
methods research (MMR) allows for the incorporation of both quantitative and qualitative 
methodologies, providing a forum in which research can be presented with greater range and 
complexity than if only one methodology has been used (Wisdom, Cavaleri, Onwuegbuzie, & 
Green, 2012).  
There is much debate within the MMR academics as to the place of MMR, whether MMR is a 
method or a methodology in its own right. It has been acknowledged in many publications that 
Tashakkori and Teddlie (2003) were the first to make MMR the third methodological approach 
within research with quantitative and qualitative the first two methodologies (Creswell & Plano 
Clark, 2017). One description Creswell and Plano Clark (2017) give for MMR, is as a superior 
methodology, used when more than one data source is required to give breadth and depth, to 
enable the answering of the research question (Creswell & Plano Clark, 2017). The benefit of 
using MMR is the ability to utilise the strongest components of both quantitative and qualitative 
research and mould them together to produce a more robust research study (Johnson, 
Onwuegbuzie, & Turner, 2007). Mixed methods research is seen as a worldview or pragmatic 
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approach to research, where both subjective and objective components are seen as valuable 
resources to the research question. Along with answering the research question, it allows for 
further answers to be found and discussed, further developing the findings (Rudestam, 2015). 
It is postulated by Creswell and Plano Clark (2017) that MMR is like a coming home paradigm 
that fits comfortably into health professionals’ psyche, due to the mix of quantitative and 
qualitative within the everyday performance of the job. Within the field of diabetes, blood 
glucose meter and log-book recordings are considered with a quantitative appraisal of the 
numbers, analysing patterns of control, or not as the case may be. This assessment is done 
alongside the patient where subjective unvalidated information is gathered on daily activities, 
changes in routines, along with anti-hyperglycaemic medication use, matching in with routine 
carbohydrate intake at meals. The information separately is useful, but has a lot more meaning 
when supported by the other, Greene (2007) refers to this as “multiple ways of seeing and 
hearing” (Greene, 2007, p. 20). In the first issue of the Journal of Mixed Methods Research 
(JMMR), MMR was defined as “research in which the investigator collects and analyses data, 
integrates the findings and draws inferences using both quantitative and qualitative approaches 
or methods in a single study or a program of inquiry” (Tashakkori & Creswell, 2007, p. 4). The 
advantage of MMR is ensuring that study findings are not just about depersonalised statistics, 
but also represent the person’s perception and experiences (Wisdom & Creswell, 2013). 
The strengths of qualitative research are that the person whose data is being collected gives 
their opinion and perceptions on the subject, therefore providing a wide and varied set of views 
for the researcher to be cognisant of. As seen in qualitative interviews there is not a right or a 
wrong answer, the important facet is the answer received and the person’s opinion that is given. 
This leads towards MMR being of a pragmatic stance in that it is realistic and real-world 
(Creswell & Plano Clark, 2017). 
Four worldviews or paradigms are described by Creswell and Plano Clark (2017) that are most 
commonly used as the foundation of MMR. The post-positivist view sits well with the 
quantitative research in this study as it allows for the testing of a hypothesis through data 
collection and analysis in an objective and impartial manner (Creswell & Plano Clark, 2017). 
Had this research been disproportionately weighted towards a qualitative angle then 
constructivism would be the dominant paradigm as this allows for multiple views to be sought 
and used to portray a viewpoint with none being wrong. Constructivism allows for subjective 
patient centred research to be undertaken with the researcher as the lead information gatherer. 
In doing so, the researcher’s bias can lead the research questions and answers towards the goal 
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they are hoping to achieve as it is collected in an informal and non-threatening manner. Using 
this paradigm, patterns and theories are created from patient views, gathered through interviews 
or questionnaires. Whilst both paradigms are the most suitable singularly for the quantitative 
and qualitative parts of this research, the worldview of pragmatism creates a stronger foundation 
for this research to build on.  
Pragmatism is the philosophical paradigm most commonly associated with MMR, as it 
combines the ontological views of post-positivism along with constructionism, through 
allowing the testing of a hypothesis as well as aligning differing viewpoints and perspectives 
to support the research. The epistemological approach of pragmatism allows for data to be 
collected in parallel, objectively and subjectively, allowing for the combining of this data at a 
time point in the research that complements the research question being asked (Creswell & 
Plano Clark, 2017). Evans, Coon and Ume (2011) define MMR most clearly as offering a view 
“in which reasoning moves back and forth between induction/deduction and 
subjectivity/objectivity”, just as will be done by this researcher as the wound healing metrics 
are discussed alongside the patient perception (Evans, Coon, & Ume, 2011, p. 2).  
The synthesis of wound healing metric results alongside findings of the patient perception 
interviews, within an MMR design, allows for the results and findings from Part 1 and Part 2 
to complement the other, is the reason this methodology has been selected for this research. 
This research will use an explanatory sequential design, where one type of data is collected 
first, prior to the collection of the second type (Andrew & Halcomb, 2009). In this research, the 
first data type is quantitative, a collection of wound healing measurements from the past three 
years, analysed retrospectively. The second type of data is qualitative, collected during the 
research period, as semi-structured interviews from current high-risk foot ulcer clinic patients. 
The development of the SSI questions was undertaken by the researcher following quantitative 
data acquisition, but prior to the analysis of the quantitative data. This temporal sequence 
ensured that the researcher had sufficient knowledge of the data to make sure that nothing of 
significance was missed when creating the qualitative questions, but also ensured that the 
researcher did not have sufficient new insights into study findings, to influence or bias the 
precise content of the SSI questions.  
Both the quantitative and qualitative data will be analysed and reported separately. As described 
by Andrew and Halcomb (2009), when using an explanatory sequential design in MMR the 
results and findings are combined in the discussion phase of the research, where it is evident 
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that one method supports the other (Andrew & Halcomb, 2009). In this study the wound healing 
results (Part 1) will be discussed together with the patient’s perception of the use of wound 
imaging within routine clinical care (Part 2) as shown in Figure 9. 
Within the discussion chapter the quantitative results relating to successful DFUs healed within 
six months and their associated healing trajectories will be discussed in relation to the 
qualitative interview findings. Person centred care will be discussed relating to wound healing 
success in association with patient participation in their care through communication, education 
and sharing of wound images shown within the routine clinical appointment.  
Rationale / justification 
The use of MMR has caused much written debate over the years, since the option of using a 
mix of quantitative and qualitative paradigms within one study has been posited. In this thesis, 
I will use MMR where quantitative and qualitative information is both reviewed. It is 
acknowledged that there are variations such as multi-method research, however it is the 
researchers understanding that multi-method research can incorporate two or more types of 
quantitative or qualitative rather than using a joint partnership of both quantitative and 
qualitative (Hesse-Biber & Johnson, 2015). For the purpose of this study, the reference to MMR 
will relate to quantitative and qualitative research used together to enhance the findings of the 
other. It is agreed the combination of quantitative and qualitative does not need to be evenly 
balanced within MMR, allowing for one to be dominant if required. The retrospective analysis 
of wound healing metrics, captured using a digital wound imaging device and associated 
software, provides a solid foundation for the perceptions of the people attending the high-risk 
foot ulcer clinic. The purpose of the qualitative research is to gain a greater understanding of 
DFU patient perception of wound imaging technology being used within routine clinical care 
to enhance self-management.  
This methodology was selected as being the most appropriate for the real-world, pragmatic 
study design being used to describe wound healing trajectories for patient’s undergoing wound 
imaging for their diabetic foot ulcers. This approach allows for a real-world survey of current 
patients attending the foot ulcer clinic to allow for sharing of their experience within this 
environment. 
Mixed methods research – Explanatory sequential design 
An explanatory sequential design will be used for this research, as the data has not been 
collected concurrently but at separate time points. Andrew and Halcomb (2009) describe 
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explanatory sequential design as involving the collection of quantitative data (Part 1) before the 
collection of the qualitative data (Part 2). The two data sets are then integrated following 
analysis of the results and findings, within the discussion chapter (Andrew & Halcomb, 2009). 
This design fits the form of data collection for this thesis the most accurately, where the 
retrospective wound healing data was collected prior to performing the semi-structured 
interviews. The quantitative data was not analysed prior to the semi-structured interviews so 
did not dictate the questions being asked, however the information, as it was being reviewed, 
did inform the researcher as to the direction the questions needed to take. The results and 
findings will be integrated in the discussion chapter, where insights will be highlighted, along 
with recognition of further research that may progress these learnings. 
 
 
Using an explanatory sequential design, the data that forms both parts of this research will be 
described separately, outlining inclusion and exclusion criteria for Part 1 and Part 2, the process 
of data collection, extraction, and analysis (Figure 9). 
This chapter has been divided into two sections. Part 1 will relate to the quantitative exploratory 
retrospective review of wound healing metrics. In Part 2, evidence is gathered from a qualitative 
review of podiatry patients attending a high-risk foot ulcer clinic and their perception of wound 
imaging within routine clinical care. The individuals used in Part 1 were de-identified and are 
unknown to the researcher, from whom the wound metrics were taken. The participants 
interviewed by the researcher for Part 2 had their results de-identified following the interviews. 
Where the setting, ethics permissions, data analysis and management were different for Part 1 
and Part 2, they will be reported as separate methods. Where there is a shared component 
between aspects of Part 1 and Part 2, they will be dealt with together, such as with the 
overarching methodology of mixed methods. 
 
Figure 9:  Explanatory sequential mixed methods design 
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Table 1: Explanatory sequential mixed methods research design 









with DFU healed 













Part 2 Qualitative 
descriptive 









Part 1 – Exploratory retrospective wound image data 
Aim 
To determine the predictive value of a DFU wound healing trajectory related to six month 
wound healing outcomes metrics in a multidisciplinary high-risk diabetic foot clinic, using 
electronic imaging. 
Design - pilot study  
Prior to the development of this research, a pilot study was undertaken by the diabetes centre 
podiatry and research staff to assess the utility of the wound healing data being collected 
electronically using the software available. This pilot project helped inform the researcher as to 
the methodology required to assess and analyse this data, as well as identifying the pitfalls of 
the data that had been gathered through routine clinical wound care. A medical student led 
summer project also occurred using a qualitative review to assess clinician preference related 
to viewing of wound metrics and images to encourage greater utility of the electronic image 
results. This initial questionnaire also gauged clinician preference relating to how to notate a 
current wound that has undergone amputation. Was their preference for the wound to continue 
under the same baseline pre-amputation classification, or should it be reclassified as a new 
wound? That is, if a right fifth toe ulcer were wound “A”, following amputation it would 
become wound “B”. This study also generated discussion within the podiatry team about the 
need for SOP and agreement around wound margin measurement for consistency, especially 
when patients were treated and imaged by fellow podiatry team members (Lunt et al., 2017). A 
podiatry team audit assessed the use of the imaging device during routine clinical care and 
64 
 
reasons for an image not being taken. This showed that patient hospitalisation or the need for 
an amputation interrupted the wound imaging process for that individual, as being the most 
common reason. This audit showed that as the imaging device was used more frequently, it 
became part of routine clinical care more readily. Reasons for an ulcer not being imaged at all, 
related to the ulcer being too small, or being considered too difficult to image, that is, the larger 
part of the ulcer was under the external skin margin may be due to a sinus tract and the depth 
of the wound could not be shown in the image.  
During discussion with the podiatry team prior to deciding on a specific methodology for this 
study, it became evident that wounds presented at the high-risk foot ulcer clinic at different 
stages. Some ulcers were noticed almost from the first day of skin breakdown, as the patient 
was already under the care of the podiatry service for another foot ulcer. Some patients during 
routine self-examination of their feet detected the ulcer and self-referred to the podiatry service 
having previously been seen there. Other DFU were first treated through a general medical 
practice or community podiatry for a number of weeks before being referred to the service. 
Having this knowledge enabled the researcher to decide that for consistency the first image 
taken during the first assessment appointment at the high-risk foot ulcer clinic should be the 
baseline image and measurement. The podiatry audit showed that over a 12-month period, 250 
patients were seen with 210 ulcers imaged over this time, with 30 patients only having one 
image taken. Following discussion with a medical biostatistician, with this prior knowledge, it 
was agreed that Part 1 of the study required at least 100 patients with at least four wound images 
available to be assessed from only one foot ulcer per patient so there would be sufficient 
information available to gain meaningful clinical insights from these data. As some foot ulcers 
showed a very lengthy time to heal, DFU which had healed within a six month period from 
baseline were chosen to assess if there was evidence of a significant wound healing trajectory 
for wounds that had successfully healed over this twenty six week period. 
Setting 
The data collection for this research took place within a secondary care, diabetes outpatient 
department, located within a tertiary hospital campus. This outpatient diabetes department hosts 
a multi-disciplinary team made up of diabetologists, diabetes nurse specialists, dieticians, 
podiatrists, psychologists, and social work clinicians. The diabetes specialist podiatrists manage 
a high-risk diabetic foot ulcer clinic, who see on average 470 patients per year with 
approximately 5.5% of these people requiring further input through a podiatry and vascular 
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clinic, which along with hosting vascular specialists, also includes specialist input from the 
infectious diseases MDT. 
The DFU measurement data has been captured during routine appointments, where electronic 
images are taken of each foot ulcer. The wound margin is traced by the podiatrist on the 
computer, allowing a software application to calculate wound surface area (cm2), showing 
wound healing progression on a surface area reduction graph to assist with determining wound 
healing progress, along with the use of comparison images. This data is stored electronically, 
through a customised digital application, behind the DHB secure firewall. 
A poster was created and placed in the podiatry rooms and the patient waiting area to inform 
people about the imaging device and the storage of their data in their electronic health record 
(e-HR) prior to the period the data for this study was collected from. The podiatry patients were 
also made aware this data was being collected, through the process of sharing current images 
alongside previous images at each appointment, to show wound healing progress. This was 
done as part of involving the podiatry patients in their care, to assist with education as an enabler 
towards wound healing.  
66 
 
Figure 10: Wound imaging and electronic health records notification poster 
 
 
Specialist podiatry clinic appointment procedures: There are two fully purposed podiatry 
rooms within the podiatry clinic, both with wound imaging devices and software applications 
installed, allowing for consistent use and accessibility. During a routine podiatry appointment, 
the patient will discuss first with the podiatrist their DFU, their thoughts and feelings about the 
DFU, along with treatment that has occurred since the last clinic appointment, often two weeks 
previously. This discussion provides a subjective overview for the podiatrist, prior to making 
their objective findings, where the dressing is removed and the wound assessed, cleaned and if 
required – debrided. A wound image is taken following preparation of the wound for dressing. 
Following completion of the wound dressing, the podiatrist will discuss the wound with the 
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patient, using the image on the computer monitor for the patient to see the wound more clearly. 
Using two monitors, the podiatrist is able to have the previous image displayed on one screen, 
with the current image on the other, allowing the patient to see the comparison, to assist in 
communicating the healing progress and why interventions are required. During this time the 
podiatrist will trace around the wound margin, using the computer mouse and cursor, which 
informs the software application, for calculation of wound length, width and surface area, 
plotting it onto a graph, so the patient can observe the wound healing trajectory. The graph of 
wound healing progression can be a useful visual for patients, as well as for clinicians as a quick 
“at a glance” overview. 
Diabetic foot ulcers 
Sample 
Sampling occurred as an exploratory retrospective analysis of people attending the high-risk 
foot ulcer clinic over a three-year period. Within this cohort, wounds were selected that had 
healed within a six-month time period from baseline. The selection of the six-month outcome 
measure relates to the study objective of assessing the wound healing data for commonality in 
the wound healing trajectory of wounds that have healed by six months. With the knowledge 
that DFU do not heal uniformly within a real-world setting, and the potential for wounds to not 
remain healed at subsequent visits, the selection of the 6 month time frame allowed for a larger 
cohort of individual wounds to meet the inclusion criteria, along with the determination that the 
wound had remained healed within this time, as per WHS guidelines. Baseline was defined as 
the first appointment where the patient was seen by the podiatrist, as opposed to when the 
wound was first noted, due to this often occurring in the community. The person is then referred 
through their general practitioner or community podiatrist to the high-risk diabetes foot ulcer 
clinic. Where a person had more than one DFU present, the DFU with the baseline measurement 
closest to the start of the data collection period is selected. Only one DFU per individual patient 
is included in this analysis.  
Inclusion criteria 
• Patient DFU, first and last wound assessment for individual wound, inside the three-year 
period. 
• Patient documented as having successfully healed DFU, with treatment range from 
baseline to healed not exceeding six months.  
• Patient DFU seen in clinic at least four times, with four measured images taken. 
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• Patients who were seen at high-risk foot ulcer clinic around four weeks, with measured 
image taken of DFU. 
• Correct patient DFU labelling throughout duration of wound treatment.  
• Patients with images of DFU, including malleolus.  
• Patients who did not undergo amputation related to DFU after baseline assessment made.  
Exclusion criteria 
• Unable to determine if patient DFU has remained healed following documentation of 
initial healing.  
• Patient individual DFU has three or fewer images available. 
• Patient has DFU images taken with no measurements (wound margin tracing). 
• Patient DFU healing progresses beyond six months. 
• Patient individual DFU images taken within the first six months of camera acquisition, 





Figure 11: Preliminary selection flow chart 
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Of note is that the wound metric data was de-identified prior to the inclusion and exclusion 
criteria being applied, so individuals were not ruled out due to any related demographics. The 
inclusion and exclusion criteria related to wounds only and the deletion of duplicate individuals, 
through a newly assigned primary key. 
During sampling, some wounds appeared to have healed within the six-month time frame, 
however on follow-up appointments the areas were shown to have broken down again. If these 
same wounds healed and remained healed for a second time within the six-month period they 
remained, with a new end of healing time point. If they did not remain healed, they were 
excluded from the study. This follows the FDA and WHS standard that wounds should be 
reassessed fortnightly on two occasions following the presumption of healing to ensure the 
wound has remained healed. 
Data Collection 
In this study, wound surface area metrics were collected electronically over a three-year period, 
from each patient appointment, using a calibrated wound imaging device (SilhouetteStar™), 
that allows for non-invasive wound tracing and which is routinely incorporated into clinical 
workflow. At the majority of podiatry patient follow-up appointments consecutive images are 
taken and tracings made. This data is collected into a centralised database stored within the 
Canterbury District Health Board secure network. 
Following the identification of de-identified individuals and wounds that meet the inclusion 
parameters, the primary identification numbers were given to the third party clinician, who 
holds the key to the primary identification numbers and their matching national health 
identification numbers. From these numbers, a list was compiled, and a request submitted to 
the DHB decision support team to extract renal, glycaemic and DFU classifications, such as 
neuropathic, ischaemic, or neuro-ischaemic, that was added for the analysis phase. 
Measuring process 
This study involves data collected through a software application associated with a 3-D imaging 
camera used within routine care, within a high-risk foot ulcer clinic for people with diabetes. 
The 3-D capability of the camera allows the calculation of length, width, and depth of the 
wound, following the wound margin being traced by the podiatrist. The wound images and 
measurements are stored on a server behind the DHB firewall, allowing for the data to be 
downloaded retrospectively for analysis at a later time. The depth measurements have not been 
used in this data analysis, as the podiatrists do not feel the depth is accurately measured in 
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sloughy wounds, or wounds with undermining or sinus tracking, also known as tunnelling. The 
clinic podiatrists have stated that biofilms can also impact on the accuracy of the depth measure. 
As depth is not required for a surface area measurement, it has not been taken into consideration 
for this research. 
The camera used is a solid round device, able to be held in one hand, enabling the podiatrist to 
move toes out of the way or move the foot for image capture with the other hand. It allows for 
the previously agreed position of wound image describing, using the clock method, to position 
the camera capture button at the twelve o’clock position towards the head of the patient to 
provide consistency between appointments and clinicians. 
The images are taken at the end of each appointment, following debridement and wound 
cleansing. Taking the image after wound cleaning gives a more accurate estimate of wound 
healing when the images are taken at the same point in the appointment. As the patient can view 
the wound image with the podiatrist and discuss the healing, it is beneficial to have the wound 
looking more aesthetically pleasing than prior to debridement. The images upload to the 
podiatrist’s computer in real time, allowing for tracing of the wound margin, using the computer 
mouse and cursor, within a specialised, uniquely developed software programme. This 
specialised software has been integrated with the DHB booking system, which allows for the 
pulling through of patient appointments into the wound imaging software programme each day. 
Once the patient's name has been selected by the podiatrist and the wound is labelled for its 
anatomical placement, the image becomes linked with the patient’s unique hospital number and 
is then stored within their electronic health record. Linking the image with the pre-populated 
patient details decreases errors in transcribing patient details and linking the images to the 
correct patient. Tracing of the wound margin by the podiatrist calculates width and length, 
which is stored alongside each image. These metrics calculate wound surface area, which were 
able to be downloaded into an excel spreadsheet to calculate wound healing trajectories, and 
percentage healing. The downloaded data was de-identified with a primary key allocated to 
each person, so as not to identify them during analysis. A third party held the key to the de-






Statistical methods and analysis 
The size of the study population was discussed with the researcher’s supervisors, along with a 
University of Otago medical biostatistician. Consideration was given regarding the need to have 
sufficient individual wound data to provide sufficient information for statistical analyses and 
provision of accurate results. Discussion took place about the practicality of increasing sample 
size by delaying the start of the study so that more clinical data could be collected and what 
impact this increase would have on statistical analyses and subsequent conclusions. As this 
research is an exploratory study, an exact power calculation was unable to be made and a 
decision was made to use a pragmatic sample size. The researcher was aware that this approach 
was unlikely to provide sufficient statistical power to enable a robust sub-group analysis of 
clinical variables that are traditionally associated with wound healing rates. 
Variable types were determined prior to analysis as categorical and continuous. Categorical 
variables included gender, diabetes type, presence, or absence of PVD, DPN and neuro-
ischaemia. Continuous variables included age, HbA1c, eGFR, and ulcer size at baseline, four 
weeks and throughout the healing period.  
Multiple wound healing papers discuss the most accurate calculation for wound healing 
progression assessments, with the Gilman (2004) equation reviewed by Jessup (2006) 
Figure 12: Wound imaging within a high-risk diabetic foot ulcer clinic (used with permission) 
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supporting the use of wound margin progression for assessing the rate of wound healing as 
being more accurate in large and small ulcers (Gilman, 2004; Jessup, 2006). 
Though there was a range of wound sizes from 0.04 – 14.64 cm2 in this research, the majority 
of these wounds (70%) were small wounds and will be assessed by surface area size reduction 
over time as well as percentage change from baseline to healing. 
The non-parametric Mann-Whitney U test and Fisher’s exact tests were used to determine the 
statistical significance of the associations between putative predictors of wound healing and 
time to healing. Median and inter-quartile ranges, frequencies, percentages, and p values are 
reported from these tests. The comparisons between the first 50% of wounds to heal (fast 
healers) and the later 50% to heal (slower healers) were similarly undertaken using the Mann-
Whitney U and Fisher’s exact tests. A two tailed p-value <0.05 was taken to indicate statistical 
significance. All analyses were undertaken using GraphPad™ Prism8.4 (GraphPad Prism, 
2020). 
Cumulative percentage healed were used for visualisation of wound healing trajectories within 
categorical groups such as male and female as well as evidence of micro-vascular disease 
compared to wounds with no diagnosis of micro-vascular disease. 
Glycaemic control parameters: Diabetes treatment parameters are driven by guidelines 
developed by the American diabetes association professional practice committee, with a 
number of publications in agreement determining that good and poor glycaemic control, relates 
to an HbA1c of less or more than 65 mmol/mol respectively (American Diabetes Association, 
2020). Some countries will express these values as an HbA1c of more or less than 8% (64 
mmol/mol). These parameters will be utilised in the analysis of Part 1 and Part 2 individuals to 
determine good or poor glycaemic control. Within Part 1, a good or poor HbA1c, that is, mean 
of blood glucose levels over a 3-month period, has been selected as a parameter to assess the 
glycaemic control of fast and slower healers. The term “poor” relates to the physiologic effects 
of an HbA1c above 64 mmol/mol and could also be interpreted as inadequate. 
Renal function categories: The American National Kidney Foundation provides six categories 
for the stages of chronic renal disease (CKD) as measured using an estimated Glomerular 
Filtration Rate (eGFR) (Daugirdas & Ovid Technologies, 2019). Stages 1 and 2 relate to a 
normal or slightly decreased eGFR of over 60.0 ml/min/1.73m2. An eGFR of less than 60 
ml/min/1.73m2 will be utilised as a marker for decreased renal function, which may be an 
indication of long-term poor glycaemic control and diabetes nephropathy, that is, micro-
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vascular complications. Stages 3 – 5 of CKD show a decline in renal function to the point of 
requiring dialysis when end-stage kidney disease is diagnosed. These categories will be utilised 
in the analysis of Part 1 and Part 2 individuals. 
Validity and reliability 
Ensuring the validity of the research data utilised for this research required assessment of the 
accuracy of the wound imaging device, adherence to SOP within the podiatry clinic related to 
use of the wound imaging device, along with unbiased wound selection for analysis by the 
researcher, achieved through de-identification of the data prior to wound selection. 
 The imaging device “SilhouetteStar™” is an ARANZ medical device (ARANZ Medical, 
2016a) with FDA 510(k) regulatory approval (ARANZ Medical, 2016b). Initially, the wound 
imaging camera required a routine calibration test to ensure accuracy, however software 
upgrades have removed the need for this as it is done electronically. No ruler or calibration 
marker is required to be placed near the wound. Reliability will be affected if the patient has 
multiple concurrent foot ulcers and the image is attached to the incorrect anatomical descriptor. 
In these situations, this can be corrected by an administrator with “super-user” permissions. The 
use of depth measurements has not been utilised in this research, as the camera is unable to 
measure the base of wounds hidden by pulpy tissue or affected by the presence of biofilms. 
Wounds with sinuses or under-running areas, obscured by a higher layer of tissue, will also not 
accurately measure depth. The observations of our specialist podiatry clinicians regarding the 
aberrant depth recording by this device is supported by Khoo & Jansen (2016) on review of 
wound measuring device comparison research undertaken within a fifteen year period (Khoo & 
Jansen, 2016). 
The podiatry team has created standard operating procedures through discussion and education 
whilst using the Silhouette camera to ensure consistent wound margin tracing. The patients 
routinely see the same podiatrist which aids in enhancing communication and building rapport, 
as well as ensuring continuity and consistency when wound margins are traced. Due to time 
constraints interrater reliability between podiatrists and wound tracing techniques were unable 
to be tested. 
The data analysis has been reviewed by Professor Christopher Frampton, biostatistician, 




Part 2 – Qualitative descriptive semi-structured interviews 
This qualitative research focused on understanding the role of wound imaging in enhancing 
education for the PwD about self-care of their feet when they are receiving treatment for an 
established DFU. This relates to recognising that different styles of learning can enhance a 
person’s understanding and health literacy, allowing for information sharing that will assist 
with decision-making regarding interventions that may decrease the risk of amputation.  
Within the diabetes arena there is a growing amount of technology for patients to use and be 
familiar, from blood glucose meters with updated technology, to insulin pumps, interstitial 
glucose monitoring devices, along with smart phone applications that can notify support people 
if blood glucose levels move outside the set parameters. The literature review revealed very 
little evidence of the PwD perspective on the use and involvement of this growing field of 
technology and how it may assist their diabetes self-management. Within the podiatry service, 
the researcher observed that patients appeared to show a greater interest and understanding of 
their healing progress when the wound images were shared and discussed with them.  
Aim 
The aim of Part 2 of this study was to gain an understanding and perspective from PwD, 
attending a high-risk foot ulcer clinic, regarding the utility of electronic imaging during routine 
clinical care. It will examine how the viewing of wound images between the patient and 
podiatrist allows for a greater understanding of required treatment and possible interventions 
that may be needed to assist with healing. 
Design 
A qualitative descriptive design was used for this research. This method, as described by 
Sandelowski (2000, 2010), allows for a combination of sampling, data collection and analysis 
that are derived from other qualitative research methods (Sandelowski, 2000a; Sandelowski, 
2000b, 2010). As Sandelowski (2010) has discussed, qualitative description allows for an 
eclectic combination of techniques related to data sampling, collection and analysis 
(Sandelowski, 2010). Kim, Sefcik and Bradway (2017) recognise the utility of qualitative 
description within health care and nursing for examining related phenomena (Kim, Sefcik, & 
Bradway, 2017). Qualitative description allows for an understanding to evolve from the patients 
experience through the creation of questions that address the participants personal insights of 
their podiatry treatment and wound imaging (Kim et al., 2017). This research in utilising a 
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Figure 13: Semi-structured interview process 
qualitative descriptive design, uses convenience sampling of participants whose data was 




The podiatry patients attend a high-risk diabetic foot ulcer clinic in the Diabetes outpatient 
department. This clinic is a secondary care facility within a DHB, which services a regional 
population of 567,870 people (Ministry of Health, 2019a). The patient population attending this 
clinic is small, as this is a specialist clinic for high-risk foot ulcers. The small number of clinic 
attendees relate to there often being other more significant comorbidities that take precedence, 
such as the need for dialysis, or progression of cognitive or visual disturbances related to the 
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long term effects with diabetes that supersede the time required for attendance at the high-risk 
foot ulcer clinic, with many other people with DFU continuing to be treated in the community. 
Participants 
Convenience sampling was used for the selection of the participants. Three podiatrists were 
asked to approach their patients initially, in line with the inclusion and exclusion criteria. It was 
felt that although convenience sampling can lead to bias, having the podiatrist first approach 
the patient to inform them of the study, would allow the patient a chance to decline in an indirect 
manner, as opposed to feeling unable to decline directly, if approached first by the researcher. 
While concerns have been raised that a convenience sampling group may not be a typical 
representation of the population being studied (Polit & Beck, 2020), the researcher determined 
from clinical experience with this patient group that the participants were a similar 
representation of the people attending the high-risk foot ulcer clinic by gender, age, and 
ethnicity. 
The participants were current clinic patients of the high-risk foot ulcer clinic, with a DFU, who 
met the inclusion criteria. The specialist podiatrists informed the patients of the study, who then 
agreed to have their names forwarded to the researcher, who later approached them to 
participate in the SSI.  
As per the inclusion and exclusion criteria if, when asked, the participant had not noticed the 
podiatrist taking a picture of their DFU during their clinic appointment, the interview would 
not continue. All participants indicated they had observed the podiatrist taking a photo of their 
DFU. 
The participants were given a choice of participating in the SSI face to face or over the phone. 
They were made aware that the interviews would be audio-recorded for later transcription and 
reassured that their answers and participation would not identify them. The podiatrists who first 
approached their patients, were not aware who participated in the SSI. 
Inclusion criteria: 
• Adult over 18 years old. 
• Able to process and answer SSI questions. 
• Current podiatry patient with DFU. 





• Time poor.  
• Visually impaired – unable to see wound or computer images. 
• Difficulty hearing or processing SSI questions. 
• Diabetes health professional recommends person not suitable to be approached (for 
example: due to patient confidentiality). A reason does not have to be given for 
individual patients. 
• Unable to give fully informed consent as per HDEC criteria of a vulnerable patient. 
• Interpreter not available to assist with translation for people who have difficulty 
communicating fluently in English. 
The podiatrists identified forty-six people who initially gave their consent to be contacted by 
the researcher. One patient later asked for his name to be withdrawn, due to other commitments. 
Following the researcher contacting the selected patients, two declined as they had since been 
discharged from the high-risk foot ulcer clinic. One person was not suitable following 
discussion with their diabetologist, another attended clinic for the interview, but could not wait 
due to another appointment commitment. On discussion with one patient, it transpired that they 
had no recall of having any images taken of their foot ulcer, which was confirmed on review of 
the image database. Nine other patients agreed to participate in the interviews but were never 
able to do so following their appointments or did not attend clinic for their appointment, 
following agreeing to participate. This resulted in thirty-one patients being available to 
participate in these interviews. 
People participating in the semi-structured interviews were able to have a support person 
accompany them during the interview. The support person, often a spouse or adult relative, was 
involved in the person's care outside of the clinic and dressed the DFU between appointments 
at home. Though not encouraged, the support person, when invited to comment by the 
participant, had some valuable insights to add to the interview and this has been included in the 
transcripts. 
Data collection 
The data was collected through semi-structured interviews (SSI) from patients attending the 
high-risk foot ulcer clinic. Semi-structured interviews were the forum selected for data 
collection, as it provided a less formal interaction with the participant that did not require 
intensive, in-depth questioning, where the person could feel under interrogation or respond in 
a defensive manner. The questions were used as a discussion guide, allowing the person to feel 
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relaxed to discuss a range of factors which may encourage them to feel more at ease during the 
interview. The fourteen questions allowed for responses to be gained that would assist in the 
answering of the research question. Other discussion about the person's family or employment 
background, that was not directly related to the research questions, were transcribed and 
considered for relevance to the research questions. These discussions were important as they 
allowed the researcher to see the participant as a person, with a family and a job, just not as a 
patient with a DFU. It allowed for a rapport to be built during the interview process, where the 
person could feel comfortable to give their full opinion. The one on one interviews created an 
environment where the participant could have the researcher’s full attention, as opposed to a 
group session where one participant may dominate the discussion where other participants' 
opinions or responses may be lost. 
After the potential participants were given initial verbal information about the study by the 
podiatrist, the researcher then contacted potential participants to ask if they would be willing to 
participate. A brief overview of the research objective was given, along with an explanation of 
what would be required of them. The potential participants were reassured that they were not 
to feel pressured into participating and if they declined, it would not affect their care within the 
diabetes / endocrine service. As per the ethics proposal, the podiatrists were not informed by 
the researcher of who had agreed to participate and who did not. Written informed consent was 
obtained from each participant. A copy of the signed patient information and consent sheet 
(PICS) (Appendix: A) was given to each participant prior to the SSI start. The majority of 
interviews took place within the clinic after the person’s podiatry appointment had taken place 
for the day.  
A room away from the main business of the clinic was selected to reduce noise interference due 
to other clinic appointments occurring at the same time. A sign was placed on the door 
informing people that an interview was being conducted to avoid interruptions. Each person 
was offered a hot or cold drink to have during the interview and were again given the 
opportunity to decline participation.  
At the beginning of each interview the participant was reminded that the interview would be 
audio-recorded for transcription purposes and their answers would not be linked to them or used 
in a way that would identify them. They were reminded that they could withdraw from the 




Two people opted to be interviewed by telephone between their own home and the researcher’s 
office. Written informed consent was obtained prior to the telephone interviews occurring at an 
earlier clinic appointment. The people being interviewed were aware that the researcher was 
using a speaker-phone so the interviews could be audio recorded and consented to this 
procedure. They were asked if it was still a convenient time to conduct the interviews before 
they proceeded. These telephone interviews were done from the researcher’s office with the 
door locked and a sign asking that they not be disturbed during these interviews. The room was 
sufficiently soundproof that the participant responses could not be heard outside of the room.  
To record the interviews, a voice activated MP3 recorder was used that allowed for the 
interviews to be transferred to a computer for storage following the interview. These were 
played back using MP3 playback software installed on the computer as a default application. 
The software allowed for the voices to be slowed down and paused to aid in the transcription 
process, which took approximately one hour for each interview. The participants were given a 
primary number and were not identified by name. All interviews were conducted individually. 
Semi-Structured Interview guidelines 
The interviews consisted of 14 questions (Appendix: B) which align with the New Zealand 
District Health Board outpatient survey parameters to assess communication, partnership, 
coordination, physical and emotional needs (Figure 14). The initial questions were constructed 
as an informal discussion of the person’s DFU and their recollection of how their DFU occurred 
or when their DFU was first noticed. The participants were also asked if they recalled who had 
first referred them to the high-risk DFU clinic. Questions were then asked to specifically target 
awareness and feelings toward the use of the imaging camera during the podiatry appointments. 
The final question gave an opportunity to the participants to add anything else that they felt was 
useful or they wanted to share about their wound healing journey or clinic visits. 
Participants were thanked for their time and were again reassured that their answers would be 
kept confidential and grouped into themes so that they would not be recognised by any comment 








This study examined the perceptions of patients who were able to visually see their wound 
healing progress. It also sought their opinions and perceptions of how this assisted with 
engagement related to clinical recommendations. The SSI questions were developed during 
review and filtering of the quantitative raw data, where wounds healed within six months were 
identified and selected if they met the inclusion criteria. The researcher’s review of the 
quantitative data was undertaken prior to any formal analysis, ensuring significant questions 
were not omitted from the qualitative interviews. These questions were created prior to the 
quantitative data being formally analysed. The researcher did not review the data in a way that 
might result in bias by being informed of the findings following structured analysis. 
Data analysis 
Thematic analysis was selected to identify common themes emerging from the data set gained 
from the interviews with the participants in this study. As the researcher undertook the 
interviews with the participants and transcribed the audio-recordings, they had a familiarity 
with the transcribed data, recalling the context in which the answer was given, and therefore 
able to categorise the comments accurately. As described by Braun and Clarke (2006), thematic 
Figure 14: Interview questions with associated themes 
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analysis allows for the identification and analysis of patterns within the data set (Braun & 
Clarke, 2006). This framework recommends a six-step approach to analysing the interview data.  
Step 1 – Familiarisation - occurred with the audio transcription verbatim of each individual 
interview and re-reading the transcripts multiple times.  
Step 2 – Generation of codes that were relevant to the research question.  
Step 3 – The search and identification of themes or categories within each general theme 
group.  
Step 4 – Review – interviews are re-read and reviewed. Comments and statements are 
summarised and grouped.  
Step 5 – Defining – the summarised comments are reviewed as to which domain and theme 
they fit within, this allows for the transition to writing a report. 
Step 6  – Writing a report – where the outcome of results can be linked to the research 
question and inform the results (Braun & Clarke, 2006, pp. 16 – 23).  
The interview transcripts became the data set that the researcher used to search through looking 
for “repeated patterns of meaning” (Braun & Clarke, 2006, p. 15). The interview data for each 
participant were grouped together and arranged per question. As patterns emerged, the 
transcripts were further reviewed for more examples to identify sub-themes and themes.  
Domains and emergent themes 
The semi-structured interview (SSI) questions were created using the five domains from the 
New Zealand DHB outpatient survey as a framework for the questions (Figure 14). These 
domains were not used during thematic analysis of the interviews as this was an inductive 
analysis using Braun and Clarkes (2006) guidelines and structure for performing a thematic 
analysis, that is, when reviewing the interview responses there was no attempt made to fit the 
responses into the predetermined domains (Braun & Clarke, 2006). The Braun and Clarke 
(2006) framework for thematic analysis sets out six steps to follow when conducting qualitative 
research of responses from data collection interviews. 
Step 1:  Understanding the data through transcribing the interview responses 
As the researcher gained consent from the participants for the interview process, an initial 
engagement between participant and researcher had already begun prior to the start of the 
interview. This continued as the interviews were undertaken and responses given, allowing the 
researcher to be fully aware of the context of the responses. This allowed for a greater 




Further to this, the interview responses were electronically reconfigured to group all responses 
to each question together before printing as a hard copy for further review. The responses were 
read several times to allow for topics and common thoughts to come to the fore. 
Step 2: Identification of codes  
As described in step 1, as the interview responses were transcribed and re-grouped as per each 
question. Initial codes appeared as each participant response was read, then added to as each 
subsequent response was reviewed. A count was kept as to how many participants reflected a 
particular code, giving it support to be considered as a theme, such as communication, clinical 
management, technology, and support. The statements that matched these initial codes were 
highlighted and tagged. 
Step 3: Firming up of identified themes 
Following further reviews of the interviews and subsequent review of the codes and potential 
sub-themes that appeared within some categories. An example of this was the communication 
theme, where responses were grouped into communication about healing, language used for 
communication, and communication of the wound images during the consultation. 
Step 4: Revision of themes 
Themes and examples from the interview responses were reviewed and discussed with the 
researcher’s supervisors to ensure they were an accurate portrayal of the interview responses. 
Step 5: Theme nomenclature 
Through the interview responses and allocation of themes, names for the themes became 
evident that encompassed the categories of information being expressed. Within these groups, 
there with sub-themes that were worthy of inclusion due to the rich information and insight they 
provided. 
Step 6: Findings of thematic analysis 
Chapter 4 will outline the findings and justification for the thematic analysis that has followed 
the framework created by Braun and Clarke (2006) (Braun & Clarke, 2006).  
Research Integrity 
Research integrity serves to verify the trustworthiness of the researcher, along with the data 
they are presenting (Lincoln, Guba, & Pilotta, 1985). Within exploratory-descriptive qualitative 
research, integrity and trustworthiness describes the rigour through which research should be 
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performed and presented (Hunter, McCallum, & Howes, 2019; Ryan, Coughlan, & Cronin, 
2007). 
Rigour relates to the need to demonstrate the research is valid and reputable, through showing 
the application of credibility of information, dependability through replication, transferability 
where repeatable results occur within other settings or situations and confirmability of the 
researcher to minimise personal bias when interpreting interview data. This will allow for 
correct themes to be gleaned from the data set (Maher, Hadfield, Hutchings, & Eyto, 2018; 
Ryan et al., 2007). Demonstrating these criteria shows authenticity of the research and integrity 
of the researcher (Ryan et al., 2007). 
The aim of this qualitative research has been to understand the person’s perception and 
experience of wound imaging, where there were no wrong answers. The rigour component of 
this research has been ascertained through the review of the interview transcripts by the 
researcher’s supervisor, along with discussions within the podiatry department about the 
responses received, to compare with their perception of the patient experience. The initial SSI 
interview responses were included into a poster presentation submitted to the Australasian 
Diabetes Congress (2019). This poster was shared with some participants who took part in the 
interviews, aiming to assess if they felt the information in the poster was an accurate reflection 
of their comments. The SSI participants gave positive feedback to the researcher relating to the 
poster representing a correct portrait of their feelings and responses. This reflects research 
credibility in addressing the research question. 
Authenticity was achieved through allowing the podiatry patient to choose if they would take 
part in the SSI, allowing them to speak freely throughout the SSI, allowing them to be heard 
and for their perceptions to be interpreted correctly. There was no time limit on the interviews 
with most ranging from 40 – 60 minutes. Examples of responses given by participants are 
included in the findings to give credibility to this research. 
Although this research relates to wound imaging of diabetic foot ulcers, it was not meant to be 
used solely within this realm. It is hoped that the findings have transferability to other areas of 
health care delivery where medical images have the potential to be used to inform and educate 
patients and their support people. It is felt that the findings will also inform clinicians of the 
importance of image sharing within collaborative care.  
The Methods section for this research clearly outlines how the participants were selected, the 
inclusion and exclusion criteria that were used to select potential participants. The process used 
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for selection, along with the consenting process and performing the SSI. This relates to being 
dependable and providing enough process information that the study can be replicated by 
another person at another time. 
In summary, the approach to this research has been to incorporate concepts of rigour, 
credibility, replication and transferability, within the study design and methodological process, 
with the aim of producing deep and insightful interactions with the data, as suggested by Maher 
et al. (2018) (Maher et al., 2018). 
Ethical considerations 
The researcher is employed as a research nurse for pharmaceutical clinical trials. Due to this, 
she has a heightened awareness of the need for principles of Good Clinical Practice (GCP), 
along with the Declaration of Helsinki, a formal guideline developed by the World Medical 
Association (WMA) that forms the ethical guidelines for Physicians and HCP who are 
undertaking research on humans (World Medical Association, 2013). The catalyst for the 
creation of the Declaration of Helsinki were the atrocities that occurred during World War II, 
outlined in the foundational Code of Nuremberg principles for the protection of human research 
subjects (Holt, 2014; Ndebele, 2013; Sprumont & Andrulionis, 2009). Described as a 
“document of conscience and responsibility”, it created a solid foundation upon which research 
involving humans should be constructed, utilising beneficence, non-maleficence, autonomy and 
justice to provide strength and legitimacy to the research (Holt, 2014, p. 407). As a “living 
document” the Declaration of Helsinki has been further developed over the years to promote 
greater transparency in research. Exploitation of study participants is a recognised trap for 
research recruiters and the need to prevent this mistreatment is included in a more recent edition 
(Arie, 2013).  
The principles of Good Clinical Practice (GCP) were developed as international quality 
standards for ethical scientific trial conduct involving human subjects, beginning with study 
design, conducting research and reporting of results (Sprumont & Andrulionis, 2009). 
Identification of under-represented populations is required to ensure this group has adequate 
opportunity to participate in research (Ndebele, 2013). Within New Zealand, Māori are 
recognised as a potentially under-represented group. In conjunction with the healthcare 
organisation ethics application, approval was sought through the local Māori consultation 
process. Māori consultation was also required and obtained, through the University of Otago, 
Health Ethics committee. It was acknowledged that within the specialist diabetes podiatry 
service there is a low ratio of Māori and Pacific Island patients receiving care, not due to 
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exclusion, but due to other co-morbidities taking priority over health and lifestyle. The New 
Zealand Government health statistics indicate that the Māori population over 25 years of age 
have a one and a half times greater likelihood of developing diabetes than non-Māori, and 
within this cohort there is a five times greater incidence of renal failure occurring (Ministry of 
Health, 2018). Following discussion with the University of Otago, Christchurch, Māori 
consultation māngai, the expectation was communicated, to share our results and findings with 
local Māori at a hui. The high-risk foot ulcer clinic podiatrists, who initially approached their 
patients to inform them of the study, enquired of their patients if they would be happy to be 
approached by the researcher to be informed further about the study and possible participation. 
The podiatrists were encouraged to approach people from all ethnicities and socio-economic 
groups to participate in the research to maintain equity, though they were unaware who agreed 
to participate, following passing the potential participants' names to the researcher.  
Research at Master’s level or below does not require New Zealand HDEC approval as per the 
Scope of Review document (Health and Disability Ethics Committees, 2017). The Diabetes 
department Clinical Director, prior to approving research that dealt directly with department 
patients, as in the case of the semi-structured interviews, requested HDEC approval be obtained 
for this research. Contact was made with an HDEC representative and this was discussed with 
them prior to submitting the application. 
Consultation also occurred with HDEC regarding the exploratory retrospective analysis of 
wound surface area metrics that are gathered during routine clinical care of our podiatry patients 
each time their DFU is imaged. It was explained that the data was to be de-identified prior to 
analysis. During the period of data collection and analysis it became apparent that new 
definitions of de-identified and anonymised data were being discussed and it was less clear as 
to clear ethical boundaries through which to conduct this research. As permission had been 
given on the earlier understandings, the researcher proceeded to work within that framework. 
A new Patient Information and Consent sheet (PICS) has now been published by HDEC that 
clearly outlines, for patients consenting to research, the differences between de-identified and 
anonymised information (Ministry of Health, 2020).  
The data used for Part 1 of this research has not been consented to individually by the patients 
whose wound healing metrics have been used, as it is an exploratory retrospective analysis. 
Through consultation with an HDEC advisor regarding the use of de-identified data for the 
quantitative analysis, we were advised that the use of the quantitative data was outside of their 
remit due, to the project not having any direct interactions with patients and therefore deemed 
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a study that did not include participants. With the need for transparency, a poster (Figure 10) 
had previously been created that was placed in the diabetes secondary care waiting room, as 
well as in the podiatry rooms, explaining the images being collected were stored on the persons 
electronic health records (e-HR). The wound images and associated metrics may be viewed as 
part of a clinical audit or for research purposes, with the aim of improving service delivery. The 
poster included a statement clarifying research data would be de-identified unless we had 
specifically asked for their written permission in advance. This poster also included the Health 
and Disability Freephone number and email address if people felt concerned and wanted to 
discuss this with someone impartial to the situation. 
The latest HDEC definition of de-identified data is data that is coded, where the person is only 
known by the code after this is assigned. A key is held by a researcher or research group that 
an individual can be identified if required, during the research. This is similar to the process 
described by Phillips & Knoppers (2016) who suggest that data should be described as 
pseudonymised, where a pseudonym code is given to unique identifiers to allow for later re-
identification if required and anonymised data, through the utilisation of de-identification 
having all identifiers removed to prevent re-identification (Phillips & Knoppers, 2016). The 
explanation of anonymised data by HDEC is data that has been de-identified or pseudonymised 
through a code being applied, then having the code removed with no ability to re-identify the 
person or specimen following this process (Ministry of Health, 2020). The researcher is aware 
of this process being used with the collection of “future use samples” within clinical research. 
To protect the patients, the data has been de-identified. That is, a code has replaced the patients' 
national health identifier (NHI), with the key stored separately for use by a third party (Decision 
support) within the DHB to provide demographic and diabetes related information to the 
researcher. All other identifying features downloaded with the wound healing metrics were also 
removed. These research methods and methodology were approved by the University of Otago 
Health Ethics Committee prior to the research commencing (Approval letter Appendix: B). The 
data has been stored electronically behind the DHB firewall in a file only accessible to the 
researcher. Following the study end, the data will be kept on a password protected external 
drive and stored within the University post-graduate nursing department secure room for ten 
years. Following this, the data will be destroyed. 
The ethical considerations for Part 2 of this research were greater as this research involved 
information collected from current patients attending the high-risk foot ulcer clinic. Following 
discussion with the researcher’s supervisors, the department clinical director was approached 
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for permission to conduct this research within the department. Research permissions were 
required through the DHB as well as the University of Otago. Along with this, HDEC out of 
scope ethics permissions were applied for and obtained with ethics approval 18/NTA/100 (see 
Appendix: C). All ethics permissions were obtained prior to any patients being approached for 
recruitment into the research. 
The researcher was very mindful of the need to conduct the research in a professional way, 
adhering to the need to provide autonomy, where patients were not coerced into participating 
in the research. Autonomy was aided by the patients being approached firstly by their 
podiatrists, who informally discussed with potential participants the research project and asked 
if they would be happy for the researcher to contact them, to ask if they may be willing to 
participate. In using the podiatrist as the first contact, it allowed the patient the opportunity to 
say they would prefer not to be contacted without feeling coerced. The podiatry patients were 
reassured that it was their right to ask not to be contacted, with the knowledge it would not 
affect any future care they were receiving. As described by Fleming and Zegwaard (2018) this 
is removing the power differential (Fleming & Zegwaard, 2018). Potential participants who 
agreed to be contacted by the researcher were given a copy of the PICS to read and review. The 
PICS gave an overview of the research. Prior to giving written consent the participant was given 
time and opportunity for discussion about the research. Participants were able to choose to 
conduct the interview following a clinic visit or over the phone.  
With regard to beneficence, it may have benefitted the person to be able to share their viewpoint 
and have a say, or it may benefit future patients. The participants were reassured that there were 
no wrong answers and that their opinion was beneficial, especially as it may assist our 
understanding of the use of technology for future patients and technologies.  
Participants were reassured that the answers they gave would be not be used in a way that would 
identify them. Their audio-recorded interviews were given a code that only the researcher held 
the identification key for, in a secure file, kept behind a firewall. Following de-identification of 
the participants, the researcher felt the risk of maleficence was low, though the researcher was 
aware that discussing ongoing care of a condition that is chronic and may result in an 
amputation can be distressing for people. The researcher also recognised that participants may 
raise concerns about their illness or treatment and endeavoured to reassure them as this arose. 
One participant raised a current concern that the researcher recognised could be dealt with after 




The last question of the interview provided the person with an opportunity to mention anything 
that they felt was important, but not previously covered in the interview. This allowed the 
participant to have a voice and showed that the researcher was interested in them as a whole 
person. There was an equitable cultural mix of participants in line with the cultural mix of 
patients attending the high-risk foot ulcer clinic. This relates to justice, where the needs of the 
participants should be prioritised above the objectives of the study. This can also relate to 
vulnerable populations, such as the elderly or people with reduced mental capacity. The 
researcher acknowledged that support people reduced the risk of the person feeling vulnerable 
and at times assisted with question answering when asked for their input by the participant. 
Summary 
This chapter has outlined the methodology behind mixed methods research and how it has been 
applied to this study with people with diabetes who have a high-risk foot ulcer, through the use 
of quantitative and qualitative research. Wound healing trajectories from clinical wound healing 
metrics, along with the patient perspective of their wound healing, have been investigated. The 
methods used to obtain these results have been outlined, along with the ethics required to allow 
for this data to be collected as per GCP guidelines. Participant selection for both the quantitative 
and qualitative aspects of this research have been explained. 
The results chapter which follows will expand on the findings from both the quantitative metric 
analysis as well as the qualitative thematic analysis of the semi-structured interviews. Quotes 
from the interviews will be included to illustrate the findings as clearly as possible, however if 






Results and Findings 
Introduction 
This chapter will be divided into two parts, with Part 1 describing the results of the exploratory 
retrospective analyses of wound healing metrics and Part 2 describing the findings from the 
semi-structured interviews. The individuals whose data has been used for Part 1 and Part 2 were 
selected from the high-risk diabetes foot ulcer clinic located within secondary care, an 
outpatient service aligned within a tertiary hospital managed by a District Health Board (DHB). 
Data collected for Part 1 and Part 2 was however collected from two different groups of 
individuals with different demographic backgrounds. 
Analyses included variables highlighted in other wound healing research that may be implicated 
in the healing or non-healing of these wounds, such as glycaemic control and renal function 
during the treatment period. It is however acknowledged that the previous research identified 
in Chapter 2 indicated that there is not a strong relationship between renal function, glycaemic 
control and healing rates, likely due to multiple clinical confounding factors such as type and 
duration of interventions attributing to the success of DFU healing. As shown in the literature 
review a background of DPN or PVD strongly influences the outcome of diabetic foot ulcers, 
the type that are predominantly referred to the service. Data has therefore been collected on 
DPN and PVD for analysis as a background risk factor. Part 2 relates to the person’s perception 
of wound imaging technology used within routine clinical workflow, as well as investigating 
clinician-patient communication and education during podiatry appointments, and the impact 
this might have on the wound healing journey.  
Part 1 – Exploratory retrospective analysis of healed wound metrics 
Purpose 
The purpose of this research was to explore DFU healing, pre-defined as those that had healed 
within six months, to evaluate if there were patterns or predictors of wound healing, for 
example: a time period early in healing, that was able to inform later rates of healing. 
Independent variables such as glycaemic control and renal function during the time of wound 
healing were also assessed along with known precipitants for DFU, such as DPN and PVD. A 
person having both PVD and DPN will be described as having neuro-ischaemia. Duration of 
known diabetes was not collected, as this was an exploratory retrospective audit of wound 
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Figure 15 Selection process for identification of individual wounds and inclusion criteria 
healing metrics and detailed data was not available without operating outside of the scope of 
ethics permissions gained to study this population group. Also, duration of known diabetes 
differs from detection of hyperglycaemia. Gaining retrospective patient consent would not have 
been possible with some patients having died or been discharged from the podiatry service since 
treatment. 
Aim 
The aim of this research was to identify a consistent identifiable wound healing trajectory for 
wounds healed by 6 months. 
Expected outcome 
The expected outcome for Part 1 will identify a consistent healing time point that can be used 
to predict successful wound healing for people with DFU, that will inform clinicians within the 






Following receipt of ethics approvals, along with related local hospital board and research office 
permissions, data from a three-year period were downloaded into a spreadsheet format where 
9258 wound images were made non-identifiable to the researcher with a primary key assigned 
for each individual patient national health identifier (de-identified) (National Ethics Advisory 
Committee, 2019). The researcher’s supervisor holds the identification key, stored within the 
hospital firewall, for the individual patients used in this review, for sharing with a DHB third 
party who will provide the patient demographics. Following making these data non-identifiable, 
data filtering techniques were used to remove any images that were taken of anatomical areas 
other than the foot, for example: lower leg; and remove duplicate images taken at the same 
appointment (n=8234) (Figure 16).  
These data from n=103 individuals relate to wound image measurements captured from 
baseline assessment until the point at which they were documented as healed within six months. 
The wound with the baseline assessment closest to the research start time was chosen, where 
multiple wounds were available to select, to reduce bias of selection. It was anticipated a sample 
size of n=100 would provide sufficient information to undertake this exploratory semi-
descriptive retrospective analysis. It also showed that many of these individuals continue to 
attend the foot ulcer clinic for concurrent or recurrent foot ulcers, some of which result in 
amputations or have a DFU that takes longer than six months to heal. A preliminary analysis 
showed that approximately 350 individual patients attended the high-risk foot ulcer clinic per 
year with 25% being seen at a specialised MDT clinic that involves the vascular and infectious 
diseases clinicians, along with diabetologists. Due to this, a pragmatic time interval of three 
years was selected for the data collection period to allow for provision of sufficient data points 
for analysis of wound healing. 
As seen in the flowchart above, 440 individuals with DFU were excluded, with the largest group 
relating to individuals with three or fewer wound images taken. The main reasons why only 
three or fewer images were taken are:  
• The wound showed fast initial healing, and the patient chose to be discharged back to 
community wound care services. 
• The wound was showing no signs of decreasing in size and required surgical debridement 
or amputation, resulting in the wound being treated in a hospital setting or being re-
labelled as a new post amputation wound. 
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• Concurrent wounds, that were outside study inclusion criteria, took precedence due to 
size or severity, with the subsidiary wounds not being further imaged, or included in the 
other wound imaging, but not labelled as such. 
• The patient may have died, as information was de-identified, it was not possible to 
confirm this outcome. 
The next group of exclusions (Figure 16) relate to i) Individuals with no podiatry input beyond 
six months or without documented evidence of healing. This group is likely to relate to the 
patient being discharged to community wound care, whether through primary care, a specialist 
home visit wound care group, or community podiatrist. ii) Wounds that did not show 100% 
surface area reduction at six months or during follow-up appointments post wound healing 
assessment were also excluded from inclusion for analysis.  
Of the 543 individual patient wounds selected, 68 individuals showed evidence of wound 
imaging, but without wound margin tracing, through which the surface area is calculated, 
resulting in these wounds being excluded. This could relate to the early implementation of the 
camera into routine clinical workflow and the clinician having not quite adjusted to its use or 
related to time constraints within the appointment and patient need. When discussed with the 
podiatrists, they agreed that at times the wounds appeared so small they did not feel the need to 
trace them as they would still document their visual inspection of the wound in conjunction 
with the image. 
Wound images that had been given the status of healed by the specialist podiatrist within a six-
month period were selected. This group of results were filtered into a separate spreadsheet that 
had at least four images and wound margin tracings taken. Many patients had multiple 
concurrent foot wounds; thus, these measurements were further cleaned to ensure only one 
wound per patient was used.  
Data analysis was performed using wound surface area (cm2) at baseline, four weeks (±7 days) 
and the time of healing, showing actual, mean, median, range and standard deviation. The 
parameters of analysis were applied to the categorical variables such as gender, diabetes 
diagnosis, presence, or absence of PVD, DPN and neuro-ischaemia, along with continuous 
variables such as age, HbA1c and eGFR. 
In summary, the wounds included in the current study are likely to show both evidence of 
healing by six months (which is one of the inclusion criteria), but are nevertheless sufficiently 
slow to heal, that it is possible to capture four or more consecutive wound images (another study 
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inclusion). In other words, wounds which heal very quickly, heal too quickly to allow 
determination of an in-clinic wound healing trajectory. 
Measurements 
Of the 103 individual wounds, there were 757 traced images with a median of seven traced 
images per individual wound (range 4 – 16). Each traced wound had surface area measurements 
recorded at baseline, around twenty-eight days and up to the end of the treatment period. 
Evidence of images being taken were seen on the downloaded data, but with no available 
metrics, as the surface area was not always traced at each appointment. On discussion with the 
specialist podiatrists, the most commonly cited reason was due to little or no change in wound 
dimensions from the previous visit, one to two weeks earlier, though at times the reason related 
to time constraints, either for the patient or the podiatrist. 
Exploratory analysis   
As discussed in Chapters 1 and 2, the underlying clinical factors that predispose some patients 
with diabetes to develop a foot ulcer, and also determine rates of healing, are complex. There 
is also some inconsistency of results between studies. The clinical comparisons included in the 
sections below are therefore exploratory in nature, with a focus on associations that have 
previously been highlighted in previous publications. 
Factors that may affect healing 
Previous chapters have described factors that may contribute to the healing of a DFU as age, 
gender, ethnicity, glycaemic control (HbA1c), renal function (eGFR), PVD, DPN or neuro-
ischaemia (NI). The variables PVD, DPN and NI relate to damage to the micro-vascular and 
sensory nerve endings, often related to periods of poor glycaemic control, which may have 
occurred prior to diabetes being diagnosed. These factors will be assessed during each stage of 
wound healing analysis. There is also an acknowledged risk factor for lower limb pathology 






Table 2: Retrospective wound healing metrics demographics 
Results are summarised in Table 2. There were 70 male and 33 females. The mean age for the 
male patients was 66.6 years and 70.2 years for the female patients. Type 2 diabetes mellitus 
was the most frequent diagnosis, with 91 having T2DM and 12 being diagnosed as T1DM. 







European 95 (92.2%) 
Māori 3 (2.9%) 
Pacific peoples 4 (3.9%) 





66.6 (±13.4) (range 30-99) 
70.2 (±14.6) (range 31-95) 
Diabetes type 
Type 2 diabetes 91 (88.3%) 
Type 1 diabetes 12 (11.7%) 
Type of diabetic foot ulcer 
Neuro-ischaemic (PVD & DPN) 64 (62.1%) 
DPN only* 29 (28.2%) 
PVD only* 4 (3.9%) 
No micro-vascular signs documented 6 (5.8%) 





61.5 (48.8-75.0)  
66.0 (48.0-81.0)                                                       
Renal function** 




63.0 (47.3-90.0)                               
52.0 (44.5-64.0)                             
* If PVD and DPN present - noted in the neuro-ischaemic category 
**eGFR is calculated using measured plasma creatinine and CKD-EPI prediction equation. 
GFR declines by 1ml/min/year over 40 years 
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Independent variables of wound healing 
Ethnicity 
Ethnographically, most patients were of European descent, with 92.2% identifying as New 
Zealand European (tauiwi). There were 2.9% Māori patients, 3.9% Pacific peoples, and 1.0% 
of Asian ethnicity. According to the New Zealand Statistics department for 2018, the population 
diversity for New Zealand shows 70.2% European, 16.5% Māori, 8.1% Pacific peoples and 
15.1% Asian, with 2.7% as other ethnicities (Statistics New Zealand, 2019).  
Age 
The healing of DFU related to age shows wounds for people 55 – 64 years of age was the largest 
group of 26 individuals with the shortest median wound healing time of 84.5 days. The group 









Of the 103 patients whose DFU healed within six months, 70 were male and 33 female. Visual 
inspection of the graph (Figure 18) suggests that the wounds from female patients took longer 
to begin to show signs of healing, however they ended healing faster and sooner than the male 
DFU. Despite this, the female cohort had a higher mean HbA1c of 66.0 mmol/mol (±20.4) and 
lower mean eGFR of 52.0 ml/min/1.73m2 (±21.9) in contrast to the males who had an mean 
HbA1c of 61.5 mmol/mol (±17.6) and mean eGFR of 63.0 ml/min/1.73m2 (±23.5). The 
obtained HbA1c and eGFR results were a combination of local community laboratory results 
and hospital laboratory results. The eGFR calculation uses the same equation with the 
community laboratory, noting that the normal eGFR range for a young male is 87-167 
ml/min/1.73m2, and for a young female the normal range is 78 – 158 ml/min/1.73m2, with a 
reduction of 1 ml/min/year from the age of 30 years for both gender groups. These eGFR values 
are consistent with the lower mean eGFR values for the female cohort being studied in this 
research. This eGFR value is corrected for age, ethnicity and gender, with some laboratories 
preferring not to document an upper or lower limit of normal (Daugirdas & Ovid Technologies, 




Figure 17: Healing time of males and females 
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Figure 18: Cumulative wound healing over time 
In the next section, the wound healing data will be assessed in three separate groups.  
• Wound healing over time, to examine if there is an observable healing trajectory for PwD 
whose wounds have healed by six months.  
• The first 50% of wounds healed will be assessed in comparison with the later 50% of 
wounds that were healed within six months, alongside continuous and categorical 
variables.  
• Wounds showing 50% surface area reduction at four weeks (from baseline), continuous 
and categorical variables will be compared to the variables of wounds that did not show 
50% surface area reduction at four weeks. 
Wound healing over time 
Wounds selected from this retrospective analysis were shown to have healed within six months 
from baseline assessment within the high-risk podiatry diabetic foot ulcer clinic. Of the wounds 
that met the selection criteria for this analysis, 103 individual patient wounds were identified. 
The range of days from baseline assessment, defined as day 0, to healed time (weeks), varied 
from four to twenty-six weeks, with a median of 13.4 weeks, interquartile range (IQR) (10.6 – 
19.3). The median surface area (SA) for the baseline wounds was 1.8cm2, IQR 0.3 – 2.2 cm2. 
As shown on the graph below, the first wound to heal did not occur until four weeks, had it 





Wounds healed by six months 
Table 3: Mann-Whitney U comparison of time to healing  
Independent factors 
(patient count) 









































DPN or PVD (97) 






    *NI = neuro-ischaemic (combination of PVD and DPN) 
Factors that may be attributed to wound healing outcomes were divided into categorical and 
continuous variables for analysis and assessed alongside time to heal results (weeks). The 
categorical variables shown in Table 3 were analysed using Mann-Whitney U (MWU) where 
results were ranked, and medians acquired for days to healing. Interquartile range showed if the 
data range was markedly skewed or consistent with the median time to healing for these 
parameters. As discussed earlier, MWU assigns a rank to each value (day) on the x axis, 
therefore assigning the same rank to duplicate values occurring on the same day within 
GraphPad Prism™ analysis software. 
Of this cohort, there were no statistically significant associations between any of the categorical 
measures and time to healing. There was a gender difference of 70:33 male to female with a 
median time to healing of 90 to 99 days respectively (p=0.46). Individuals were compared 
related to their diabetes type of either T2DM or T1DM, with 88.3% being diagnosed as T2DM 
and 11.7% having a diagnosis of T1DM. The median time to healing for this comparison group 
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Figure 19: No evidence of DPN and PVD compared to those with PVD or DPN 
was 93 days and 102 days respectively (p=0.38). The wounds of patients with a diagnosis of 
PVD versus those without showed the greatest amount of difference in healing times (p=0.07). 
A greater percentage of wounds had a diagnosis of DPN (90.3%) than no DPN (9.7%), yet the 
median healing between these two parameters was 97 and 87 days (p=0.59). Patients with 
neuro-ischaemic DFU, that is a combination of both PVD & DPN, were grouped against those 
with no defined neuro-ischaemia (NI), showing non-significant trend in healing times between 
the two groups of 108 and 84 days (p=0.08). 
Another group compared were those individuals with no evidence of DPN or PVD, versus all 
the other individuals that either had either PVD or DPN. These two groups varied in size vastly 
with only 6 individuals having neither PDN nor PVD compared with 97 in the opposing group. 
Whilst it was not possible to access the electronic health records for the 6 patients without a 
diagnosis of PVD or DPN to discover what the antecedent event that triggered foot ulcer 
development, relevant background publications, such as “The Diabetic Foot” Boulton (2020) 
suggests acute trauma as the likely cause for a break in skin integrity prior to the development 
of a DFU (Boulton, 2020). The smaller cohort had a median time to healing of 87 days 





Fast and slower healing 
Table 4: Mann-Whitney U analysis of fast and slower healers 
 Fast healers (n=52) Slower healers (n=51)  
Median (IQR) Median (IQR) 
P values 
(95% CI) 
Time to healing (days) 74.5 (56.3-83.6) 135.0 (115.0-155.0)  
Baseline wound surface area (cm2) 0.6 (0.3-1.8) 1.2 (0.5-3.0) 0.03* 
Wound area reduction @ 4 weeks (%) 74.3 (49.0-86.7) 55.7 (16.8-78.2) 0.02* 
Age (years) 65.0 (57.5-80.0) 70.0 (57.0-78.0) 0.82 
HbA1c (mmol/mol) 58.0 (46.0-73.0) 65.0 (50.0-77.0) 0.13 
eGFR (ml/min/1.73m2) 60.0 (48.3-85.3) 56.0 (40.0-80.0) 0.37 
Neuro-ischaemia n (%) 28 (53.9%) 36 (70.6%) 0.11 
* statistically significant 
An analysis was made of the first 50% of wounds to heal (n=52), with this target being met by 
thirteen weeks. For the purposes of subsequent analyses, we therefore used an operational 
definition for categorising patients into fast and slower healers. The latter 50% wounds healed 
between weeks fourteen to twenty-six were labelled slower healers, with the group consisting 
of 51 wounds. Using MWU, to compare factors that may predict successful wound healing 
between the two groups, baseline wound surface area (cm2) was first assessed. The MWU 
showed a significant difference between the fast and slower healers with a p value of 0.03, 
despite the fast healing group having the largest baseline wound of 14.64cm2 in its cohort, this 
was an outlier of large proportions. Median wound healing at four weeks showed a 74.3% 
reduction in wound surface area (SA) in the fast healing group compared with a 55.7% median 
SA reduction in the slower to heal group (p=0.02). Neuro-ischaemia was present in the fast and 
slower healing groups, with a statistically significant median time to healing between the fast 
healers (76.0 days) and slower healers (134.5 days) (p=<0.001). The slower healing group had 




Age: The individuals with fast to heal wounds had a median age of 65.0 years in contrast for 
the individuals with slower to heal wounds with a median age of 70.0 years. There was no 
statistical significance in age between the fast and slower healers (p=0.82). 
Gender: As gender has previously been shown to be heavily weighted 2:1 for male versus 
female, the percentage difference between each group of fast or slower healers was compared 
to the whole cohort of n=103. Males represented 68.0% of the whole and females 32.0%. In the 
fast healing group there was a 71.2% to 28.9% break down of males to females and in the slower 
to heal group there was a 64.7% to 35.3% of male to female comparison, which is not 
statistically significant with p=0.53 using a Fisher’s exact test. 
Ethnicity: Of the n=103 cohort, 92.2% were of European descent with 2.9% Māori, 3.9% 
Pasifika, and 1.0% Asian. It is recognised that this is quite an under-representation of Māori, as 
stated in the Māori Health Profile 2015 document there are 9.0% Māori living within the DHB 
region (Robson et al., 2015). It is agreed that Māori have an increased risk of diabetes, 
cardiovascular disease and renal failure and it is possible that the latter two conditions may take 
precedence over DFU within this population, or that those of Māori descent have DFU that 
require more than six months to heal. The ethnicity break-down for fast healers and slower 
healers show Māori only in the slower healing group at 6% representation, compared with 2% 
Pasifika and 90% European. The fast to heal group consisted of 96% European, 2% Asian and 
Pasifika. A comparison of the fast and slower to heal groups indicated no difference in ethnicity 
composition between the two groups (p=0.80). 
Glycaemic control: It was unable to be determined if the patients included in this analysis were 
being treated with oral and, or sub-cutaneous anti-hyperglycaemic medications. Glycaemic 
control is encouraged through an individualised treatment plan created for each person with 
diabetes related to multi-factorial subjective and objective characteristics of that person. The 
median HbA1c for fast healers was 58.0 mmol/mol equating to mean blood glucose levels of 
9.3 mmol/L over approximately three months. The median HbA1c for slower healers was 65.0 
mmol/mol giving a mean blood glucose value 10.3 mmol/L which is not statistically significant 
(p=0.13) 
Renal function: The median eGFR for the fast healers was 60.0 ml/min/1.73m2, at the lower 
end of stage 2 CKD. The slower to heal group had a median eGFR of 56.0 ml/min/1.73m2, 
resulting in a p value of 0.37 for the comparison of these two groups. 
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Peripheral vascular disease: As previously identified in chapter one, peripheral vascular 
disease can be exacerbated by hyperglycaemia and can be implicated in the non-healing of foot 
wounds in people with diabetes leading to a DFU. Due to the retrospective analysis of this de-
identified data, it was unable to be determined which patients had a surgical intervention for 
PVD, such as a popliteal bypass graft or placement of a stent to enhance vascularity to the foot 
to aid healing during treatment time frame. The diagnosis of PVD was obtained through an 
independent third party, as discussed in Part 1 methods. Of the patients whose wounds healed 
within the first thirteen weeks (fast healers) 57.7% had PVD with a median wound healing time 
of seventy five days, whereas the slower healing group had a median healing time of 137 days 
with 74.5% having a diagnosis of PVD, with or without diabetic peripheral neuropathy. A 
Fishers exact calculation between the fast and slow healing groups with PVD reveal a 
statistically significant difference (p=0.02).  
Diabetic peripheral neuropathy: Foot injuries not treated, due to lack of pain to identify a break 
in the skin integrity, or due to lacking sensory perception of friction that may lead to a blister 
or foot wound are often associated with DPN. Examining the fast and slower healing patient 
groups revealed 46 (88.5%) fast healers and 47 (92.2%) slower healers being diagnosed with 
DPN with a median healing time of 75 and 135 days, respectively. The Fishers exact calculation 
shows the two groups of healers did not differ significantly from each other (p=0.63). 
Neuro-ischaemia: The presence of neuro-ischaemia, that is, peripheral vascular disease and 
diabetic peripheral neuropathy previously diagnosed in each person, was present in 70.6% of 
the slower healers as opposed to 53.9% of the fast healers. Evaluating median time to healing 
days for the PVD, DPN groups compared to those with neuro-ischaemia, there is no notable 
difference in time taken to heal between these groups. Using a Fisher’s exact test to compare 
the fast healers with and without NI against the slower healers returned a statistically non-
significant p value of 0.11. 
There were no statistically significant associations between age, glycaemic control, renal 





Figure 20: Left and right (combined) foot 
ulcer locations for male and female patients 
 









Figure 22: Right and left location of DFU (male and female combined) 
Figure 21: Male and female (combined) 






Foot ulcer location for each wound was assessed to determine if there was a predominant 
location noted in these successfully healed wounds. As shown in Figure 23, most of the wounds 
populated the hallux and 2nd to 5th toe regions, at 27% and 35% frequency. There was no 
statistically significant difference in location between male and female patients or the left and 
the right feet (Table 5). Of note, as shown in the table above, is the difference related to gender 
where the majority of the male wounds occupied the right foot (58.6%) compared with the 
majority of the female DFU occupying the left foot (57.6%). A Fisher’s exact analysis returned 
a p value of 0.14, revealing a non-significant gender-related trend when considering which foot 
(right or left) has the most wounds, a finding that cannot be explained clinically without 
knowledge of footedness for each patient.  
 






 Male (70) Female (33) 
Left Foot N=29 (41.4%) N=19 (57.6%) 
Right Foot N=41 (58.6%) N=14 (42.4%) 
Figure 23: Foot ulcer by gender 
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Wound healing trajectory 
Surface area (cm2) measurement 
Surface area (SA) recordings were analysed over the course of healing with an emphasis put on 
measurements recorded at baseline and four weeks into healing. As seen in the density plot 
below, 70% of the baseline wound surface area measurements were between 0.04 and 1.84 cm2. 
 
 






















Median days to 
healing (days) 
155 115 83 57 
Baseline median 
surface area (cm2) 
1.07 1.39 0.83 0.42 
28-day median 
surface area (cm2) 
0.77 0.63 0.32 0.11 
Figure 24: Baseline surface area distribution (cm2) 
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As Figure 25 shows, there are multiple trajectories that may occur during the successful healing 




WHS outcome measure 
The reduction in wound surface area 50% or greater at four weeks is a marker that is often used 
to determine success of wound healing (Coerper et al., 2009; Gottrup et al., 2010; Sheehan et 
al., 2003; Warriner et al., 2011; Woo, Botros, Kuhnke, Evans, & Alavi, 2013). This outcome 
measure was used to retrospectively assess if wounds healed within six months, showed healing 




Figure 25: Wound healing trajectories for 103 wounds 
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Table 7: Clinical variables of wounds with 50% surface area reduction at 4 weeks 
 
Wound surface area reduction by more than 50% at four weeks 
On analysis, 63 of the 103 individual patient DFU showed greater than 50% reduction in wound 
surface area (cm2), an indicator of outcome success as per the WHS guidelines. The median 
baseline surface area was 0.90cm2 (±2.23), of these 63 DFU with the wounds reaching healing 
between 4 and 25.1 weeks (p=<0.001). Median time to healing was twelve weeks. Of this cohort 
88.9% had T2DM and 58.7% had evidence of neuro-ischaemia as documented by the specialist 
podiatrist. As shown in the plot below (Figure 26, page 109) the wound healing trajectory has 
not declined at an even rate as especially evident in wounds A #122 and A #251.  
Wounds >50% healing at  
four weeks (n=63) 
<50% healing at  
four weeks (n=40) 
Mann Whitney U 
comparison and 
Fisher’s exact  
(p value) 






















64.9 (±18.0) 64.4 (±21.3) 0.75 
eGFR (ml/min/1.73m2) 
mean (SD) 
66.1 (±22.9) 53.9 (±27.4) 0.22 
T2DM  
Male n (%) 
38 (60.3%) 24 (60.0%) >0.99 
T1DM 
Male n (%) 
4 (6.3%) 4 (1.0%) 0.58 
Neuro-ischaemic 
Male n (%) 
24 (38.1%) 17 (42.5%) >0.99  
DPN 
Male n (%) 
15 (23.8%) 7 (17.5%) >0.99 
PVD 
Male n (%) 
0 (0.0%) 3 (7.5%) 0.40 
No PVD/DPN 
Male n (%) 
3 (4.8%) 1 (2.5%) >0.99  
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These two aberrant wound healing trajectories were validated by the podiatrist holding the 
primary de-identification key for patient identifiers. They verified that the measurements shown 
below were correct for the DFU healing. 
 
 
Wound surface area reduction by less than 50% at four weeks 
Forty individual DFU did not meet the parameters of greater than 50% healing at four weeks, 
indicating they would not successfully heal by six months. As evidenced by the spaghetti plot 
in Figure 27, these wounds displayed a greater variation in healing trajectories. None of these 
wounds had a surgical intervention, such as amputation during this healing trajectory, as clinic 
SOP dictated that an amputation would call for the wound to be re-categorised and labelled as 
such. A specialist podiatrist independently verified the authenticity of these images due to the 
variation and outliers shown. 
The mean baseline surface area of these 40 DFU is 1.57 cm2 (±2.63) with wound size ranging 
from 0.04 – 14.64 cm2. At four weeks the mean surface area decreased to 1.44 cm2 (±1.88) with 
a range of 0.07 – 8.69 cm2 (p=0.11). Median time to healing was 17 weeks (range 6 – 26 weeks). 






Glycaemic and renal characteristics of wounds healed at six months 
The cohort of 63 people with DFU showing healing of greater than 50% at four weeks had 
a mean HbA1c of 64.9 mmol/mol (±18.0) compared with the 40 individual DFU which did 
not show 50% or more surface area reduction at four weeks who had a mean HbA1c of 64.4 
mmol/mol (±21.3) around the time of DFU baseline (p=0.75). Similarly, the estimated 
glomerular filtration rate (eGFR) for those 63 people with DFU surface area reduction of greater 
than 50% at four weeks was 66.1 ml/min/1.73m2 (±22.9) compared with the cohort who showed 
less than 50% wound area reduction at four weeks with an eGFR of 53.9 ml/min/1.73m2 (±27.4) 
(p=0.22).  
Summary 
The aim of this research was to examine data relating to wounds healed at six months to see if 
there is a consistent identifiable wound healing trajectory. Although selected patients in 
previous evidenced research have been reported using simple algorithms showing a distinct 
healing trajectory, in our real-world setting using four or more data points per patient, this was 
not evident. Of the 543 original individuals with 9258 wound images, 42.2% were excluded 
due to insufficient concurrent wound images, a limiting factor for a broader analysis of wound 
 




healing trajectories. It was felt that by including wounds with three or fewer images there would 
not be sufficient depth of wound healing data, the wounds that appeared to have healed quickly 
and been discharged into community care may have added a bias to the wound healing data, as 
opposed to bias being added to this data by not selecting them. As patient notes were unable to 
be accessed for review by the researcher due to ethical constraints, it was not possible to 
discover if the larger wounds were transferred to another service for surgical intervention or if 
the patient required hospitalisation related to another co-morbidity or if they died. 
Mann-Whitney U non-parametric analysis was used to assess differences between independent 
data groups that occurred as variables of wound healing within the group of 103 individual 
wounds. The independent variables were assessed alongside time to heal in days for each 
wound. Within this cohort of healed wounds, the MWU analysis showed that most wounds with 
a greater than 50% wound surface area reduction at around four weeks have continued to heal 
at a consistent rate with completion of healing occurring with a median of twelve weeks (range 
5-25 weeks). Baseline wound surface area was also shown to have a significant impact on the 
speed of wound healing, though within the group of fast healers, there were a small number of 
outliers that tested this finding as shown in the range. There were no categorical or continuous 
variables, such as age, gender, glycaemic control, renal function or diabetes diagnosis type that 
were revealed to significantly impact on successful healing of these DFU. It should though be 
noted that some of these groups, such as those without any evidence of PVD as well as DPN 
were very small groups (n=6), making the exploration of associations difficult due to inadequate 
power. What was found was the high association of DPN, PVD, male gender and T2DM, in 
wounds that were referred to the high-risk foot ulcer clinic, showing that they were recognised 
as requiring specialist podiatry input to ensure successful healing. There was no consistent 
increase in the number of individuals with neuro-ischaemia, in the group of wounds that took 
longer to heal (over thirteen weeks). Neither was there an evident change or increase in median 
glycaemic control, renal function, or age for these slower to heal wounds. 
These exploratory retrospective analyses have the complexities associated with the 
interpretation of wound healing data in a routine clinic setting. In contrast to popular clinical 
opinion, diabetic foot ulcers healed by six months did not uniformly show greater than 50% 
wound surface area reduction at four weeks, with some wounds increasing in size at this time 
period from baseline. These wounds were treated through a real-world secondary care high-risk 
diabetic foot ulcer clinic, either weekly or fortnightly, with dressings done by a significant other 
or community wound care nurse two to three times a week in between visits. Though diabetes 
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control prior to the development of the wound will have led to the development of PVD and 
DPN, it did not appear to be a direct contributing factor to the healing of the wound, along with 
renal function. The mean age of the people whose wound metrics were analysed was 67.8 years 
(±13.8), though the age range was widely variable ranging from 30 – 99 years. These metrics 
support the findings in the literature review that age, glycaemic control and renal function do 
not have a direct impact on wound healing predictive outcomes for diabetic foot ulcers. An 
identifiable healing time point at which all wounds healed at six months showed progression 
towards successful healing at six months was not detected to inform clinicians as to a certain 
outcome. 
Findings of the qualitative descriptive research (Part 2) will be explained next, relating to 
wound image sharing with patients attending the same high-risk foot ulcer clinic, to examine if 
the use of wound image technology had informed the patients understanding of their DFU 




Part 2 – Qualitative descriptive analysis 
This qualitative descriptive research focuses on the person in the centre of the care being given, 
that is, the PwD, who is attending the high-risk foot ulcer clinic. The aim was to gain an 
enhanced understanding of how wound image sharing impacts on patient education and 
understanding, to promote DFU self-care and self-management.  
The purpose of the semi-structured interviews undertaken in this research, was to enhance the 
exploratory retrospective analysis of wound measurements, through understanding the patient’s 
perception of the use of wound image sharing within routine clinic appointments and the 
optimisation of communication between patient and clinician.  
Participant demographics 
The data for this research was captured using semi-structured interviews (SSIs) in which thirty-
one PwD from the high-risk foot ulcer clinic agreed to participate. Initially forty-six high-risk 
podiatry patients agreed to have their names forwarded to the researcher after hearing about the 
research from the podiatrist. Two patients contacted by the researcher declined participation as 
they were no longer current high-risk foot ulcer patients and did not meet the inclusion criteria. 
One person was not suitable following discussion with their diabetologist, another attended 
clinic for the interview, but could not wait due to another appointment commitment. On 
discussion with one patient, it transpired they had no recall of having any images taken of their 
foot ulcer, which was confirmed on review of the image database. Nine other patients agreed 
to participate in the interviews but were never able to do so following their appointments or did 
not attend clinic for their appointment, following agreeing to participate. This resulted in 31 
patients being available to participate in these interviews. 
The seventeen male and fourteen female participants were all current patients of a specialist 
high-risk foot ulcer clinic within a diabetes outpatient department. Participants mean age was 
65 years, ranging from 38 to 85 years. Mean duration from diagnosis of diabetes was 18 years 
(± 9 years). Of this cohort, only one participant had T1DM with the other thirty being diagnosed 




















Summary of emergent themes  
Following collection of data from the semi-structured interviews, they were analysed for 
identification of themes and sub-themes. The emergent themes and sub-themes identified in 
these findings are: 
• Communication - between the patient and clinician 
o Patient Understanding  
o Feeling Informed  
o Easy to understand Language  
o Communicating Progress 
• Wound imaging - patient perception in relation to supporting wound management 
o HCP collaboration  
o Self-management 
 









   







Diabetes type Type 2 diabetes 
Type 1 diabetes 
30 (97.0%) 
  1 (3.0%) 
Diabetes duration 
mean (SD) 
Time since diagnosis 18 years (±9.1) 
Type of diabetic foot 
ulcer 
Neuro-ischaemic 15 (48.4%) 
DPN only 13 (41.9%) 
PVD only   3 (9.7%) 









63.6 (±26.2)                         
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• Technology - utility of wound imaging camera 
o Visualisation  
o Alternative perception 
• Support - family, community, and significant others 
These findings will be reported and described as per the themes listed above. 
Participant perspective of DFU causality 
To engage the participants in the interview, the first question asked the participants what the 
precipitant, for their first attendance at the high-risk foot ulcer clinic was. As some participants 
had been attending the service for many years and had difficulty remembering when asked to 
recount what, if anything, preceded their DFU, they were asked if they could remember what 
preceded their current DFU. Only three participants were first aware of an ulcer or break in skin 
integrity through foot self-examination. Five participants recalled a physical injury to their foot 
preceding the ulcer, this included cutting the foot themselves when attempting to slice excess 
dead skin from a callous, dropping a heavy object on the foot or having a sharp object in their 
shoe while walking. A common response during the interviews from more than ten participants 
related to having an unsteady gait, and they had subsequently been referred to either an orthotist 
clinic or had been advised to purchase new shoes for better support when walking. Fourteen 
participants could not recall an earlier injury to their foot. Participants reported a range of 
severity in their DFU that lead to their presentation at the high-risk foot ulcer clinic, as some 
DFU were noted by the podiatrist at a very early stage when they were being seen for 
consecutive DFU at the same time, whereas other folk had no awareness of the severity of their 
DFU until it was observed by another HCP. One participant commented they mentioned in 
passing to a care giver their toe was sore. This care giver removed their sock for closer 
inspection to find the toe necrotic resulting in an amputation. “one of the community nurses 
came to do my finger prick and give my insulin and she asked if there was anything else, so I 
mentioned I had a sore foot, so she whipped my sock off and said “Oh my God” (P #21). 
As shown in the demographic data 90.3% had DPN or a combination of DPN and PVD together, 
a leading precipitant for foot injury prior to the progression to a DFU. The lack of sensation or 
awareness of foot injury is supported by the responses above, with people not being aware of 





Throughout the interviews, statements reflecting the importance of communication between 
participant and podiatrists were expressed through exuberant facial expressions and 
explanations. It was clear throughout the interviews that the participants felt a strong connection 
with their current podiatrist and clearly wanted it noted they were very grateful for the care they 
were receiving. One participant noted a close association with their podiatrist by saying: “I see 
these people more than my own family” (P #16), due to the regular appointments they had for 
their DFU. Respect was discussed and demonstrated in the following ways. The participants 
discussed their desire to follow the podiatrist’s recommendations, due to the respect they had 
for their knowledge and expertise: “they are professionals, and you listen to what they say” (P 
#2). In return the participants also identified their feeling that the podiatrists treated them in a 
respectful manner through the way they interacted and discussed their treatment with them: 
“their manner is wonderful, and they obviously know what they are doing” (P #21). Respectful 
communication allows a pathway where a person is more likely to listen to the HCP and have 
a greater understanding of what is being said. 
Understanding wound healing progress through communication 
The participants discussed having a greater understanding of their wound healing when wound 
images were “used to explain about healing” (P #1, #26). The podiatrist shared the PwD wound 
images with them to aid understanding and used a surface area reduction graph, which plotted 
the wound healing trajectory of each wound. This graph also appeared on the .pdf report that 
could be accessed by other health professionals, who may wish to discuss wound healing 
progress with the individual. One participant commented they “understand the graph and 
association with wound healing trajectory” (P #3); another was very aware that when high 
points occurred on the graph, it related “to a bad week” (P #6), where wound healing had not 
progressed favourably. Through the sharing of these images and discussing them with them, 
the participants expressed a feeling of being informed of their progress. 
Informed – communication of wound healing progress 
Participants indicated a sense of being better informed about their wound healing as the e-
images were shared and discussed with them, stating: “good at keeping a person informed” (P 
#3); As explained by the participants, they often stand or sit beside the podiatrist as the wound 
is traced and their progress is shared with them “(they) show me and mark it (the wound) out. 
You can see the shape and how well it is healing” (P #6). Participants commented that seeing 
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and discussing the wound images gave them a greater sense of being informed, and this was 
validated by them being able to visualise the healing progress. “(seeing & discussing pictures) 
makes me feel better because you can see what’s going on” (P #22); “makes me feel good as I 
know exactly what is going on” (P #13); “I feel informed. Reassuring to see wound is actually 
healing” (P #16). Being able to discuss with the podiatrist how the DFU is healing enhanced 
the feeling of being informed “(I) feel comfortable discussing ulcers, makes me feel like there’s 
a light at the end of the tunnel” (P #3). The one on one discussion with the podiatrists as they 
were viewing the wound images together allowed for a tailoring of information, with the 
podiatrists knowledge and understanding of how much detail the patient would appreciate “(the 
podiatrist) discusses ulcer size, exudate, colour and whether it (the wound) is getting smaller” 
(P #31); Participants discussed their anxieties that the wound may never heal. Some participants 
had been attending the high-risk foot ulcer clinic for several years with consecutive ulcers, 
along with wounds that healed and then became ulcerated again. Having information shared 
with them so they not only understood the healing process but also didn’t have expectations 
that were unrealistic was helpful “(the podiatrist) has explained to me the healing will slow 
down as it gets closer to being 100% healed” (P #10); “I feel informed, (it’s) reassuring to see 
(the) wound is actually healing” (P #16). Typically, the PwD are seen by the same podiatrist 
for consistency, however when you are a long term service user of podiatry service the 
participants became very familiar with each podiatrist and their different ways of presenting 
information in a way that promoted health literacy “the podiatrists are very informative, they 
each have different styles (of communicating)” (P #18). 
Language – communicating without the medical jargon 
The language used by clinicians, when discussing health with a patient needs to be clear and at 
a level where it can be easily understood by the patient. Participants voiced their appreciation 
that the podiatrists communicated wound healing progress and management information to 
them in a way that showed understanding of their level of health literacy. “discusses healing in 
very good all-day terms – easy to understand, no big jargon” (P #1); “It is in a language that 
you know what they are saying” (P #21). Communicating with informal language removed the 
subconscious hierarchy between clinician and patient, allowing for a two way conversation 
“they are good at answering my questions” (P #15, #18); through allowing two way 




Progress of wound healing communicated 
Several of the participants acknowledged that they had been attending the high-risk foot ulcer 
clinic for multiple years, and at times lost track of which ulcer was being treated or if any 
healing was occurring. They offered that they felt it was beneficial being made aware of 
progress, even if did not always relate to improvement. “if you don’t get told progress, how do 
you know how you are doing?” (P #1). Participants felt the wound image comparisons on the 
two computer monitors was very useful and allowed for communication about treatment 
options, for example: “we look at the previous (image) with the first (image) and you can (see 
the change), so that’s part of the recovery process, seeing how well we’re doing – if we’re not 
doing so well, what we need to do, to make it do better” (P #9). Participants acknowledged that 
the wound images acted to reality-orientate them as to how their wound was progressing “your 
brain’s a funny thing – you think back and then you have a look (at previous image) and it’s 
totally (different) you know” (P #9). However, not all participants had the same view, or their 
view varied depending on what the information indicated about their condition: One participant 
stated that if the healing progress shared wasn’t good they “refused to hear the negative side of 
the discussion, like amputation” (P #23), this participant further elaborated that in their 
discussion with the podiatrist about their DFU, the podiatrist would inform them of the 
alternative outcome in the DFU did not heal. They described not wanting to hear the negative 
as like a defence mechanism to protect themselves from anything negative that may upset them 
or lead to a low mood. 
Wound healing progress was most often discussed alongside comparison wound images, 
though wound surface area reduction graphs were also present on the computer monitor below 
the wound image for the patients to see. Some participants found these graphs more interesting 
and useful than others. Two-thirds of participants were able to verify they had seen the wound 
healing graphs by describing the presence of a downward trajectory which reflected a wound 
decreasing in size relating to healing progress. One participant was unable to explain clearly 
what the changing trajectory of the wound healing graph represented, instead stating they 








Another participant shared they had been attending the high-risk foot ulcer clinic over several 
years, prior to the implementation of the wound imaging device. They disclosed how their own 
experience of trust and belief in the information being shared with them by the podiatrist had 
changed since wound imaging began within routine clinical care by sharing: prior to their 
wounds being imaged they never believed the podiatrist when they commented on healing 
progress at each appointment, thinking to themselves that the podiatrist had seen thirty to forty 
other individuals with foot ulcers since their last appointment and how could the podiatrist 
possibly recall, to make such a statement. “(The podiatrist would say) … and it used to look 
like this last month and now this month it looks like this because of this treatment …(the 
participant thought) it's always  frustrating when you go back and  see someone and they say it 
looks really good,  and ...you.. (think) well, how do you remember what it looks like, you must 
see a hundred patients, between visits, but when they've got a photo to come back and say, this 
is what it looked like two weeks ago, and this is what it looks like this week and here are the 
measurements, and by doing the off-loading or whatever it is, this is what happens…” (P #29) 
The comparison wound images provided solid evidence for patients to show that the wound 
was improving. This wound imaging technology has allowed the podiatrists to share wound 
healing progress with their patients, even if it is not always relating to a positive progression. 
Wound imaging related to self-management 
This theme relates to how wound imaging can support wound management, whether between 
patient and clinician, or with the involvement of other HCP and specialist areas, these will be 
denoted as sub-themes.  
“(the graph) looks like a heart graph (ECG tracing)” (P #3) 
 





Wound imaging is used to allow the podiatrist to keep a record of the wound size, and state at 
each appointment. This information is also shared with the patients to assist with conversations 
that may be needed to assist explanation of interventions that may be required, such as off-
loading, investigation and treatment of infection, larvae application, surgical debridement, 
amputation, or vascular procedures, for example, a femoral popliteal artery by-pass. These 
procedures require the involvement of other HCP specialty services. 
HCP collaboration 
HCP collaboration relates to the multiple health care professionals and departments that may 
be drawn on to assist in the care of the person with the DFU, selected individually on the basis 
of need for each individual patient. Participants described being referred to the following 
services: the Pain clinic, orthopaedic surgeons, vascular team, infectious diseases group, 
hospital outpatient orthopaedic service, Charcot foot clinic, orthotists, as well as community 
care nurses, whether for dressing changes or medication issuing. Most participants described 
collaboration with community podiatry services outside of their specialist podiatry clinic care, 
with the most often mentioned outside collaboration being with their general practitioner or 
practice nurses. All services that are linked to the DHB, including general practices, have access 
to the person’s electronic health records and are able to view the latest image taken of each foot 
ulcer for each person, along with a graph that plots the wound surface area and healing 
trajectory. Participants spoke of appointments with their GP where they discuss hospital letters 
and documents including the wound images, “(it’s) quite handy – for my GP to access stuff and 
use the tools to see how it is going, is excellent” (P #6); “They can look straight at it (the report) 
and find out what they should and shouldn’t do” (P #20). 
When asked how the participants felt about their wound images being uploaded to their 
electronic health record to be accessible by other health professionals with access, the majority 
expressed relief that it would assist them and their health professionals. As shown above, the 
participants are involved with multiple agencies across the health sector, often being seen by a 
new medical registrar at each visit, requiring them to give a full history of their medical 
condition at each appointment, which they expressed as being an exhausting and frustrating 
process. These experiences aid their appreciation of the podiatrists they see, as they rarely 
change, and the participants valued the clinical association that forms between them and the 
clinician. Due to the participants often having multiple co-morbidities and seeing other services 
within the hospital system, the availability of their wound images and podiatry reports were 
appreciated with one participant commenting “it means I don’t have to spend two hours telling 
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them (the HCP) what is in my health record” (P #30). Others stated: “I love the culture of 
sharing notes…because it means I don’t have to explain (repeatedly) from one person to 
another” (P #4); Others found it reassuring that the other HCP were being kept up to date “I 
don’t visit my GP often so it is great they can access the (records, photos, reports)” (P #16); 
“One of the plusses of the digital age” (P #10). When asked how they felt about their wound 
images and podiatry reports being available to other health professionals, a couple of patients 
voiced opinions about how they would feel if their records were accessed by people who 
shouldn’t be viewing them by commenting: “I wouldn’t want it accessed for non-specific 
purposes” (P #29); “You must have protocols that you need to adhere to?” (P #18).  
One participant described being on holiday in another region of New Zealand and becoming 
unwell, where they needed to visit the emergency department. They were surprised to find their 
electronic medical records were not available outside of their region and felt if they were not 
conscious and able to speak for themselves, that the staff at the other hospital would have no 
idea about this person's multiple co-morbidities. They expressed the desire for the sharing of 
DHB electronic health records, which included their DFU images, to occur between DHBs. 
Within New Zealand, each DHB has its own electronic health record system and although 
people have national health identifiers (NHI), the electronic health record is not available 
nationally between each DHB, limiting the sharing of information. This participant explained 
this as a limitation for those who travel to other parts of the country and require medical help, 
to not have their medical records easily available through a secure portal, “I wish my health 
records could be shared amongst all the district health boards, for when I’m out of town and 
need medical help” (P #7). The wish for greater availability of health records between HCP 
nationally relates to self-management and the participant wishing their health to be managed in 
an optimal way. 
Promoting self-management 
The use of wound imaging to promote self-management relates to decision-making in 
association with viewing the wound images and discussing them with the podiatrist or other 
HCP. The aim of this research was to examine if viewing and discussing the images within a 
clinical setting assisted people to understand treatment advice being given and making the 
conscious decision to follow advice that would aid the healing process. Some people described 
the images as promoting their understanding as to why the podiatrist was asking them to manage 
their foot or wound in a certain way, “if I don’t discuss the wound with the podiatrist, it won’t 
get any better” (P #1). Others were more succinct with describing participation in their care 
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following discussing the wound images: “(discussing the wound) makes you more confident 
and more inclined to strive hard to follow advice” (P #10). When asked what advice they had 
been given by the podiatrist to aid healing, most people showed understanding of the need to 
keep their foot elevated (off-loading) to assist with healing: “the more you can keep weight off 
the affected area the better” (P #10); others described knowing that wearing their custom made 
orthotics had improved their DFU healing as shown to them in the wound images: “correct 
footwear is critical” (P #9); “stay off it, keep it dry, wear orthotics” (P #25). Participants showed 
appreciation of wound image sharing to consolidate the advice being given and enhance self-
awareness relating to glucose control and taking antibiotics correctly being discussed in the 
clinic. Responses to the questions were very honest and open with one participant feeling 
comfortable enough to disclose that they enjoy the discussion and the information given, but 
they have not been able to follow all the advice, even though they know this may be detrimental 
to their wound healing: “I smoke and there’s very little blood flow going to the lower foot. I 
know it (smoking) doesn’t help” (P #20). The participants comment showed evidence of 
educational information being given, but as self-management is a choice for someone to 
participate in, it may take some time for them to make that choice. 
Wound care education can occur during the wound cleansing and debridement part of the 
appointment, but with the patient viewing the images beside the podiatrist as the wound margin 
is being traced, it can allow for the podiatrist to emphasise the importance of self-management, 
including daily foot inspections and self-care. Participants verbalised their own self-care and 
self-management activities by stating: “(I) noticed a crack when moisturising (my) feet” (P 
#18); “I know my body, I know it didn’t smell right” (P #19); “good foot care with moisturising 
and foot inspection” (P #18). Wound imaging linked with the patient e-health record rarely 
occurs as seamlessly as it does in this DHB and is now an accepted norm within the high-risk 
podiatry foot ulcer clinic. As discussed, earlier technology is often introduced for the benefit of 
the clinical team and patient, but the person at the centre of this care is not usually surveyed for 
their perceived benefit of it. 
Technology 
The wound imaging camera was initially introduced in this service at the beginning of 2015, 
and it was a number of months later before it was integrated with the electronic patient booking 
and management system. Initial comments relating to foot ulcers being photographed during 
podiatry appointments were offered when the participants were asked if they were aware their 
wounds were being digitally recorded with the following comments: “they’ve made me aware 
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of (the camera) – they’ve taken the time to explain it and show me what they can see” (P #4); 
“I’m fascinated with the camera – it is just a ball (referring to shape of the SilhouetteStar™ 
device)” (P #23); During the course of the interviews taking place in this study, the outpatient 
building was flooded, resulting in the podiatry clinic being re-located to another hospital for a 
three week period. Software licencing did not allow for the wound imaging camera to be used 
over this time. The wound imaging had become part of the routine clinical work flow and this 
participant missed not being able to view their wound image: “I reckon the camera is awesome 
– we didn’t have it at (the other hospital) and missed tracking the progress” (P #13). As stated 
here, the podiatry patients appreciated being able to visualise their wounds, which may not have 
been possible previously. 
Visualisation 
Due to the location of the DFU, such as underneath the foot, or diabetes related visual 
impairments, the DFU cannot always be visualised by the person, so being able to see the wound 
images and comparison image adds to the validity of the information being shared by the 
podiatrist: “it allows me to see underneath my foot which I cannot see” (P #2). In these times 
of fake news and misleading information on social media, people can find it reassuring to be 
on the receiving end of real evidence. The participants communicated this through their 
appreciation of the information they were seeing and receiving: “concrete measurement, 
completely factual, measurement is clear and concise, so no doubts how big (the wound) it is – 
it’s there in black and white” (P #4); “one of the plusses of the digital age” (P #10). 
Though most participants discussed the technology used during their podiatry appointments for 
the recording of their wound images, one participant made a relevant connection to another 
form of imaging that had assisted in their decision-making during medical treatment. This came 
in the form of X-ray images, that when shared with the person, heightened their awareness of 
bone deterioration and the need for surgery (P #6), evidencing that when clinicians share images 
with the patient it optimises understanding. Similar perspectives were shared in relation to the 
wound imaging shared with participants during their podiatry appointments, as the length of 
time it can take for a DFU to be managed and healed can impact on a person’s mood and quality 
of life: “I’m looking for some positive, so the comparison photos are good, it is encouraging to 
see them” (P #25); “makes me feel good as I know exactly what’s going on” (P #13); “(seeing 
and discussing images) makes me feel better because you can see what’s going on” (P #22). 
Participants appreciated that it proved to them that progress was occurring between 
appointments, as they did not have access to wound imaging when being treated at the 
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community podiatrist or through their GP practice: “makes you realise (the treatment) is 
actually working – when you (get treatment) at the GP or practice nurse you don’t know – you 
can’t see anything” (P #6). One participant stated the analogy that as a parent you do not see 
your children growing as you are with them constantly, whereas people who have not seen the 
family for a while will notice a change – they likened this to the difference seen in the wound 
size change when comparison images are used: “it is just encouraging that you can see it – like 
a babies growth progress – you can’t see it when they are with you 24/7” (P #7). 
“it’s like the old saying, a picture is 1000 words, you actually physically can see it” (P #9) 
Alternative view 
An advantage of interviewing 31 people was that there was a wide range of opinions and 
perspectives, and it is important that, of note, there was an alternate view when participants 
were asked their opinion of the utility of wound imaging. One participant said they had no 
interest in the technology or the images, but did not have a problem with the wounds being 
imaged “I don’t really get over the moon about it (does not think camera and images have 
enhanced care in any way)” (P #11). Some people did not wish to view the pictures whether 
due to feeling squeamish or a disinterest. “I don’t take much notice” (P #17); “I can see how 
my (foot) is healing by looking at it – I don’t need a comparison picture – I know how bad it 
was” (P #30); One person brought their spouse with them and was happy for the spouse to see 
the wound images and discuss them with the podiatrist, but the participant was not interested 
in viewing them “(the) podiatrist explains everything to me, so I don’t have to look at it (the 
screen)” (P #12); some discussed that although they knew the GP could access their wound 
images when they had looked for them during an appointment they had great difficulty locating 
them: “they (the reports) are difficult to find (at GP) but they are there” (P #30).  
Three people discussed difficulty seeing the pictures as opposed to not wanting to see them for 
varying reasons: “I know I can see it (the graph), but with eyesight problems I couldn’t tell you 
exactly what it says” (P #20); “early on the photos were too dark and hard to see, they are 
better now, the podiatrist said there had been a software upgrade” (P #29); “(the images) hard 
to see as the screen is too far away – would be good to see it on a tablet” (P #2). This was a 
helpful suggestion about the wound imaging being able to be transferred to a tablet for the 
patient to hold and view while they were sitting in the podiatry chair. 
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Support – involvement of others 
Whether physically present at the interviews or referred to, it was evident that some participants 
had strong and caring family support during their treatment and healing process. They often 
had photos taken on a phone camera and shared them with their family of their wound progress. 
The participant support person is often involved in the wound care, changing dressings between 
appointments, assisting the person with self-care, and transporting them to appointments. The 
partners or support people that accompanied the participant to the interviews had the option of 
staying with the person or waiting elsewhere, with the participants making it clear they were 
part of the process also and they would like them to stay. This was not discouraged, and the 
support people all allowed the participant to have their say without interjecting, unless asked 
for their opinion. Their presence or mention of them allowed the researcher to understand how 
important their role in the participants care is, with responses as follows: “my wife saw a crack 
in my foot and alerted the GP” (P #2); “my partner does my dressings” (P #13); “(my) husband 
accompanies me to each appointment, he takes photos on his phone and shares them with the 
family, I don’t look at the photos with the podiatrist, but my husband looks and is interested in 
the progress” (P #21); “(my) grandchildren take photos of (my) ulcer and show me on the 
phone, they moisturise my feet” (P #3); “my wife takes photos, we keep our own record” (P 
#25). 
Summary 
These interviews have provided a valuable insight into the use of digital imaging within routine 
clinical care from the perspective of the PwD attending these clinics. Though all participants 
were aware they were having images taken of their wounds at most appointments, no one felt 
this was an intrusion, or voiced that they didn’t want this done, though some were honest 
enough to state they didn’t think the use of imaging had benefitted their care or understanding 
in any way, whereas most felt it did enhance their understanding of how their wound was 
healing and allowed for discussion of concerns they may have.  
Through discussion with the participants it became evident that DPN removed awareness of the 
initial injury, which was substantiated on review of medical records that 90.3% had a diagnosis 
of DPN. The importance of quality communication enhanced understanding, using easy to 
understand language, and did not decrease the importance of the information being shared, just 
because the medical jargon was removed. Another important feature of communication was the 
openness that was felt between patient and clinician when discussing the wound imaging, 
assisting with understanding of healing progression, even if it was not always positive. Through 
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the sharing of wound images with the podiatry patients, they felt more included in their care 
process. The participants felt sharing of the wound images through their electronic health record 
enabled wider discussion with other HCP and highlighted the benefit of sharing medical images 
with patients. 
Participants voiced appreciation and relief that other HCP could view their images through their 
e-health record. Some described this as enhancing their consultation as the HCP more fully 
understood the nature of their DFU. Some participants, prior to the wound imaging, had not 
seen their DFU, unless a family member had taken a photo on their phone and showed them 
during a dressing change. Viewing the DFU allowed a greater understanding of the need for 
self-care and self-management regarding dressing changes as well as following podiatrist 
advice. Wound images aided discussions about decision-making around the need for 
interventions that may assist a positive outcome. 
The use of the wound imaging technology became part of routine clinical care so seamlessly 
for the participants, that it was only when it was not available due to temporary shift in premises 
that its absence was noticed.  
Support through family, significant others or community carers were very important to these 
participants, and very much appreciated. Not everyone wanted to view their images or hear 
anything negative about their healing progression, with some being honest enough to say they 
hear the self-management advice but choose not to follow it. 
One particularly useful recommendation made by a participant was having a tablet they could 
hold and view the wound image on, making visibility easier for them in real time. Another 
discussed that it was not just viewing of wound images that has been beneficial in their care. 
They described how they had been shown an x-ray as part of the decision-making process 
relating to the need for an intervention, and it was the x-ray and discussion associated with the 
x-ray that enabled the participant to make a fully informed decision. 
Conclusion 
The results presented in Part 1 have shown DFU can heal within six months, even if they have 
not all shown greater than 50% surface area reduction at four weeks. Part 1 results also showed 
that PwD have multiple confounding factors, such as age, diabetes duration, type, along with 
the implications of micro and macro vascular disease, that impact on a steady and anticipated 
wound healing trajectory. The findings identified in Part 2 are the benefits to patient 
understanding and knowledge, when wound images are shared with patients within a routine 
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clinic appointment. This empowered the patient to feel involved with their care and to follow 
the treatment advice of the clinician to optimise wound healing.  
The next chapter will discuss these results and findings and discuss wound healing and person-






Discussion and conclusion 
Introduction 
This chapter will discuss the results and findings of this research, in association with the drawn 
conclusions of previous literature, along with limitations found therein.  
A brief synopsis of the study’s background, purpose, results, and findings will precede this 
discussion, along with an overview of the research questions that gave rise to this research. The 
outcome of this chapter is the identification of the need for an education model associated with 
collaborative care and medical image sharing, that will direct future research towards a model 
of enhanced person-centred care. 
Purpose and background of the study  
The prevalence of PwD and complications related to chronic hyperglycaemia are increasing. 
Type 2 diabetes is occurring at a younger age, thus PwD have a longer life-time exposure to 
hyperglycaemia. The development of micro- and macro-vascular effects of hyperglycaemia are 
affecting PwD through the earlier emergence of complications which include retinopathy, 
chronic kidney disease, PVD, and DPN, leading to DFU. Foot wounds in PwD do not heal 
along the “usual” (non-diabetic) healing pathway, often becoming inhibited in the inflammatory 
stage, progressing to a chronic wound, and requiring specialist podiatry input. Wound healing 
publications state that DFU showing a decrease in surface area of over 50% following four 
weeks of healing, predicts complete healing by six months. This six-month outcome was used 
when data selection was made for the exploratory retrospective analysis of the quantitative data 
in this research. The purpose was to determine if wounds successfully healed at six months, 
showed both a uniform healing trajectory, and healing of over 50% at four weeks, as predicted 
progressive healing, indicated at the earlier time point. If there was certainty around wound 
healing outcomes, based on early wound healing trajectories, this would allow clinicians to use 
this marker for discharging patients to the community with the knowledge the wound should 
heal. It would also help answer patient’s most frequent question of “how long will it take for 
my wound to heal?”. Better use of scarce specialist podiatrist resources would increase access 
to high-risk foot ulcer clinic services.  
The purpose of the qualitative study was to assess the patient’s perception and perspective of 
the use of wound imaging during the routine podiatry clinic appointment, to determine if this 
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enhanced communication, education and collaborative care between the patient and the 
attending clinician. These responses could be fed back to clinicians, so they could incorporate 
positive, clinically useful findings into the patient’s routine clinical care. 
An explanatory sequential mixed methods design was selected for this research. Multiple 
studies describe wound healing but focus almost exclusively on quantitative aspects of wound 
healing. In comparison, studies examining the patient perception of devices to aid 
understanding of self-management are few and tend to have a qualitative focus on information 
gathering and reporting. The qualitative findings add a patient-centred focus to this research, 
providing additional insights into the quantitative retrospective analysis of the wound healing 
metrics. 
Results overview (Part 1) 
The aim of this research was to examine data relating to wounds healed at six months to see if 
there is a consistent identifiable wound healing trajectory. Of the 103 individuals with DFU 
used for these analyses, there were seventy males and thirty-three females. A diagnosis of DPN 
was found for 90.3% of these individuals, with 66.0% also having PVD.  
Wound healing was assessed through comparing healing rates of wounds relating to surface 
area reduction at four weeks. A comparison was also made between wounds healed within the 
first 13 weeks and the last 13 weeks. Wounds with greater than 50% surface area reduction at 
four weeks had a median healing time of twelve weeks compared with a median healing time 
of seventeen weeks for wounds whose surface area did not show reduction by more than 50% 
at four weeks. The median baseline surface area for wounds with greater than 50% surface area 
reduction was 0.90cm2 compared with 1.57cm2 for the comparison group of wounds with less 
than 50% surface area reduction at four weeks. There were no statistically significant difference 
relating to age, gender, diabetes type, HbA1c, PVD or DPN between the two groups that 
showed healing at four weeks of greater than 50% surface area reduction and less than 50% 
surface area reduction. The median difference in eGFR between the individuals wounds that 
had greater than 50% surface reduction at four weeks compared with the individuals with 
wounds with less than 50% surface area reduction at four weeks was 66.1 ml/min/1.73m2 and 
53.9 ml/min/1.73m2 respectively. Though the difference is not statistically significant, it does 
show that the cohort who did not achieve 50% wound area reduction met the chronic kidney 
disease stage 3 parameter, whereas the cohort who did meet the greater than 50% wound surface 
area reduction with a more efficient eGFR were Stage 2 for kidney health (Rayner et al., 2020). 
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The 103 individual wounds were divided into two groups: fast healers and slower healers. The 
fast healers (n=52) were defined as patients who had wounds which healed within thirteen 
weeks from baseline first visit to the diabetes high-risk foot ulcer clinic. The slower healers 
(n=51) healed in the latter thirteen weeks of the time end point of six months. That is, the 
baseline wound size was smaller in the fast healing group with a median surface area of 0.6cm2 
compared with the slower healers, whose median baseline wound surface area was 1.2cm2, 
twice as big in size as the fast healers. This difference in the surface area between the two 
healing groups at baseline was statistically significant (p=0.03). Comparison of these two 
groups (fast healers and slow healers) also showed a significant difference in wound surface 
area reduction at four weeks. Fast healers showed a 74.3% surface area reduction, and the 
slower healers showed a 55.7% reduction in surface area at four weeks from baseline (p=0.02). 
The fast healers showed a trend towards lower HbA1c with a higher estimated glomerular 
filtration rate compared to the slower healers. The slower healers showed a non-significant trend 
towards having both PVD and DPN. Although non-significant, these trends are in keeping with 
those described in previous literature. 
Although previous evidenced research has described distinct healing trajectories, their 
conclusions have been drawn from use of selected patients only and also a limited number of 
time points for example, baseline, four weeks of healing and wound closure at six months. In 
our real-world setting, which used an average of seven data points per patient, a uniform wound 
healing trajectory was not evident.  
Findings overview (Part 2) 
The ethnicity breakdown of the thirty-one participants who were interviewed reflected that of 
the DHB catchment population. The participants had an average age of 64.8 years and a mean 
duration of diabetes of 18 years, with 58.1% having evidence of PVD and 90.3% having 
evidence of DPN. Their glycaemic control and renal function might be considered clinically 
“reasonable”, with a mean HbA1c of 63.8 mmol/mol and a mean eGFR of 63.6 ml/min/1.73m2. 
Themes that emerged following transcription of the interviews and subsequent review of these 
data showed the importance of communication to enhance patient understanding. Using easy-
to-understand language by the podiatrists, when discussing wound healing progress with 
patients, enhanced patient understanding. Participants felt the sharing of wound images enabled 
them to form a collaborative partnership with the podiatrists, allowing participants to feel more 
confident in their diabetes and wound self-management. Some participants were excited to talk 
about the camera technology being used and how useful it was to see their wound, which 
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normally would have remained hidden from view due to the location on their foot. In contrast, 
some participants voiced an alternative perception of the wound imaging technology, saying 
that it had no value to them clinically. They also discussed support of family and whānau. Most 
participants required some support from family and whānau, which might be with dressings, 
moisturising of their feet or driving the PwD to their wound care appointments. 
Discussion 
Time to healing predictions may impair the trust foundation between patient and clinician 
Sheehan et al., (2003) described percentage reduction in wound surface area of more than 50% 
at four weeks post baseline wound assessment (Day 0), as a strong predictor of successful 
wound healing (Sheehan et al., 2003). Many researchers have adopted this treatment guideline 
as a determinant of outcome success for wound treatment (Hingorani et al., 2016; Laurent, 
Astère, Wang, Cheng, & Li, 2017; Niederauer et al., 2018; Snyder et al., 2010). With Frykberg 
and Banks (2015) describing Sheehan et al., (2003) guideline as being a “widely accepted and 
robust indicator for predicting healing” (Frykberg & Banks, 2015, p. 568). It was of passing 
interest to note that, in a secondary care clinic setting, despite having successfully healed 
wounds at six months (as defined by study inclusion criterion in Part 1), only 63% showed at 
four weeks the potential to heal successfully, using the “greater than 50% wound area 
reduction” parameter of Sheehan et al., (2003). As Figure 27 shows, even these wounds meeting 
this “robust” four-week predictor, did not always continue to heal uniformly. For example, 
eleven of these wounds increased in surface area before being determined as healed, including 
one wound that had a surface area of 0.0cm2 at week four and not being registered as completely 
healed until week fourteen. 
Involving a patient in their care promotes self management and optimises wound care 
This research has shown that DFU do not have a consistently linear healing trajectory that can 
be used to inform clinicians and patients of the likelihood their wound will heal. On discussion 
with the clinic podiatrists, they have confirmed that the most common question asked of them 
from their podiatry patients is “how long will this DFU take to heal?”. This could be interpreted 
as patients asking, “when can I get my life back?” due to the burden felt by people with long 
term conditions that require ongoing care and support (Demain et al., 2015). The need to feel 
informed and included in care being given is a valid expectation, born out by the need for 
understanding that is gained through quality communication between the patient and clinician 
as part of collaborative care. Heng et al., (2020) describes the benefits of collaborative care for 
patients with DFU in a comparative study using a collaborative care model alongside a didactic 
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educational approach, to assist with self-care and self-management (Heng et al., 2020). 
Utilising collaborative care that acknowledges the importance of a patient-clinician 
professional interaction resulted in greater knowledge retention for the patient, along with 
improved self-care practices. The study participants voiced their appreciation of being part of 
the wound treatment discussions with the podiatrist, so that a management plan was co-
designed, that would suit the patient. 
Educative information sharing provides self-management guidance in line with patient 
capacity and resources 
There is no shortage of diabetes self-management education packages along with electronic 
health self-management and education applications for PwD, who have made a conscious 
decision to partake in self-management education as described by Zhang, Schmidt, White and 
Mulvaney (2018) who utilised the “Internet of Things” to drive behavioural medicine for people 
with T1DM to optimise self-management (Zhang, Schmidt, White, & Mulvaney, 2018). Mitev 
(2018)  describes the adoption of  digital diabetes applications to aid self-management for PwD 
(Mitev, 2018). This relates to a population of people who have consciously taken ownership of 
their long-term condition and have the cognitive and social resources to do so. These research 
papers show foundation education that PwD can build on to understand their illness better and 
take ownership of their treatment and self-care. In contrast, there is limited literature that relates 
to the person who has been living with a long-term condition and the physiological 
consequences of that condition for a large majority of their life. Research has shown that people 
with DFU have reduced QoL scores, higher rates of depression, along with morbidity and 
mortality. Wukich and Raspovic (2018) describe health-related quality of life (HRQoL) survey 
results for PwD and foot disease had a lower QoL than in people with kidney disease, 
cardiovascular disease or neurological disorders (Wukich & Raspovic, 2018). Wukich and 
Raspovic (2018) also noted it that a person’s QoL score increased when a DFU healed. Of note, 
was the impact on mental QoL for the person with DFU affecting mood, concentration, and 
information retention, which can impact on treatment adherence (Gonzalez et al., 2008; Snoek, 
Bremmer, & Hermanns, 2015). Hence a formal self-management education package or digital 
application may not be suitable or effective within the high-risk foot ulcer clinic setting. Digital 
apps and external education may be too taxing on someone exhausted with their condition and 
having an informal ‘under the radar’ discussion may be just as, or more, effective. Guidance 
regarding self-management can be incorporated into a person’s routine when they are included 
in their care through a collaborative model of care. This collaborative approach to information 
sharing may be considered to be a form of adult learning, as it involves active patient 
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participation in learning on a topic that is personally relevant to the patient and provides them 
with a sense of personal control and responsibility (Merriam, 2001; Wilkinson, 2013). 
 
Utilising wound imaging within routine clinical care informs decisions and ’ownership of 
care’ 
The qualitative interview participants discussed evidence of collaborative care between 
themselves and the podiatrist, by describing the increased interaction that now occurred with 
the introduction of the wound imaging within routine clinic appointments. The participants felt 
a greater involvement in their care, along with an increased understanding of how their wound 
was healing. As they viewed the wound images, the podiatrist would discuss their treatment 
options and develop a plan with the participant, such as the need to utilise off-loading. Patients 
discussed their appreciation of the patient-clinician interface where they felt comfortable and 
able to discuss their concerns about their wounds. Enhanced understanding was promoted with 
the podiatrist able to show the PwD areas on the wound image that they had identified as being 
areas of concern. These might have shown signs of infection, or it could be a macerated area, 
used to describe the increased risk of infection and delayed healing if the PwD did not 
endeavour to keep the wound less moist. Through patient-clinician collaborative interaction and 
information sharing with PwD the researcher felt this developed an intrinsic motivation by the 
patients to optimise their wound self-care and diabetes self-management to create a higher 
likelihood of successful wound healing (Hölzel, Kriston, & Härter, 2013).  
Discussing wound treatment using everyday language aids understanding and enhances 
wound healing and self-management 
The collaborative care model starts with patient-clinician discussion on the PwD subjective 
assessment of their wound and any concerns they may have about it. As the wound is further 
assessed objectively, cleaned, and treated by the podiatrists, a running dialogue is occurring 
about the wound to add to the PwD understanding of the healing and need for treatment and 
suggested self-care and management outside of clinic. This information is further supported 
with the use of wound images during the appointment to solidify the information and advice 
being given and allow for further discussion between patient and clinician, which can assist 
with patients’ health literacy (Fearns, Heller-Murphy, Kelly, & Harbour, 2017). Richard, Glaser 
and Lussier (2017) discuss the importance of quality clinician communication with their patient 
to enable later recall of key self-management information (Richard, Glaser, & Lussier, 2017). 
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Their observational survey within a RCT showed that through an increased involvement in their 
care, patients had greater recall related to key points of information, which aids health literacy. 
As discussed in the literature review, people have differing styles of learning and information 
processing. Through discussing the wound, with an associated image, it allows for the patient 
to hear and see the evidence, increasing their likelihood of understanding the healing or non-
healing and the justification for a different treatment option. Using jargon free language when 
interacting with patients assists with understanding, which has a positive effect on health 
literacy (Muscat et al., 2019). 
Sharing information through various formats allows understanding at differing knowledge 
levels to work towards the end goal of optimal foot care 
The participants in the current study voiced their appreciation of easy-to-understand language 
during these discussions that aided their understanding (McKenna, Sixsmith, & Barry, 2017). 
It optimised the podiatrists reasoning as to why PwD needed to follow self-management advice, 
such as off-loading to assist with wound healing, along with wearing footwear inside their home 
to protect feet from injury and the potential for new foot ulcers. There was no evidence collected 
in this study of wound healing trajectories for the specific participants in the qualitative part of 
the study, to show improved wound healing through the sharing of wound images, and a 
collaborative care approach. Instead, participants responded by sharing that – seeing their 
wound images and discussing healing with the podiatrists, encouraged increased self-care and 
heightened their understanding of what the podiatry team is attempting to achieve through these 
appointments. This may apply not just to healing of the current wound, but prevention of the 
next “hypothetical” DFU as well. 
Maintaining integrity with information sharing maintains communication pathways for 
shared decision-making 
As demonstrated in Figure 26, the 103 individual patient wounds healed at six months did not 
show a uniform wound healing trajectory. This makes any predictive assessment by the patient 
or clinician, based on wound healing trajectory, problematic. One aim of this research was to 
identify a marker within the twenty-six week time period where all the wounds showed a steady 
downward healing trajectory towards being successfully healed. This marker was to be used to 
assist in discussions with patients when they asked the inevitable questions of “how long with 
this take to heal?”. The absence of this marker, though unfortunate, allows for discussion to be 
differently oriented, away from a pre-determined end point, towards a more full and frank 
discussion of potential differing outcomes. Patients, being aware that there is no definite time 
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point, can enter discussions about different realities and be informed as to what outcomes the 
podiatrist is looking for. One participant mentioned they did not like hearing the bad, which 
related to the podiatrist informing them early in the wound healing journey that there was a 
possibility, if their toe did not heal, that it would need to be amputated. This information sharing  
was not done in a way to shock or distress the person, but to lay the foundation for this 
possibility if it arose, so it was less of a surprise when the decision needed to be made. 
Discussions about the need for revascularisation can be made if the podiatrist feels that this will 
enhance wound healing for a particular patient. Participants found that having these discussions 
and being able to view their wound images on the computer monitor aided their understanding 
about why treatment changes or interventions were needed. Creating a communication 
environment based on trust, that has been gained through giving accurate information that has 
not led the person to form false hope, such as incorrectly predicting time to healing, benefits 
self-management, and assists the achievement of successful health outcomes (Birkhäuer et al., 
2017). 
Engagement between patient and clinician cultivates greater health literacy towards 
optimal self-care and self-management 
The merging of the results about wound healing trajectories and findings about the patient’s 
experiences of wound imaging have shown the importance of a mixed methodology approach, 
when considering the person as the centre of clinical care delivery that includes a component 
of shared decision-making. This is highlighted by the results that showed there are no defined 
signs of healing within the wound healing reduction metrics that can be used to predetermine 
when a wound will successfully heal. The ability to communicate this to patients in a way that 
is conducive to open discussion allows for successful information flow between the clinician 
and patient, where concerns can be raised, and options for increased likelihood of success. The 
building of a relationship that allows for a two-way discussion increases the patient’s ability to 
listen and understand what is being said, and through this engagement, builds health literacy 
(McKenna et al., 2017).  
Patients and podiatrists have different ways of communicating and sharing information with 
the end goal of successful wound healing the same 
The patients participating in the interviews attended the high-risk foot ulcer clinic between two 
differently set up podiatry rooms, each with benefits to information sharing, but in different 
ways. One room was set up where the podiatry chair faced the computer monitor, where the 
patient could observe the podiatrist tracing around the wound margin. While doing this the 
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podiatrist would discuss the wound with the patient. Due to the impact of diabetes associated 
eye disease such as retinopathy, it is possible the picture or image was not that clear to the 
patient and they would also have a discussion standing beside the podiatrist after the 
appointment for a better view of the screen. The other podiatry room is set up with the patient 
sitting alongside the computer monitor, giving them no view of their foot ulcer on the screen 
during treatment. However, the positioning of the chair allows for a face to face discussion 
between the patient and podiatrist, while they are in the podiatry chair, and while the podiatrist 
writes their notes. This allows for eye contact and assessment of facial expression during the 
conversation to further promote communication. The patient can then view the digital images 
alongside the podiatrist after they dress the DFU. A valid point raised by a participant during 
the SSI was how beneficial they would find being able to view their DFU on a handheld tablet 
during the consultation to further the discussion and aid in shared decision-making. As noted 
here, both podiatry rooms set up have their own advantages and disadvantages when sharing 
the wound imaging information with their patients and discussion of it. Like the semi-structured 
interview questions, there is no wrong answer, just a different way of information sharing 
during routine clinical care. Floss, Hoedebecke and Vidal-Alaball (2019) investigated clinician 
and patient chair placement within a consultation appointment from 502 individual clinicians. 
They acknowledged the computer has changed the focus during the patient-clinician interface 
and within a general practice consultation can negatively impact on patient-clinician interaction 
(Floss, Hoedebecke, & Vidal-Alaball, 2019). Conversely, it has been found that this does not 
occur within the high-risk foot ulcer clinic as the computer information is shared with the 
patient and does not sit as a physical barrier between them and the clinician. The importance of 
sharing information within the outpatient clinic consultation related to room set up and lap-top 
placement has been researched by Ajiboye, Dong, Moore, Kallail and Baughman (2015) in their 
patient-centred survey, where participants were able to view the clinicians lap-top screen at any 
time during the consultation as helpful (Ajiboye, Dong, Moore, Kallail, & Baughman, 2015). 
Collaborative care enhances self-management for the current DFU as well as the prevention 
of the next potential DFU 
The merging of this mixed methods research has shown that without patient shared decision-
making and collaboration between the PwD and specialist clinicians there is less chance for 
information sharing, education and understanding. As there is not a clear wound healing 
trajectory for clinicians to use to inform patients of expected healing outcomes, they should 
avoid discussing a time frame with which the DFU may heal as incorrect predictions could 
impact on trust in the clinician if the DFU does not heal in this time frame. The risk of 
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subsequent DFU is 20% greater for PwD following the occurrence of their first DFU (Banik et 
al., 2020), with an increased risk of amputation occurring as well. This solidifies the need for a 
respectful and considerate working relationship between the PwD and clinicians, due to the 
high probability of PwD and a history of foot ulcers, requiring multiple appointments over an 
extended period of time. Optimal education that focuses on factors that might reduce the risk 
of harm that may lead to foot ulceration, may in turn improve foot self-care and diabetes self-
management and lead to better health outcomes for these people. 
As shown in Figure 24, 70% of baseline wound SA measured between 0.04 and 1.84cm2. This 
could relate to the close surveillance the podiatry patients undergo, either through primary care 
medical practice follow up or community podiatry care, or the identification of a new DFU in 
the early stages of progression could occur within the specialist diabetes podiatry clinic when 
another DFU is being treated. The rapport that develops between clinician and patient allows 
them to present regularly for follow up appointments to ensure treatment is maintained and new 
DFUs are found and treated as early as possible. On discussion with the specialist diabetes 
podiatrists, regarding the baseline DFU SA, it was suggested that these wounds could have the 
appearance of being small in size related to their recorded SA, but may involve a deep tracking 
sinus, that is not able to be captured in the image. Due to patient privacy permissions, we were 
unable to determine the type of wound that was represented.  
Adhering to the Picker framework of person-centred care enhances communication, 
understanding, shared-decision-making to support self-management practices 
As stated earlier, the New Zealand Ministry of Health adopted the Picker institute framework 
principles of person-centred care (Ministry of Health, 2016) which encourages the provision of 
health care: i) in a respectful and dignified way; ii) sharing of information taking into account 
the person’s health literacy; iii) encouraging self-participation in care and decision-making; iv) 
allowing for collaboration between the patient, their family, multi-disciplinary team for the 
provision of optimal care through shared decision-making (Munthe et al., 2012). This research 
has shown the appreciation of information being shared in a way that encourages understanding 
and concordance with the treatment objectives. The manner in which the information has been 
imparted to the podiatry patients has been at a level where it has been easy to understand, and 
if not, the person has felt comfortable to ask for greater clarity. The participants have 
commented that they feel more informed and involved in their care within their podiatry 
appointments as opposed to their experience of other departments within the hospital, where 
they felt the department was only interested in the specific bodily function under review, not 
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the whole person. The value of involving the person in their care encourages “buy-in” regarding 
self-management. The importance of enhanced self-care and self-management practices relates 
to the person investing more time in foot self-examination, moisturising dry skin, and attending 
regular wound dressing appointments (self-care). Adhering to advice with regard to wearing 
protective footwear, off-loading the foot with the DFU and managing glycaemic control (self-
management) optimises wound healing in an environment where the time to healing cannot be 
predicted, but actions that can remove impediments to wound healing, can be implemented. 
The qualitative findings and themes revealed through the participant responses, show that these 
principles are being met and can be applied to other areas of healthcare that involve 
collaboration between patient and clinician in an environment of shared care. 
Limitations 
The inclusion and exclusion criteria for the wound metrics in Part 1 excluded multiple wounds 
that had healed within the six-month period if they were from the same individual. A wider 
selection of wound surface area measurements would have been available for analysis if all 
these wounds had been included and analysed. An analysis of all wounds and wound images 
would have been difficult from a methodological perspective. Wound healing trajectory data 
would then need to have been considered within the context of multiple interventions, such as 
surgical interventions for non-healing wounds. The analysis of only wounds that were healed 
by six months, also removed a comparison group of wounds that had not healed. As there was 
no obvious wound healing trajectory noted in the group of patients pre-selected based on having 
a healed wound at six months, it is not felt that this excluded information would have altered 
any conclusions of this research. Due to time constraints and ethics permissions, the onset of 
hyperglycaemia, which often differs from the known duration of diabetes, could not be found 
easily for the 103 people with DFU. With most patients having T2DM it is likely that their time 
with hyperglycaemia was significantly longer that their time with a known diagnosis of 
diabetes. They may already have formerly developed DPN and had some evidence of PVD, by 
the time they were diagnosed.  
A meaningful sub-group analysis by ethnicity could not be performed because of the relatively 
low sample size, and also because of the low numbers of patients available in some ethnic 
groups. In the future, any further study should aim to incorporate more representative 
ethnographic populations, with an emphasis on Māori health outcomes.  
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A hypothetical study that compared wound healing metrics, before and after the introduction of 
an imaging camera, used as part of routine care in the podiatry clinic, may have established a 
clear improvement in patient education and self-care behaviours following the introduction of 
a camera and associated changes in clinical care delivery. This may have shown in a more direct 
way, the utility of sharing wound images with patients within a routine clinic setting. 
One of the limitations of study design was that information about the person’s level of education 
and an assessment of their health literacy, was not collected on SSI participants. Studies have 
shown a greater than tertiary level of education enhances the person's health literacy and 
understanding (Miller, 2016). Information about participants’ footedness, plus length of time 
attending the high-risk foot ulcer clinic, along with common area of foot ulceration, may have 
augmented our understanding of the findings of this study. 
This study has shown that a catchment population of over half a million people requires the 
analysis of several years of data to obtain 103 PwD who fulfilled study eligibility criteria. 
Obtaining much larger sample sizes is therefore only likely to be possible, using a multicentre 
approach. Currently, this is hampered by the fact that only a small number of specialist podiatry 
clinics, use and store digital images of DFU. Wound healing determinants, including clinical 
interventions such as re-vascularisation or prescribed antibiotics were unable to be evaluated 
due to the ethical constraints related to retrospective access of detailed clinical records. 
Given this was an exploratory study, an exact power calculation was not calculated. Nor was 
this study sufficiently powered to enable a sub-group analysis. The size of the group for analysis 
was discussed with the researcher’s supervisors, along with a clinical biostatistician.  
Recommendations 
Wound imaging should occur at every diabetes foot ulcer clinic appointment. This would 
validate treatment and enhance information sharing between clinician, patient, and other HCP. 
The majority of podiatry patients interviewed clearly expressed their appreciation of being able 
to view their wound on the computer monitor and be able to discuss the treatment and healing 
aims and objectives with the podiatrists. Having a retrievable visual record of their wound 
assisted the patient in future discussions with other clinicians about progress and the possible 
need for interventions to promote healing. 
The provision of a hand-held tablet through which the patient can view their foot ulcer and have 
more input into the discussion and decision-making about treatment modes would be beneficial. 
Future design considerations of the built environment, including digital hardware within a 
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specialised podiatry clinic should allow for both face-to-face communication, but also easy 
sharing of e-images. 
Future research 
During routine podiatry clinical care, information sharing between the podiatrist and patient 
could be assessed using a structured assessment that includes pre-determined discussion points. 
This will occur in contrast to a usual care discussion regarding wound healing and progress. 
The observational assessment will allow the researcher to examine the benefit of a more mindful 
approach to patient communication. These new learnings could lead to the creation of an 
education model to inform clinicians of optimal ways to communicate clinical expectations, 
treatment modes and outcomes with patients and their support people to enhance knowledge 
and understanding.  
The current research methodology and findings could be expanded beyond diabetes podiatry 
services, to other areas of wound care. In contrast to the non-uniform wound healing trajectories 
seen in DFU, less complex ulcers may show greater uniformity in healing trajectory, such as 
venous leg ulcers as described by Cardinal, Eisenbud, Philipps and Harding (2007) as showing 
a “powerful predictor” of wound healing at four weeks (Cardinal et al., 2008). Research should 
also be undertaken between clinician and patient groups outside of diabetes podiatry who are 
using patient specific medical images, to assess ways that these images can be shared with the 
patient in a non-threatening and informative way.  
Conclusion 
Collaborative care and shared decision-making should be encouraged and supported within a 
long-term condition clinical environment, where long term treatment and clinician-patient 
interactions will occur. This supports a positive environment where information can be shared, 
and self-management encouraged and supported. 
The PwD and DFU are all individuals with complex individual foot wounds. The wound healing 
metrics have shown that there is not a standard wound healing trajectory that can be used to 
inform patients or clinicians on expected time to healing for DFU. This is likely to be due to 
the complexity of DFU, where a vicious cycle can occur between treatment recommendations, 
such as off-loading and hyperglycaemia due to inactivity. Due to the lack of sensation related 
to DPN, the PwD and DFU is more susceptible to new micro-trauma from inability to weight 
bear effectively due to impaired proprioception. This inactivity related hyperglycaemia 
increases the risk of infection leading to the foot ulcer not-healing and requiring further 
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interventions, with either surgical debridement, larvae therapy and, or anti-biotics. This 
supports not discussing a healing endpoint with patients where they may feel they have been 
given false hope, when the DFU does not heal within the given time frame, as there are too 
many known and unknown confounding factors that can affect the outcome. Not meeting a 
given target is likely to impair the collaborative partnership and model of care that has been 
developed between patient and clinician, hindering an ongoing trusting relationship through 
which to promote further care and self-management. 
The increasing digitisation of healthcare presents many new opportunities and challenges, that 
both HCP and PwD will need to navigate for the delivery of optimal care. As shown by this 
study, this journey into an increasingly digitised clinical world is best made using a co-designed 
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Participant Information Sheet 
 
Study title:  Assessing wound measurement within a high-risk diabetic foot ulcer clinic, clinical 
perspectives and patient perspective 
 
Locality: Christchurch Diabetes Centre    Ethics committee ref: 18/NTA/100 
 
Lead investigator:  Helen Heenan     Contact phone number: 3640 860 
    
 
You are invited to take part in a study on wound photographs (imaging) within the Diabetes 
Centre.  Whether you take part or not, is your choice.  If you do not wish to take part, you do 
not have to give a reason. It will not affect the care you receive.  If you would like to take part 
now, but change your mind later, you can pull out of the study at any time.   
This Participant Information Sheet will help you decide if you would like to take part. It sets out:  
• why we are doing the study  
• what your participation will involve 
• what the benefits and risks to you might be  
• what will happen after the study ends  
We will go through this information with you and answer any questions you may have.    You 
do not have to decide today whether or not you will take part in this study. Before you decide, 
you may want to talk about the study with other people, such as family, whānau, friends, or 
healthcare providers.  Feel free to do this. 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet and 
the Consent Form to keep. 
This document is 6 pages long, including the Consent Form.  Please make sure you have read 
and understood all the pages. 
164 
 
What is the purpose of the study? 
The purpose of this study is to understand your thoughts related to the wound photographs 
taken in the podiatry clinic. We will also be asking other patients to share their experiences 
related to the wound camera being used in the podiatry clinic. 
Although taking pictures of wounds is not a new idea, being able to photograph wounds and 
also compare the size of the wound at each appointment electronically is relatively new. The 
wound image software records the measurements of your wound in a computer file, which 
allows graphs to be made to show you how the wound is healing. 
We are aware that often when new equipment is introduced, patients are not asked for their 
opinion of the new equipment. Do patients see it as adding value to their care? It is important 
that our care remains patient centered and as such, your opinion is important to us. 
We plan to interview 30 patients currently attending the podiatry clinic for treatment of foot 
ulcers or wounds. Written consent will be obtained first from each patient.  The interviews will 
be audio recorded for accuracy. The interviews will later be played back and written out from 
the recordings. This will allow responses to be sorted into themes. Following writing out of the 
interview, the accuracy of the written document will be assessed by an independent person, 
following this the recordings will be deleted. The risk of harm to those participating is low. You 
may feel anxious about your responses and if your answers are correct. There are no right or 
wrong answers. Only your personal opinion is required. Your responses will be made 
anonymous. No one can look at the results and know that it was you who gave specific 
answers. We feel the insight we will gain from your answers will give us a better understanding 
of patients’ views around new technology being used in a clinical setting. 
This study is part of a nursing Master’s degree. The study team consists of the Master’s student 
– Helen Heenan; Diabetes Centre podiatrists and the Master’s student clinical supervisors – 
Associate Professors Helen Lunt and Philippa Seaton. 
This study has been submitted to New Zealand’s Health and Disability Ethics Committee 
(HDEC) for approval. 
What will my participation in the study involve? 
You have been approached to be involved in this study as you are currently attending the high-
risk foot ulcer clinic at the Diabetes Centre. 
You will be asked to provide written or verbal consent if unable to write before taking part in 
this study. A time will be arranged that suits you to answer approximately 12 interview 
questions. This could be at the Diabetes Centre, scheduled around the time of your podiatry 
clinic.  Alternatively, it could take place over the phone. The interviews will be recorded with 
an audio device to allow for the interview to be written out. This will ensure your answers are 
recorded accurately. The interviews will take 20 - 30 minutes. The interview questions are 


















You will also be asked about your wound healing and how information has been shared with 
you about your wound. Advice or additional treatment that you have been given to assist with 
your wound healing will also be gathered. 
The electronic wound imaging software links with your hospital number (National Health 
Identifier which is unique to you).  Each wound image is saved to your hospital file. In this 
study, information about your type of diabetes and foot ulcer will be recorded to show a varied 
group of patients have been interviewed. Your diabetes related laboratory results, such as 
HbA1c will also be recorded. This will show a range of people have been interviewed, giving 
greater credibility to the study results. 
What are the possible benefits and risks of this study? 
This is a very low risk study. If you feel being asked questions about your care may make you 
feel uncomfortable, please do not feel obliged to participate.  There are no direct benefits to 
participants in taking part in this study. 
If during the interview questions, your answers cause concern about your safety or someone 
else’s safety, the interviewer will discuss these concerns with you as well as a health 
professional.  
Who pays for the study? 
Those participating in this research will not incur any financial costs, only their time. 
What if something goes wrong? 
Should you feel unwell or upset during the interview it will be stopped. You should not feel the 
need to continue. If the recording equipment fails, you may be asked to repeat the interview, 
however every effort will be made to ensure this does not happen. 
If you were injured in this study, which is unlikely, you would be eligible to apply for 
compensation from ACC. Just as you would be if you were injured in an accident at work or at 
home. This does not mean that your claim will automatically be accepted. You will have to 
Podiatrist imaging patient’s diabetic foot ulcer (used with permission) 
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lodge a claim with ACC, which may take some time to assess. If your claim is accepted, you 
will receive funding to assist in your recovery. 
If you have private health or life insurance, you may wish to check with your insurer that taking 
part in this study won’t affect your cover. 
What are my rights? 
This study is voluntary. Your information and interview transcripts will be coded so as not to 
identify you. 
We are unable to provide interpreters for this study. 
What happens after the study or if I change my mind? 
This study is part of a nursing Master’s thesis looking at wound healing over time, along with 
patient views of the imaging equipment used to obtain the wound healing measurement data. 
It is hoped that the results from these interviews will assist our understanding of: i) how the 
use of this device is viewed by patients and ii) if it has any benefit to the wound healing journey 
for patients. These learnings will be included into usual care within the diabetes podiatry 
service.  
Longer term, results may be published to share our learnings with other health professionals.  
De-identified data and results will be stored in a password protected file for ten years to meet 
the standard study archiving requirements.  
Who do I contact for more information or if I have concerns? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
Dr Helen Lunt, Diabetes Physician and Clinical Associate Professor 
Phone:  03 3640 860 
Email:  Helen.Lunt@cdhb.health.nz 
If you want to talk to someone who isn’t involved with the study, you can contact an 
independent health and disability advocate on: 
Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678)  
Email:   advocacy@hdc.org.nz 
For Maori Heath support please contact: 
Debbie Rawiri, Diabetes Nurse Specialist 
Phone:  03 364 0860 
Email:  Debbie.Rawiri@cdhb.health.nz  
You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
Phone:  0800 4 ETHICS 












Please tick to indicate you consent to the following  
 
I have read, or have had read to me in my first language.                 
I understand the Participant Information Sheet.   
  
I have been given sufficient time to consider whether or not to 
participate in this study. 
  
I have had the opportunity to use a legal representative, whānau/ 
family support or a friend to help me ask questions and understand 
the study. 
  
I am satisfied with the answers I have been given to my questions 
regarding the study. I have a copy of this consent form and 
information sheet. 
  
I understand that taking part in this study is voluntary (my choice).   
I may withdraw from the study at any time without this affecting my 
medical care. 
  
I consent to the research staff collecting and processing my 
information, including information about my health. 
  
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 
be processed. 
 Yes  No  
I consent to my GP or current health care professional being 
informed about my participation in the study and of any significant 
abnormal results obtained during the study. 
 Yes  No  
I agree to an approved auditor appointed by the New Zealand 
Health and Disability Ethic Committees, or any relevant regulatory 
authority or their approved representative reviewing my relevant 
medical records for the sole purpose of checking the accuracy of 
the information recorded for the study. 
    
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I understand that my participation in this study is confidential and 
that no material, which could identify me personally, will be used in 
any reports on this study. 
     
I understand the compensation provisions in case of injury during 
the study. 
      
I know who to contact if I have any questions about the study in 
general. 
      
 
I understand my responsibilities as a study participant.                                                   
  
I wish to receive a summary of the results from the study. Yes  No  
 
 
Declaration by participant: 







Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant and have 
answered the participant’s questions about it.  
 










Semi-structured interview questions 
Semi-structured interview questions - Communication, partnership, coordination, physical 
and emotional needs. 
1. Do you know who first referred you to the diabetes foot ulcer clinic? 
2. Do you remember injuring your foot prior to the ulcer forming, or was it found during 
a routine foot examination? 
3. Have you noticed the podiatrist taking a photo of your foot wounds during your 
appointment? (setting the scene) 
4. Have you been able to see a photograph of your wound on the computer – the podiatrist 
may have shown it to you to explain about your healing?  
5. Have you been shown the graph of your wound? 
6. Can you describe what the graph showed?  
7. How has the podiatrist discussed the graph or the pictures with you? (communication) 
8. Do you feel comfortable discussing your foot wound with your podiatrist? 
(communication) 
9. How has having your wound images and healing progress shared with you made you 
feel about the treatment you are receiving? (partnership)  
10. Did you know that your G.P. and other health professionals can view the latest photos 
of your wound through your e-health records?  (coordination) 
11. How do you feel about your information being available to multiple clinicians? 
12. Were you aware you are able to ask your GP or podiatrist to be referred to other services 
within the Diabetes Centre? What other services available through the Diabetes Centre 
are you aware of? (physical and emotional needs) 
13. What advice have you been given by the podiatrists for you to do that will help your 
foot ulcer heal? (offloading/take antibiotics as prescribed/engage with recommended 
health professionals either within DC or GP practice) (physical & emotional) 
14. Is there anything else you feel would be useful to share with me about your wound 














Manager, Academic Committees, Mr. Gary Witte 
 
 
Assoc. Prof. H Lunt             27 August 2018 
Department of Medicine (Chichi) 
University of Otago, Christchurch 
University of Otago Medical School 
 
Dear Assoc. Prof. Lunt 
 
I   am   again   writing   to   you   concerning   your   proposal   entitled “Assessing   
wound measurement within a  high-risk diabetic foot ulcer clinic, clinical 
perspectives and patient perspectives”, Ethics Committee reference number 
H18/092. 
 
Thank you for your email of 23rd August 2018 with response attached addressing 
the issues raised by the Committee. 
 
On the basis of this response, I am pleased to confirm that the proposal now has 
full ethical approval to proceed. 
 
The standard conditions of approval for all human research projects reviewed and 
approved by the Committee are the following: 
 
Conduct the research project strictly in accordance with the research proposal 
submitted and granted ethics approval, including any amendments required to be 
made to the proposal by the Human Research Ethics Committee. 
 
Inform the Human Research Ethics Committee immediately of anything which may 
warrant review of ethics approval of the research project, including: serious or 
unexpected adverse effects on participants; unforeseen events that might affect 
continued ethical acceptability of the project; and a written report about these 
matters must be submitted to the Academic Committees Office by no later than 
the next working day after recognition of an adverse occurrence/event. Please 
note that in cases of adverse events an incident report should also be made to the 







Advise the Committee in writing as soon as practicable if the research project is 
discontinued. Make no change to the project as approved in its entirety by the 
Committee, including any wording in any document approved as part of the project, 
without prior written approval of the Committee for any change. If you are applying for 





Approval is for up to three years from the date of this letter. If this project has not 
been completed within three years from the date of this letter, re-approval or an 
extension of approval must be requested.  If the nature, consent, location, procedures 
or personnel of your approved application change, please advise me in writing. 
 
The Human Ethics Committee (Health) asks for a Final Report to be provided upon 
completion of the study. The Final Report template can be found on the  










Mr. Gary Witte 
Manager, Academic Committees 



















New Zealand Health and Disability Ethics Approval 
Health and Disability Ethics Committees 
Ministry of Health 
133 Molesworth Street 




0800 4 ETHICS 
hdecs@moh.govt.nz 
 
09 August 2018 
 
Mrs. Helen Heenan 
Diabetes Centre 




Dear Mrs. Heenan 
 
Re:      Ethics ref:                     18/NTA/100 
 
Study title:                      Assessing patient perspectives of wound imaging within a 
high risk foot ulcer diabetes podiatry clinic 
 
I am pleased to advise that this application has been approved by the Northern A 
Health and Disability Ethics Committee. This decision was made through the HDEC-
Expedited Review pathway. 
 
Conditions of HDEC 
approval 
 
HDEC approval for this study is subject to the following conditions being met prior 
to the commencement of the study in New Zealand. It is your responsibility, and 
that of the study’s sponsor, to ensure that these conditions are met. No further 




1. Before the study commences at any locality in New Zealand, all 
relevant regulatory approvals must be obtained. 
 
2. Before the study commences at each given locality in New Zealand, it 
must be authorised by that locality in Online Forms. Locality authorisation 
confirms that the locality is suitable for the safe and effective conduct of 
the study, and that local research governance issues have been 
addressed. 
 
After HDEC review 
 
Please refer to the Standard Operating Procedures for Health and Disability Ethics 
Committees (available on www.ethics.health.govt.nz) for HDEC requirements 
relating to amendments and other post-approval processes. 
Your next progress report is due by 08 August 2019.  
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Participant access to ACC 
 
The Northern A Health and Disability Ethics Committee is satisfied that your study is 
not a clinical trial that is to be conducted principally for the benefit of the 
manufacturer or distributor of the medicine or item being trialed. Participants injured 
as a result of treatment received as part of your study may therefore be eligible for 
publicly-funded compensation through the Accident Compensation Corporation 
(ACC). 
 
Please don’t hesitate to contact the HDEC secretariat for further information. We 









Dr Brian Fergus 
Chairperson 
Northern A Health and Disability Ethics Committee 
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Disability Ethics Committees, and with the principles of international good 
clinical practice (GCP) 
   is approved by the Health Research Council of New Zealand’s Ethics Committee 
for the purposes of section 25(1)(c) of the Health Research Council Act 
1990 
   is registered (number 00008714) with the US Department of Health and Human 
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Assessing wound measurement within a high-risk diabetic foot ulcer clinic, clinical 
perspectives and patient perspectives 
Study Investigator(s) 
Principal Investigator (A):  Helen Heenan1, 2  
     Ph. 027 8123 720 
Email: heehe479@otago.ac.nz 
Co-Investigator (A):  Clinical Associate Professor Helen Lunt1, 2  
Co-Investigator (B):   Associate Professor Philippa Seaton2 
1. Canterbury District Health Board 
2: University of Otago, Christchurch 
 
1. Introduction 
The specialist diabetes podiatry team operating within the Canterbury District Health 
Board (CDHB) secondary care Diabetes Centre, utilise a wound imaging device and 
associated software as part of routine clinical work flow. This software technology allows 
for wounds to be imaged and associated wound metrics, such as surface area, to be 
recorded. This allows for the compilation of wound healing trajectories. Individual 
patient’s wound images and also associated graphed wound trajectories can be shared 
with the patient during their appointments. Following internal clinical discussions about 
standardisation of process between members of the diabetes podiatry team, a high level 
of consistency and accuracy with regard to wound area tracing of imaged wounds has now 
occurred.  
The primary quantitative aim of this study is to determine the predictive value of a 
diabetic foot ulcer (DFU) wound healing trajectory, related to six month wound healing 
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outcome metrics in a multidisciplinary high risk diabetic foot clinic, using 2-D electronic 
imaging (e-imaging). 
Previous studies of DFU’s typically use a six month time “cut off”, to define healed i.e. 
healed a within six months, versus non healed ulcers. Evidence of partial healing at 28 
days – usually reported as a reduction in wound surface area by 20-40%, appears to be 
the best predictor of attaining healing by six months. 
Current studies do not however focus on differentiating between early healing and later 
healing. A better understanding of clinical predictors of early and late healing is likely to 
be clinically useful:  Patients want information about the likely healing rate of their ulcers. 
Also, if it is possible to predict which patient subpopulations are likely to experience the 
burden of a slow-to-heal ulcer, future clinical interventional studies could then be 
designed to focus on this subpopulation. 
This clinical audit will explore clinical predictors of slow and fast wound healing. 
Following discussion with biostatistician, Professor Chris Frampton it was agreed a 
sample size of approximately 150 patients / wounds will allow an exploratory analysis of: 
a) Time to full (complete) healing of the ulcer, which in turn will help define 
categorisation of fast and slow healers  
b) Clinical factors that predict fast versus slow healing. 
Clinical factors that are known to have an influence on healing rates include glycaemic 
control, renal function, infection, neuropathy and vascular disease. These will be explored 
as potential predictors of wound healing, in this clinical audit. 
This real world research may assist in providing documented evidence of the time taken 
to heal diabetic foot ulcers and also assist with podiatrist time allocation, thereby 
providing data for clinical managers and administrators, regarding the need for ongoing 
treatment beyond that documented previously in published RCT papers and similar 
research based settings.  
In subsequent sections of this protocol, use of the term “wound imaging” should be read as 







Diabetes can be described as a complex chronic illness (Gospin, Leu, & Zonszein, 2017). 
For those with type one diabetes mellitus (T1DM), there is no chance of remission or cure 
from the diagnosis or treatment regimen. A few people with type 2 diabetes mellitus 
(T2DM) manage to gain and maintain remission (McCombie et al., 2017), though with the 
disease progression and required adherence to a strict change in lifestyle this is often 
short lived.  
Diabetes leads to an increased risk of microvascular and macrovascular complications 
over time, the progression of which is increased in association with poor glycaemic 
control, mainly hyperglycaemia (Dabelea et al., 2017), though cognitive dysfunction and 
decline can also be associated with episodes of hypoglycaemia (Ojo & Brooke, 2015). 
Over 50% of people diagnosed with T2DM have diabetic peripheral neuropathy (DPN) 
(Heydari, Radi, Razmjou, & Amiri, 2010). People with greater than 30 year history of 
requiring exogenous insulin as with T1DM also have a heightened risk of developing DPN 
(National Clinical Audit Programme, 2014-2016). Along with DPN, diabetic peripheral 
vascular disease (PVD) may or may not be present.  
Diabetic foot ulcers can result from DPN, where proprioception and balance are affected, 
causing wear, a resulting blister, a break in the skin barrier and creating a possible site 
for infection to occur (Deshpande, Harris-Hayes, & Schootman, 2008). With the lack of 
sensation associated with DPN, the blister and incorrect gait is often unnoticed and 
therefore untreated. Foot injuries, such as stubbed toes or penetration by sharp objects 
can go undetected due to the lack of sensation on the foot. 
Hypertension and hyperlipidaemia enhance the risk of developing PVD in PwD 
(Deshpande et al., 2008). The resultant decrease in blood circulation to the lower 
extremities and oxygen deprivation adds to the increased risk of a DFU with resultant 
decreased availability of inflammation and infection fighting cells to aid in healing 
(Yagihashi, Mizukami, & Sugimoto, 2011). 
 
The need for a secondary care multidisciplinary high-risk foot ulcer clinic arises from the 
insidious nature of diabetes and the detrimental effects that can occur on the diabetic foot. 
The multidisciplinary high-risk foot clinic specialist diabetes podiatrists are required to 
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assess, manage and treat the DFUs that are likely to be slow to heal, in a community 
setting. 
In specialised research clinic settings, a four week wound healing trajectory is used as a 
predictor of complete wound healing at six months. High risk foot clinic data within our 
service suggests that this may not be an accurate predictor where multiple variables 
associated with the chronicity of diabetes affect the end result, some of these include 
glycaemic control, renal function, infection, neuropathy and vascular disease. Whilst 
(Sheehan et al., 2003) describe a study of diabetic foot ulcers showing signs of healing at 
28 days, it was seen in retrospect, after healing was definitely evident at 12 weeks. This 
information was gathered from a multicentre RCT for a new wound healing compound 
and the wounds were required to be less than 30 days old at baseline. Another RCT 
showed healing at 28 days as an indicator of “ultimate total wound closure” (Cardinal et 
al., 2008) in venous leg and diabetic foot ulcers though they did not state parameters of 
wound age for entry into these trials. 
The imaging of wounds has been used historically as an educational tool. The use of 
multiple images of the same wound as a comparison, to assess the rate of healing, has 
occurred only recently as digital technology has matured and become more accessible 
(Miller, Karimi, Donohue, & Kapp, 2012).  
Patients are often referred to the diabetes high risk foot clinic, when traditional primary 
care methods of wound healing appear to be working suboptimally (Chaplin, 2016), not 
due to the lack of skills within primary care, but the complex nature of diabetes and the 
disease morphology, leading to the non-healing wound.  
The utilisation of electronic imaging to capture the wound and map its healing trajectory 
allows for accurate consecutive data capture (see figure 1 below). This enables a more 
accurate indication of the average wound healing time. To predict healing of a DFU, by 
either visual inspection of previous images, or as a more sophisticated use of wound 
measurements enabling numerical documentation changes to wound surface area. 
Previous studies of wound healing trajectory within the context of DFUs have been in 
research settings, such as randomised control trials (RCTs), not in the real world setting. 









3. Study Aim (quantitative) 
This study aims to describe the DFU wound healing trajectories of patients whose ulcers 
have healed at six months, then link this with standard clinical predictors of wound 
healing, namely: 
• Reduction in wound surface area by 20-40% 1-2 months from baseline 
• Signs of infection 
• Glycaemic indices i.e. HbA1c 
• Renal function 
• Evidence of peripheral vascular disease or diabetic peripheral neuropathy 
• Smoking status 
The study setting is a multidisciplinary high risk diabetic foot clinic, thus we also plan to 
present the study findings in a way that is generalisable i.e. relevant to those working in 
similar settings.  
 
Figure 30: Silhouette wound image as seen on patient e-health record (used with written 
permission of the patient) and stored on District Health Board servers.   
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4. Objectives  
Wound surface area metrics will explore clinical predictors of slow and fast wound 
healing through analysing wound healing trajectories of DFU wounds healed at six 
months. This will be achieved by: 
• Exploring patient demographics, including age, sex, ethnicity 
• Determining diabetes diagnosis i.e. Type 1 or type 2  
• Determination of wound type i.e. PVD or PND 
• Collating baseline glycaemic control i.e. HbA1c 
• Linking renal function tests undertaken during wound healing appointments 
with wound healing outcomes 
• Recording the association between interventions used to assist wound healing, 
and wound healing outcomes 
Documenting the association between these variables and fast and slow wound healing 
will provide evidence that may help future clinical predictions of speed of ulcer healing. 
5. Study Design  
The broader Master’s research project incorporates a convergent mixed methods design 
for the qualitative and quantitative components – see separate qualitative research 
protocol. The study described below focuses on the quantitate aspects of the Master’s 
research project only.  
In this study, e-wound area metrics collected over a three year period, from each patient 
appointment, using a calibrated wound imaging device, that allows for non-invasive 
wound tracing, which is routinely incorporated into clinical workflow, will be used. At the 
majority of patient follow-up appointments consecutive images are taken and tracings 
made. These data is collected into a centralised database stored within the hospital secure 
network. The imaging device “Silhouette™” is an ARANZ medical device (ARANZ Medical, 
2016a).  
A multi-level approach to expand the evaluation of the wound metric data will be used 
due to the complexity of DFUs. This will involve data obtained through the patient e-health 
record along with the Silhouette wound imaging database: 
Level one will examine wound surface area trajectories from baseline to healed at 
six months using T tests to assess the following comparisons between  i) male 
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versus female  ii) T1DM and T2DM, and  iii) PVD versus DPN. Additionally, the time 
point at which wounds began to show signs of healing will be detected and it will 
be determined if the wound is a fast or slow healing wound. Percentage area 
reduction or mean surface area advance could be considered, as used by Cardinal 
et al., 2008.   
Level two will assess glycaemic control and renal function during the time of 
treatment by accessing glycated haemoglobin and eGFR (estimated glomerular 
filtration rates) laboratory results, obtained through the patients’ e-health record 
(Sharp & Clark, 2011).  
Level three will investigate a variety of interventions commonly used to assist 
with wound healing, including popliteal bypass graft, antibiotic therapy, negative 
pressure therapy and/or change to anti hyperglycaemic therapy.  
6. Study Setting/ Location  
Patients are referred to the Christchurch Diabetes centre high risk foot ulcer clinic where 
four podiatrists are employed. The Canterbury District Health Board (CDHB) podiatrists 
operate with the support of a multi-disciplinary team (MDT) that includes diabetologists, 
nurses, dieticians and psychologists.  
7. Study Population  
De-identified quantitative patient data will be analysed for a 36 month period between 
2015 and 2018. This will allow for over 4500 images to be assessed from 450 individual 
patients who have attended the diabetes high risk foot clinic. At six months from baseline 
patients’ wounds will be deemed healed or non-healed. i.e. follow up will be up until the 
end of six months for non-healing wounds rather than until wound healing or death. 
Inclusion/exclusion parameters have been discussed with biostatistician Professor 
Christopher Frampton (see Appendix 1).   
This setting provides an initial patient sample of 450 individuals, following data cleaning. 
To find wounds that are healed at six months with at least four images, it is anticipated 






8. Eligibility Criteria  
This is a retrospective clinical audit of wound healing trajectories collected into a central 
data base through specialized software which records the surface area of each wound that 
is imaged and traced. 
8a. Inclusion criteria  
• Baseline line image of wound with surface area recorded 
• Evidence of wound healed at six months post baseline image 
• Evidence of glycaemic control (HbA1c) around time of wound treatment 
• Recent renal function eGFR related to healing capacity 
• Wound relates to diagnosis of peripheral vascular or neuropathic disease  
 
8b. Exclusion criteria 
• No evidence of a foot wound at baseline 
• Patient has already had another wound recorded in this analysis 
• Patient under 18 years of age 
• Less than four wound images available if wound shown as healed by last image 
• Evidence that the wound has been mislabeled 
• Amputation through course of treatment with no new wound label used 
9. Study Outcomes  
9a. Primary Secondary Outcome 
Documented evidence of time to heal can assist with podiatrist time allocation and also 
awareness by managers and administrators as to need for ongoing treatment beyond 
what has been documented as normal through published randomised controlled trial 
(RCT) papers.  
9b. Secondary Outcome 
Through the identification of fast and slow healing wounds, a sub group of patients may 
be identified, who show clear wound healing trajectories after initial high risk foot clinic. 
This sub-group may be managed in primary care. 
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10. Study Procedures  
10a. Recruitment of participants 
Participants will be selected from a secure database linked with the specific wound 
imaging software. 
10b. Study procedure  
1. Super-user will access secure server for Silhouette wound metric data storage. 
2. Wound metrics for three year period filtered n=~4500 
3. Wounds healed at six months identified and colour coded n=~3000 
4. Of the wounds healed at six months n=~1000n 
a. wound identified with at least four images from baseline image 
b. wounds with less than four images but healed by last image included into 
“fast” healing group. 
5. Wounds selected  – one per individual national health identifier/patient                            
n=~120. 
6. Images examined to ensure images are from the same wound and below the ankle. 
7. Individual glycaemic and renal health indicators collected for each patient through e-
health records from as close to time of wound image. 
8. Identification of diabetic foot wound etiology ie. Peripheral neuropathy or peripheral 
vascular disease through podiatry records. 
9. Associated demographics collected i.e. Patient age, sex, ethnicity, type of diabetes 
identified through diabetes centre e-health records. 
10. Individual patient identifiers replaced with a non-identifying primary number, with 
an associated key kept by the researcher and stored electronically within a password 
protected file. 
11. Examine date difference from baseline image to each consecutive image recorded for 
collective comparison. 
12. Determine wound area change from baseline as a percentage calculated at each 
image time point. 
10c. Measurement tools used  
• ARANZ medical Silhouette™ 3-D wound imaging camera and associated software. 




11. Statistical Considerations and Data Analysis 
Following discussion with Professor Christopher Frampton, biostatistician, University of 
Otago, Christchurch, the wound metric data, dimension and changes in dimension, will be 
analysed using independent T tests between male and female, those with T1DM and 
T2DM,  PVD and DPN,  and intervention vs no intervention. From first wound image 
captured, linear regression analysis of the wound healing trajectories at 28 days, to the 
outcomes at six months, will show if healed wounds did show signs of healing at this 
earlier time. Results will be reported with tables and figures. 
Quantitative data reliability is regulated by patients being selected from a pre-populated 
appointment list using patient national health identifiers (NHI) which are unique to them. 
The four podiatrists working within the high-risk foot clinic have agreed standard 
operating procedures to follow with regard to wound tracing parameters to ensure 
consistency and accuracy. Often the same podiatrist sees the same patient consecutively 
to aid in consistency.  
The decision to analyse a sample size of 100 wounds is not based on formal statistical 
criteria, but allows for sub-grouping of wound types and patients for comparison and is 
in keeping with published data in this field. 
 
12. Ethical Considerations  
The researcher will adhere to the International Conference on Harmonisation Code of 
Good Clinical Practice (Cingi, 2016). 
This research is an outcome analysis clinical audit that is closely connected to the purpose 
for which the information was originally collected. The attending podiatrists and diabetes 
clinicians consider that this clinical audit could reasonably be assumed to be within the 
expectations of the person from whom data was collected.  
 
13. Outcomes and Significance  
Through the data analysis of over 100 wounds we will show that DFU wounds, whilst not 
showing signs of healing at the usual four weeks, can heal within six months. A 
differentiation will be made between fast and slow healing wounds, providing a better 
understanding of clinical predictors that may pre-determine clinical care requirements. 
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This information can assist with care planning and also validate podiatrists in the long 
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Qualitative protocol                   
Semi structured interview protocol 
Title Patient perspectives of wound imaging device utilised during routine care within a diabetes 
high risk foot ulcer podiatry clinic 
Study Investigators: 
Principal Investigator: Helen Heenan1,2 
Co Investigator:  Associate Professor Helen Lunt1 
Co investigator:  Associate Professor Philippa Seaton2 
1. Diabetes Centre, Canterbury District Health Board 
2. University of Otago, Christchurch campus 
Introduction 
Wound imaging and associated wound metrics such as surface area, are used within a specialised clinic 
setting. This allows for capture and recording of wound healing trajectories, within the diabetes high 
risk foot ulcer (DFU) clinic, whose core clinical team consists of a small number of specialised 
podiatrists. This team has had internal discussions about standardisation of process and as such there 
is a high level of consistency and accuracy with regard to wound area tracing of imaged wounds within 
routine clinical workflow.  
The primary aims of this study are to gain and understanding:  i) from the patient’s perspective 
regarding the utility of e-imaging, ii) of the possible effects of using this technology on patient’s 
treatment understanding and also iii) of the potential to enhance their sense of involvement in their 
wound care. 
In subsequent sections of this protocol, use of the term ‘wound imaging’ should be read as ‘wound 
imaging and associated metrics’.  
 
Through the use of semi-structured interviews, we hope to survey responses from approximately thirty 
patients regarding the use of wound imaging. Current patients attending the DFU clinic will first be 
assessed by their specialist diabetes podiatrist regarding suitability to participate. The interviews will 
be conducted at the Diabetes Centre or over the phone, depending on patient preference. Informed 
consent will be gained prior to the interview. The interview will be recorded with an audio device to 
allow for transcription and thematic analysis. The semi structured interview will consist of 





The need for a secondary care multidisciplinary DFU clinic arises from the insidious nature of diabetes 
and the detrimental effects that can occur with the diabetic foot. The specialist diabetes podiatrists 
working within this clinic are required to assess, manage and treat DFU that are likely to be slow to 
heal in a community setting. 
Imaging of wounds has historically been used as an educational tool. The use of multiple images of the 
same wound as a comparison, to assess the rate of healing, has occurred only recently as digital 
technology has matured and become more accessible (Miller et al., 2012).  
The utilisation of electronic imaging to capture the wound and map its healing trajectory allows for 
accurate consecutive data capture. This enables a more accurate indication of the average wound 
healing time. To predict healing of a DFU, by either visual inspection of previous images, or as a more 
sophisticated use of wound measurements enabling numerical documentation of changes to wound 
surface area. Previous studies of wound healing trajectory within the context of DFUs have been in 
research settings, such as randomised control trials (RCTs), not in the real world setting. (Lavery, 
Barnes, et al., 2008).  
Through literature review, there is a paucity of published material describing the perceptions of 
patients around the use of imaging technology and the effects it has had on health literacy and 
understanding. In other disciplines in-clinic imaging has been reported as  giving patients a sense of 
inclusion in their clinical care process, enabling them to feel more involved, enhancing awareness of 
the wound healing state and encouraging concordance with treatment modalities (Entwistle, Brown, 
Morgan, & Skea, 2014). Local clinicians have commented on patients’ interest at being able to view 
their wound images and healing progression, helping with understanding of the need for intervention 
when a wound may become static or show signs of deterioration. La Vela’s patient centred interview 
discusses the benefit of involving the patient in their care (LaVela & Gallan, 2014). We hypothesise that 
similar patient perceptions are present in patients attending the diabetes foot ulcer clinic. Patients 
who can visualise their wound healing progress will be more open to discussion surrounding the need 
for interventions required and will demonstrate this through engagement with clinical 
recommendations. 
Aims 
The primary aims of this study are to gain an understanding: i) from the patient’s perspective regarding 
the utility of e-imaging, ii) of the possible effects of using this technology on patient’s treatment 







Through the sharing of wound images and graphs depicting wound healing or progression, patients 
will have a greater understanding of their wound healing progress.  
 
Study Design 
This is a qualitative study of podiatry patients attending the high risk foot ulcer clinic within secondary 
care, using semi structured interviews, either face to face or over the telephone following obtaining 
full and informed written consent. 
The study will document wound types with regard to non-surgical interventions recommended to 
patients by the podiatrist to aid with healing, such as the limitation of weight bearing, which requires 
understanding and active participation from the patient.  Thematic analysis of pre-determined 
interview question responses will provide an overview of perceptions from a cross section of the 
diabetes population who attend the high risk foot ulcer clinic. 
The design will be based on the NZ Health Quality & Safety Commission survey framework which 
incorporates communication, partnership, coordination along with physical and emotional needs as 
its domains. 
Study setting 
Patients will be recruited from the DFU clinic within the Diabetes Centre.  This is a single centre study. 
Patients will have the opportunity to complete the interview at the Diabetes Centre, Christchurch or 
to answer questions over the phone. Both interview methods will be audio recorded and transcribed. 
Study population 
The majority of patients attending the high-risk foot ulcer clinic have type 1 or type 2 diabetes mellitus. 
The age span is approximately 70 years (15-85 years). Diabetic peripheral neuropathy, peripheral 
vascular disease related to disease progression and sub optimal glycaemic control increases the 
likelihood of requiring specialised treatment through the high-risk foot ulcer clinic. A mix of ethnic 
backgrounds are represented in the population attending this clinic. Cognitive decline and associated 
short term memory loss can partner with diabetes disease progression, along with retinopathy and 
loss of fine motor coordination. This has led to the decision to conduct this survey as an orally 
administered interview, so as to remove difficulties associated with reading, writing and interpretation 








Current patients at Diabetes Centre, high risk foot ulcer clinic. 
Inclusion criteria 
• Over 18 years old 
• Recommended suitability by primary podiatrist 
• Able to process and answer survey questions 
• Current podiatry patient with DFU 
• Diagnosis of diabetes mellitus 
Exclusion criteria 
• Time poor 
• Visually impaired – unable to see wound or computer images 
• Difficulty hearing or processing survey questions 
• Diabetes health professional recommends person not suitable to be approached (for 
example due to patient confidentiality). A reason does not have to be given for individual 
patients. 
• Unable to give fully informed consent as per HDEC criteria of a vulnerable patient 
• Interpreter not available to assist with translation for people who have difficulty 
communicating fluently in English. 
Study Outcome: 
Through thematic analysis of the semi structured interview, a clear understanding of the patient’s 
perspective of the wound imaging. They will show an awareness of the device being used and an 
understanding of its purpose. The patient will show awareness of the images and associated reports 
being available on their e-health records for other health professionals involved in their care to view. 
Through viewing the graphs, populated after each image is traced, they will be aware of the 
progression of healing for their wound. This may help in understanding the need for required 
interventions to assist with healing success. In sharing this information during DFU clinic appointments, 
the patient will feel more involved with their care, which may lead to improved engagement with 










1. Inform podiatry team of upcoming semi structured interviews and convey need for patients 
to be approached by them to remove sense of coercion, as podiatrists involvement is only as 
a third party. 
2. Discuss inclusion/exclusion criteria with podiatry team to assist them in selecting suitable 
patients. 
3. Current podiatry patient appointment lists will be assessed by podiatrists using 
inclusion/exclusion criteria for suitability to approach for semi structured interview, being 
aware of those who may struggle to understand semi structured interview questions, 
whether due to cognitive dysfunction, hearing loss, dysarthria, time constraints or meet 
criteria as a  vulnerable patient. 
4. Podiatrists will invite patients who meet suitability criteria to be involved in 20-30 minute 
interview, assuring them that they must not feel pressured to participate and can decline 
without fear that their clinical care will be affected in any way. 
5. Podiatrists to give names of patients willing to participate to researcher to approach. 
6. Researcher to approach patients to discuss aim of study and requirements of semi structured 
interview with opportunity for patient to ask questions. Patient to be made aware they still 
have the right to decline at any time. 
7. Written informed consent obtained between patient and researcher.  
8. Copy of written consent to be given to patient on day consent is signed. 
9. Arrange suitable time and day with patient to perform semi structured interview, either face 
to face in clinic or over the telephone as per the patient’s preference. 
10. Approximately twelve interview questions (see appendix 1) will be used, to gather patient 
perspective of wound imaging. Interview will be recorded with audio device. Patients will be 
reminded of interview recording prior to start as outlined in patient information and consent 
sheet. 
11. Following patient interview, recording will be transcribed by researcher. Five randomly 
selected interview recordings will be transcribed by an independent administrator to ensure 
accuracy and to further validate the data. 
12. Transcribed interviews will undergo thematic analysis by researcher. 
13. Patient recordings will be assigned a primary number that can not identify them and will be 





Measurement tools used 
• Patient podiatry appointment list 
• Podiatrist knowledge of patients and limitations which may exclude them from participation 
• Semi structured interview questions (appendix 1) 
• Audio recorder for transcription 
• Independent audio transcriber to ensure accuracy and validity 
• Thematic analysis of interview answers 
Patient Safety 
Patient interview recordings will not be stored with any identifiable information on the recording file. 
A key will be held by the researcher to link a primary identification code to the patient national health 
identifier. This key will be kept on the CDHB secure server within a password protected file. 
Throughout thematic analysis, no answers given throughout the interview that could identify an 
individual person will be used. 
Should information given during the patient interview provide concern with regard to patient safety 
this will be followed up with a health professional. The interviewer will inform the patient that this will 
occur. 
 
Sample Size and analysis 
Approximately 50 podiatry patients will be approached to gain their permission to participate in the 
semi structured interviews.  It is envisaged that ~40% of those approached will not meet the inclusion 
criteria or agree to participate. Leaving a sample size of approximately n=30 will allow for a richness of 
diversity of themes across the clinically heterogeneous population to be interviewed. 
Interviews will be transcribed word for word from audio recordings made during the interview process. 
The interview text will be read and categorised into descriptive themes, using the patient’s own words 
where possible. Themes will be compared and discussed amongst investigators to reach a common 
understanding of outcomes. Using a critical realist approach (Archer et al., 2016), it is recognised that 
each patient will have their own individual responses. We will draw on a pragmatic understanding that 
there is no right or wrong answer, but allow for themes to develop as the data is analysed (Hackmann 
et al., 2017).  
Interview results will be analysed by thematic analysis, within each of the four domains set out in the 
New Zealand District Health Board patient experience survey (New Zealand Health Quality & Safety 
Commission, 2013) that incorporate: communication, partnership, coordination along with physical 
and emotional needs. 
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A pilot study of five patients will be undertaken to test the interviewer’s skills, recording device and 
data analysis system before the main study is started to allow for critiquing and improvement of this 
study design. 
Ethical considerations 
The researcher will adhere to the International Conference on Harmonisation Code of Good Clinical 
Practice (Cingi, 2016). As an observational study the risks of physical injury to patients is not a 
consideration. The risk of misuse of patient data, or the identification of someone through their 
answers is understood. All patient data will be de-identified and only the researcher will hold the 
primary key in a secured database. Patient data will be de-identified and reported as a group, not as 
individual data to decrease these risks.  
Informed consent for patient interviews will be collected in a written format, explaining the reason for 
the interview and data collection reasons. Patients will not be coerced into participating in the patient 
centred interview and will be made very aware that declining to participate will not in any way affect 
their ongoing care within the diabetes service. A written poster in the podiatry rooms informs patients 
of the sharing of their wound images and metrics within the patient e-health records. Opportunity is 
given for them to discuss concerns related to the sharing of this information with the podiatry team. 
Due to our diverse podiatry population with people from multiple cultures the Māori diabetes nurse 
specialist along with our Pacific Island diabetes nurse prescriber have been made aware of this 
research, they are both very supportive of these research objectives. 
Significance of research 
Interview results will inform our multidisciplinary team about aspects of care that are important to 
patients and allow insight into what can be developed further. 
 
 
 
 
 
 
 
